<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25138021</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1521-0103</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of pharmacology and experimental therapeutics</Title>
                <ISOAbbreviation>J. Pharmacol. Exp. Ther.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Thrombin inhibition with dabigatran protects against high fat diet-induced fatty liver disease in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">jpet.114.218545</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome. Robust coagulation cascade activation is common in obese patients with NAFLD. We identified a critical temporal relationship between thrombin generation and the manifestation of hepatic steatosis, inflammation and injury in C57BL/6J mice fed a high fat diet (HFD) for 1, 2 and 3 months. Mice fed a HFD exhibited dramatic increases in hepatocellular injury and inflammation over time. Hepatic fibrin deposition preceded an increase in serum alanine aminotransferase, and the most dramatic changes in liver histopathology occurred in conjunction with a detectable increase in plasma thrombin-antithrombin levels at 3 months. To directly determine whether thrombin activity promotes NAFLD pathogenesis, mice were fed a HFD and simultaneously treated with the direct thrombin inhibitor dabigatran etexilate for 3 months. Notably, dabigatran treatment significantly reduced hepatic fibrin deposition, hepatic inflammation, hepatocellular injury and steatosis in mice fed a HFD. Of interest, dabigatran treatment also significantly attenuated HFD-induced body weight gain. Gene expression analysis suggested that thrombin potentially drives NAFLD pathogenesis by altering the expression of genes associated with lipid metabolism and bile acid synthesis. Collectively, the results suggest that thrombin activity is central to HFD-induced body weight gain, liver injury and inflammation, and provide the proof-of-principle evidence that pharmacological thrombin inhibition could be effective in limiting NAFLD and associated pathologies.</AbstractText>
                <CopyrightInformation>The American Society for Pharmacology and Experimental Therapeutics.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Kopec</LastName>
                    <ForeName>Anna K</ForeName>
                    <Initials>AK</Initials>
                    <Affiliation>Michigan State University;</Affiliation>
                </Author>
                <Author>
                    <LastName>Joshi</LastName>
                    <ForeName>Nikita</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Michigan State University;</Affiliation>
                </Author>
                <Author>
                    <LastName>Towery</LastName>
                    <ForeName>Keara L</ForeName>
                    <Initials>KL</Initials>
                    <Affiliation>Michigan State University;</Affiliation>
                </Author>
                <Author>
                    <LastName>Kassel</LastName>
                    <ForeName>Karen M</ForeName>
                    <Initials>KM</Initials>
                    <Affiliation>University of Kansas Medical Center;</Affiliation>
                </Author>
                <Author>
                    <LastName>Sullivan</LastName>
                    <ForeName>Bradley P</ForeName>
                    <Initials>BP</Initials>
                    <Affiliation>University of Kansas Medical Center;</Affiliation>
                </Author>
                <Author>
                    <LastName>Flick</LastName>
                    <ForeName>Matthew J</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Cincinnati Children's Hospital.</Affiliation>
                </Author>
                <Author>
                    <LastName>Luyendyk</LastName>
                    <ForeName>James P</ForeName>
                    <Initials>JP</Initials>
                    <Affiliation>Michigan State University; luyendyk@cvm.msu.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Pharmacol Exp Ther</MedlineTA>
            <NlmUniqueID>0376362</NlmUniqueID>
            <ISSNLinking>0022-3565</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">inflammation</Keyword>
            <Keyword MajorTopicYN="N">liver disease</Keyword>
            <Keyword MajorTopicYN="N">liver injury</Keyword>
            <Keyword MajorTopicYN="N">obesity</Keyword>
            <Keyword MajorTopicYN="N">thrombin/PAR</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">jpet.114.218545</ArticleId>
            <ArticleId IdType="doi">10.1124/jpet.114.218545</ArticleId>
            <ArticleId IdType="pubmed">25138021</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25138017</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0023</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cytokine</Title>
                <ISOAbbreviation>Cytokine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Interleukin-28A enhances autoimmune disease in a retinal autoimmunity model.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1043-4666(14)00477-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.cyto.2014.07.252</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Interleukin-28A (IL-28A), a member of type III interferons (IFN-??s), promotes antiviral, antitumor and immune responses. However, its ability to regulate autoimmune diseases is poorly understood. In this study, we examined the effect of IL-28A on retinal antigen-induced experimental autoimmune uveoretinitis (EAU), a mouse model of human T-cell-mediated autoimmune eye disease. We found that administration of IL-28A enhanced EAU scores and autoimmune response parameters including delayed-type hypersensitivity (DTH), Ag-specific T cell proliferation and the production of Ag-specific IL-17 and IFN-?? in the priming phase. The effect of IL-28A was abrogated by administration of a neutralizing antibody against IL-28A. Our results suggest that IL-28A is capable of exacerbating a T-cell-mediated autoimmune disease. Thus, targeting IL-28A may provide a new therapeutic approach to T cell-mediated autoimmune diseases such as uveitis.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ren</LastName>
                    <ForeName>Xiangrong</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>The State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhou</LastName>
                    <ForeName>Hongyan</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>The State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Xialin</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>The State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Su</LastName>
                    <ForeName>Shao Bo</ForeName>
                    <Initials>SB</Initials>
                    <Affiliation>The State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China. Electronic address: sushaobo7836@gmail.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cytokine</MedlineTA>
            <NlmUniqueID>9005353</NlmUniqueID>
            <ISSNLinking>1043-4666</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Autoimmune disease</Keyword>
            <Keyword MajorTopicYN="N">Type III interferon</Keyword>
            <Keyword MajorTopicYN="N">Uveitis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1043-4666(14)00477-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cyto.2014.07.252</ArticleId>
            <ArticleId IdType="pubmed">25138017</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25138015</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0023</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cytokine</Title>
                <ISOAbbreviation>Cytokine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Development of a cytokine-producing immortalized murine Kupffer cell line.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1043-4666(14)00476-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.cyto.2014.07.251</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Kupffer cells (KC) play a critical role in both liver physiology and the pathogenesis of various liver diseases. Isolated primary KC have a limited lifespan in culture, and due to the relatively low number obtained, limit their study in vitro. Here, a cytokine-producing immortalized KC (ImKC) line was established from transgenic mice that express the thermolabile mutant tsA58 of the Simian virus 40 large T antigen under the control of the H-2k(b) promoter. Primary KC were obtained using a three step procedure: liver perfusion, centrifugal elutriation, and sorting for F4/80(+) cells. ImKC were identified within the small-intermediate population of KC that maintained stable expression of F4/80, and the surface antigens CD11b, CD14 and TLR4. ImKC grow at IFN??-independent manner at 37??C and exhibited a doubling time of ???24h when cultured in RPMI 1640 with 5% FBS. Our observations indicate that both activation of telomerase and expression of P53 are markedly increased, suggesting that enhanced telomerase activity and P53 expression may contribute to the immortalization of this cell population. ImKC cells maintained a high capacity to phagocytose FITC-latex beads, and bind/phagocytose erythrocytes. In addition, similar to primary KC, ImKC responded to stimulation with lipopolysaccharide (LPS: 0.1-1??g/ml) by upregulating mRNA levels of TNF?? (23-fold), IL-6 (28-fold), and IL-1?? (1459-fold), as measured by qRT-PCR. Protein levels of TNF?? and IL-6 were also increased, 10-fold and 12-fold, respectively. Reactive oxygen species (ROS) and nitric oxide (NO) production were significantly enhanced in ImKC following an LPS challenge. Furthermore, LPS elicited a marked increase in mitogen activated protein kinase (MAPK) phospho-(ERK1/2, JNK) and NF-??B p50 with decreased I??B?? in ImKC, as assessed by Western blot. Collectively, these results demonstrate that the ImKC line retains critical characteristics of primary KC, and thus provides a useful tool to assess the role of KC in liver injury and chronic diseases.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Zheng-Yu</ForeName>
                    <Initials>ZY</Initials>
                    <Affiliation>Department of Surgery, Indiana University School of Medicine, MS B005, 635 Barnhill Dr., Indianapolis, IN 46202, United States. Electronic address: zywang@iupui.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Burlak</LastName>
                    <ForeName>Christopher</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Surgery, Indiana University School of Medicine, MS B005, 635 Barnhill Dr., Indianapolis, IN 46202, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Klaunig</LastName>
                    <ForeName>James E</ForeName>
                    <Initials>JE</Initials>
                    <Affiliation>Department of Environmental Health, Indiana University School of Public Health, 925 E 7th, Bloomington, IN 47405, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kamendulis</LastName>
                    <ForeName>Lisa M</ForeName>
                    <Initials>LM</Initials>
                    <Affiliation>Department of Environmental Health, Indiana University School of Public Health, 925 E 7th, Bloomington, IN 47405, United States.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cytokine</MedlineTA>
            <NlmUniqueID>9005353</NlmUniqueID>
            <ISSNLinking>1043-4666</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cell immortalization</Keyword>
            <Keyword MajorTopicYN="N">Cytokine</Keyword>
            <Keyword MajorTopicYN="N">Kupffer cell</Keyword>
            <Keyword MajorTopicYN="N">Mouse</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1043-4666(14)00476-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cyto.2014.07.251</ArticleId>
            <ArticleId IdType="pubmed">25138015</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">25137914</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0023-2157</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>116</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Klinika oczna</Title>
                <ISOAbbreviation>Klin Oczna</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In vivo imaging of the mouse retina using high-resolution optical coherence tomography.</ArticleTitle>
            <Pagination>
                <MedlinePgn>11-5</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">In this study, we demonstrate the advantages of high-resolution optical coherence tomography for the non-invasive, in vivo, three-dimensional imaging of the mouse retina.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">High-resolution optical coherence tomography images of the mouse retina were acquired using the Bioptigen Envisu R2200-HR SD-OCT system. We measured the retinal thickness and compared the measurements to those obtained using conventional histology techniques.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">High-resolution spectral-domain optical coherence tomography enables high-quality in vivo visualization of retinal structures in mice, providing an accurate quantitative description of retinal layers. Additionally, the ultra-high-speed system offers many advantages over histology, e.g., it permits the visualization of retinal microvasculature and pulsatile flow dynamics.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Spectral domain optical coherence tomography is a new important tool for the in vivo analysis of mouse eyes.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Machali??ska</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lejkowska</LastName>
                    <ForeName>Renata</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duchnik</LastName>
                    <ForeName>Micha??</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rogi??ska</LastName>
                    <ForeName>Dorota</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kawa</LastName>
                    <ForeName>Mi??osz</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wiszniewska</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
                <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Poland</Country>
            <MedlineTA>Klin Oczna</MedlineTA>
            <NlmUniqueID>0376614</NlmUniqueID>
            <ISSNLinking>0023-2157</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25137914</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">25137854</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1003-5370</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>34</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban</Title>
                <ISOAbbreviation>Zhongguo Zhong Xi Yi Jie He Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Roles of TRPV1 receptor in electroacupuncture regulating the jejunal motility of mice: an experimental study].</ArticleTitle>
            <Pagination>
                <MedlinePgn>859-63</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To observe the intestinal movement of transient receptor potential vanilloid 1 or vanilloid receptor 1 (TRPV1) knockout mice after stimulated by electroacupuncture (EA), and to primarily explore the roles of TRPV1 receptor in the jejunal motility regulated by acupuncture.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Normal wild-type CL57BL/6 and TRPV1 gene knockout mice were recruited in two groups, the B6 group and the TRPV1 group, 15 in each group. The thermal threshold and the mechanical pain threshold were respectively detected using JL-F digital photo thermal analyzer instrument and ALMEMO2450 machine. The difference between the two thresholds were compared. Meanwhile, a self-made pressure head was placed in the jejunum. The internal pressure was monitored. When the pressure was stable, 2 mA 2/15 Hz EA at Quchi (LI11), Tianshu (ST25), Shangjuxu (ST37), and Dachangshu (BL25) to observe the changes of intestinal pressure value between before and after EA. The curve of internal pressures was recorded.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">(1) The stimulation of light/heat and mechanical stimulation were obviously slowed in the TRPV1 group than in the B6 group (P &lt; 0.01). (2) In the intestinal pressure observation experiment, the bowel movement was not obviously seen in the two groups when acupunctured at Quchi (LI11) and Shangjuxu (ST37) (P &gt; 0.05). (3) Acupuncture at Tianshu (ST25) and Dachangshu (BL25) of TRPV1 knockout mice could lead to intestinal movement (P &lt; 0.05), mainly inhibited bowel movement. The changing degree was equivalent to that of B6 mice.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Under the physiological condition, TRPV1 might be mediated by thermal and mechanical stimulation. But TRPV1 mediated acupuncture effect was quite complex, indicating TRPV1 mice might be one of intestinal movement mediating factors.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>Hong</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Zhi</ForeName>
                    <Initials>Z</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Bin</ForeName>
                    <Initials>B</Initials>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType>English Abstract</PublicationType>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhongguo Zhong Xi Yi Jie He Za Zhi</MedlineTA>
            <NlmUniqueID>9211576</NlmUniqueID>
            <ISSNLinking>1003-5370</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25137854</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">25137853</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1003-5370</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>34</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban</Title>
                <ISOAbbreviation>Zhongguo Zhong Xi Yi Jie He Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Effect of Mudan Granule on islets beta cell function in monosodium glutamate induced obese mice with insulin resistance: an experimental study].</ArticleTitle>
            <Pagination>
                <MedlinePgn>853-8</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the effect of Mudan Granule (MD) on the glucose metabolism and beta cell function in monosodium glutamate (MSG) induced obese mice with insulin resistance (IR).</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">MSG obese mice were induced by subcutaneous injecting MSG (4 g/kg for 7 successive days in neonatal ICR mice). Forty MSG mice with IR features were recruited and divided into four groups according to body weight, fasting blood glucose, triglyceride (TG), total cholesterol (TC), and the percentage of blood glucose decreased within 40 min in the IR test, i.e., the model group (Con), the low dose MD group, the high dose MD group, and the Metformin group (Met). Besides, another 10 ICR mice were recruited as the normal control group (Nor). The water solvent of 2.5 g/kg MD or 5 g/kg MD was respectively administered to mice in the low dose MD group and the high dose MD group. Metformin hydrochloride was given to mice in the Met group at 0.2 g/kg body weight. Equal dose solvent distilled water was administered to mice in the Nor group and the Con group by gastrogavage, once per day. All medication was lasted for 15 weeks. Insulin tolerance test (ITT) and oral glucose tolerance test (OGTT) were performed after 6 weeks of treatment. Beta cell function was assessed by hyperglycemic clamp technique. The morphological changes in the pancreas were evaluated by hematoxylin-eosin (HE) staining. Changes of iNOS, NF-kappaB p65, and p-NF-kappaB p65 in the pancreas were tested.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with the Nor group, the blood glucose level, AUC, and fasting blood insulin, ONOO-contents, iNOS activities, and the expression of iNOS, NF-kappaB p65 subunit, pNF-kappaB p65 subunit obviously increased; decreased percentage of blood glucose within 40 min in ITT, glucose infusion rate (GIR), Clamp 1 min insulin, and Max-Insulin obviously decreased in the Con group (P &lt; 0.05, P &lt; 0.01). Compared with the Con group, the aforesaid indices could be improved in the Met group (P &lt; 0.05, P &lt; 0.01). In the low dose MD group, AUC, iNOS activities, and the expression of iNOS and p-NF-kappaB p65 subunit obviously decreased; percentage of blood glucose within 40 min in ITT and GIR obviously increased (P &lt; 0.05, P &lt; 0.01). In the high dose MD group, AUC, ONOO-contents, iNOS activities, and the expression of iNOS, NF-kappaB p65 subunit, and p-NF-KB p65 subunit obviously decreased; percentage of blood glucose within 40 min in ITT, Max-Insulin, and GIR obviously increased (P &lt; 0.05, P &lt; 0.01).</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MD could significantly improve IR and functional disorder of 3 cells in MSG obese mice, which might be associated with lowering inflammatory reaction in the pancreas.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Shuai-Nan</ForeName>
                    <Initials>SN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Su-Juan</ForeName>
                    <Initials>SJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Quan</ForeName>
                    <Initials>Q</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hou</LastName>
                    <ForeName>Shao-Cong</ForeName>
                    <Initials>SC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>Zhu-Fang</ForeName>
                    <Initials>ZF</Initials>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType>English Abstract</PublicationType>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhongguo Zhong Xi Yi Jie He Za Zhi</MedlineTA>
            <NlmUniqueID>9211576</NlmUniqueID>
            <ISSNLinking>1003-5370</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25137853</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137723</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1558-1756</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>IEEE computer graphics and applications</Title>
                <ISOAbbreviation>IEEE Comput Graph Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Visualization Beyond the Desktop - the next big thing.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Visualization is coming of age: with visual depictions being seamlessly integrated into documents and data visualization techniques being used to understand datasets that are ever-growing in size and complexity, the term visualization is becoming used in everyday conversations. But we are on a cusp; visualization researchers need to develop and adapt to today's new devices and tomorrows technology. Today, we are interacting with visual depictions through a mouse. Tomorrow, we will be touching, swiping, grasping, feeling, hearing, smelling and even tasting our data. The next big thing is multi-sensory visualization that goes beyond the desktop.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Roberts</LastName>
                    <ForeName>Jonathan</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Ritsos</LastName>
                    <ForeName>Panagiotis</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Badam</LastName>
                    <ForeName>Sriram Karthik</ForeName>
                    <Initials>SK</Initials>
                </Author>
                <Author>
                    <LastName>Brodbeck</LastName>
                    <ForeName>Dominique</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Kennedy</LastName>
                    <ForeName>Jessie</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Elmqvist</LastName>
                    <ForeName>Niklas</ForeName>
                    <Initials>N</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>IEEE Comput Graph Appl</MedlineTA>
            <NlmUniqueID>9881869</NlmUniqueID>
            <ISSNLinking>0272-1716</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1109/MCG.2014.82</ArticleId>
            <ArticleId IdType="pubmed">25137723</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137631</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1613-6829</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Small (Weinheim an der Bergstrasse, Germany)</Title>
                <ISOAbbreviation>Small</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Low-Density Lipoprotein-Mimicking Nanoparticles for Tumor-Targeted Theranostic Applications.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/smll.201303277</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">This study introduces multifunctional lipid nanoparticles (LNPs), mimicking the structure and compositions of low-density lipoproteins, for the tumor-targeted co-delivery of anti-cancer drugs and superparamagnetic nanocrystals. Paclitaxel (4.7 wt%) and iron oxide nanocrystals (6.8 wt%, 11 nm in diameter) are co-encapsulated within folate-functionalized LNPs, which contain a cluster of nanocrystals with an overall diameter of about 170 nm and a zeta potential of about -40 mV. The folate-functionalized LNPs enable the targeted detection of MCF-7, human breast adenocarcinoma expressing folate receptors, in T2 -weighted magnetic resonance images as well as the efficient intracellular delivery of paclitaxel. Paclitaxel-free LNPs show no significant cytotoxicity up to 0.2 mg mL(-1) , indicating the excellent biocompatibility of the LNPs for intracellular drug delivery applications. The targeted anti-tumor activities of the LNPs in a mouse tumor model suggest that the low-density lipoprotein-mimetic LNPs can be an effective theranostic platform with excellent biocompatibility for the tumor-targeted co-delivery of various anti-cancer agents.</AbstractText>
                <CopyrightInformation>?? 2014 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Jeong Yu</ForeName>
                    <Initials>JY</Initials>
                    <Affiliation>Department of Materials Science and Engineering, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseung-gu, Daejeon, 305-701, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Jin-Ho</ForeName>
                    <Initials>JH</Initials>
                </Author>
                <Author>
                    <LastName>Bae</LastName>
                    <ForeName>Ki Hyun</ForeName>
                    <Initials>KH</Initials>
                </Author>
                <Author>
                    <LastName>Oh</LastName>
                    <ForeName>Mi Hwa</ForeName>
                    <Initials>MH</Initials>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Youngwook</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Jee Seon</ForeName>
                    <Initials>JS</Initials>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Tae Gwan</ForeName>
                    <Initials>TG</Initials>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Keunchil</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Jung Hee</ForeName>
                    <Initials>JH</Initials>
                </Author>
                <Author>
                    <LastName>Nam</LastName>
                    <ForeName>Yoon Sung</ForeName>
                    <Initials>YS</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Small</MedlineTA>
            <NlmUniqueID>101235338</NlmUniqueID>
            <ISSNLinking>1613-6810</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">anti-cancer agents</Keyword>
            <Keyword MajorTopicYN="N">imaging</Keyword>
            <Keyword MajorTopicYN="N">low-density lipoproteins</Keyword>
            <Keyword MajorTopicYN="N">nanoparticles</Keyword>
            <Keyword MajorTopicYN="N">self-assembly</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/smll.201303277</ArticleId>
            <ArticleId IdType="pubmed">25137631</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137629</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1948-7193</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>ACS chemical neuroscience</Title>
                <ISOAbbreviation>ACS Chem Neurosci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Positive allosteric modulators (PAMs) of the M4 muscarinic acetylcholine receptor (mAChR) represent a novel approach for the treatment of psychotic symptoms associated with schizophrenia and other neuropsychiatric disorders. We recently reported that the selective M4 PAM VU0152100 produced an antipsychotic drug-like profile in rodents after amphetamine challenge. Previous studies suggest that enhanced cholinergic activity may also improve cognitive function and reverse deficits observed with reduced signaling through the N-methyl-d-aspartate subtype of the glutamate receptor (NMDAR) in the central nervous system. Prior to this study, the M1 mAChR subtype was viewed as the primary candidate for these actions relative to the other mAChR subtypes. Here we describe the discovery of a novel M4 PAM, VU0467154, with enhanced in vitro potency and improved pharmacokinetic properties relative to other M4 PAMs, enabling a more extensive characterization of M4 actions in rodent models. We used VU0467154 to test the hypothesis that selective potentiation of M4 receptor signaling could ameliorate the behavioral, cognitive, and neurochemical impairments induced by the noncompetitive NMDAR antagonist MK-801. VU0467154 produced a robust dose-dependent reversal of MK-801-induced hyperlocomotion and deficits in preclinical models of associative learning and memory functions, including the touchscreen pairwise visual discrimination task in wild-type mice, but failed to reverse these stimulant-induced deficits in M4 KO mice. VU0467154 also enhanced the acquisition of both contextual and cue-mediated fear conditioning when administered alone in wild-type mice. These novel findings suggest that M4 PAMs may provide a strategy for addressing the more complex affective and cognitive disruptions associated with schizophrenia and other neuropsychiatric disorders.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Bubser</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Pharmacology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bridges</LastName>
                    <ForeName>Thomas M</ForeName>
                    <Initials>TM</Initials>
                </Author>
                <Author>
                    <LastName>Dencker</LastName>
                    <ForeName>Ditte</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Gould</LastName>
                    <ForeName>Robert W</ForeName>
                    <Initials>RW</Initials>
                </Author>
                <Author>
                    <LastName>Grannan</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Noetzel</LastName>
                    <ForeName>Meredith J</ForeName>
                    <Initials>MJ</Initials>
                </Author>
                <Author>
                    <LastName>Lamsal</LastName>
                    <ForeName>Atin</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Niswender</LastName>
                    <ForeName>Colleen M</ForeName>
                    <Initials>CM</Initials>
                </Author>
                <Author>
                    <LastName>Daniels</LastName>
                    <ForeName>J Scott</ForeName>
                    <Initials>JS</Initials>
                </Author>
                <Author>
                    <LastName>Poslusney</LastName>
                    <ForeName>Michael S</ForeName>
                    <Initials>MS</Initials>
                </Author>
                <Author>
                    <LastName>Melancon</LastName>
                    <ForeName>Bruce J</ForeName>
                    <Initials>BJ</Initials>
                </Author>
                <Author>
                    <LastName>Tarr</LastName>
                    <ForeName>James C</ForeName>
                    <Initials>JC</Initials>
                </Author>
                <Author>
                    <LastName>Byers</LastName>
                    <ForeName>Frank W</ForeName>
                    <Initials>FW</Initials>
                </Author>
                <Author>
                    <LastName>Wess</LastName>
                    <ForeName>J??rgen</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Duggan</LastName>
                    <ForeName>Mark E</ForeName>
                    <Initials>ME</Initials>
                </Author>
                <Author>
                    <LastName>Dunlop</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Wood</LastName>
                    <ForeName>Michael W</ForeName>
                    <Initials>MW</Initials>
                </Author>
                <Author>
                    <LastName>Brandon</LastName>
                    <ForeName>Nicholas J</ForeName>
                    <Initials>NJ</Initials>
                </Author>
                <Author>
                    <LastName>Wood</LastName>
                    <ForeName>Michael R</ForeName>
                    <Initials>MR</Initials>
                </Author>
                <Author>
                    <LastName>Lindsley</LastName>
                    <ForeName>Craig W</ForeName>
                    <Initials>CW</Initials>
                </Author>
                <Author>
                    <LastName>Conn</LastName>
                    <ForeName>P Jeffrey</ForeName>
                    <Initials>PJ</Initials>
                </Author>
                <Author>
                    <LastName>Jones</LastName>
                    <ForeName>Carrie K</ForeName>
                    <Initials>CK</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>ACS Chem Neurosci</MedlineTA>
            <NlmUniqueID>101525337</NlmUniqueID>
            <ISSNLinking>1948-7193</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/cn500128b</ArticleId>
            <ArticleId IdType="pubmed">25137629</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137620</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1520-5010</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Chemical research in toxicology</Title>
                <ISOAbbreviation>Chem. Res. Toxicol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Organophosphorus Pesticide Chlorpyrifos and its Metabolites Alter the Expression of Biomarker Genes of Differentiation in D3 Mouse Embryonic Stem Cells in a Comparable Way to Other Model Neurodevelopmental Toxicants.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">There are discrepancies about whether chlorpyrifos is able to induce neurodevelopmental toxicity or not. We previously reported alterations in the pattern of expression of biomarker genes of differentiation in D3 mouse embryonic stem cells caused by chlorpyrifos and its metabolites chlorpyrifos-oxon and 3,5,6-trichloro-2-pyridinol. Now, we reanalyze these data comparing the effects on these genes with those caused in the same genes by retinoic acid, valproic acid and penicillin-G (model compounds considered as strong, weak and non-neurodevelopmental toxicants, respectively). We also compare the effects of chlorpyrifos and its metabolites on cell viability of D3 cells and 3T3 mouse fibroblasts with the effects caused in the same cells by the three model compounds. We conclude that chlorpyrifos and its metabolites act, regarding these end-points, as the weak neurodevelopmental toxicant valproic acid and consequently a principle of caution should be applied avoiding occupational exposures in pregnant women. A second independent experiment run with different cellular batches coming from the same clone obtained the same result as the first one.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Estevan</LastName>
                    <ForeName>Carmen</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Fuster</LastName>
                    <ForeName>Encarnaci??n</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Del R??o</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Pamies</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Vilanova</LastName>
                    <ForeName>Eugenio</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Sogorb</LastName>
                    <ForeName>Miguel A</ForeName>
                    <Initials>MA</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Chem Res Toxicol</MedlineTA>
            <NlmUniqueID>8807448</NlmUniqueID>
            <ISSNLinking>0893-228X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/tx500051k</ArticleId>
            <ArticleId IdType="pubmed">25137620</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137562</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1759-507X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature reviews. Nephrology</Title>
                <ISOAbbreviation>Nat Rev Nephrol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Translational research in ADPKD: lessons from animal models.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/nrneph.2014.137</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in PKD1 or PKD2, which encode polycystin-1 and polycystin-2, respectively. Rodent models are available to study the pathogenesis of polycystic kidney disease (PKD) and for preclinical testing of potential therapies-either genetically engineered models carrying mutations in Pkd1 or Pkd2 or models of renal cystic disease that do not have mutations in these genes. The models are characterized by age at onset of disease, rate of disease progression, the affected nephron segment, the number of affected nephrons, synchronized or unsynchronized cyst formation and the extent of fibrosis and inflammation. Mouse models have provided valuable mechanistic insights into the pathogenesis of PKD; for example, mutated Pkd1 or Pkd2 cause renal cysts but additional factors are also required, and the rate of cyst formation is increased in the presence of renal injury. Animal studies have also revealed complex genetic and functional interactions among various genes and proteins associated with PKD. Here, we provide an update on the preclinical models commonly used to study the molecular pathogenesis of ADPKD and test potential therapeutic strategies. Progress made in understanding the pathophysiology of human ADPKD through these animal models is also discussed.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Happ??</LastName>
                    <ForeName>Hester</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Human Genetics, Leiden University Medical Center, S4-P, PO Box 9600, Albinusdreef 2, Leiden, 2333 ZA Leiden, Netherlands.</Affiliation>
                </Author>
                <Author>
                    <LastName>Peters</LastName>
                    <ForeName>Dorien J M</ForeName>
                    <Initials>DJ</Initials>
                    <Affiliation>Department of Human Genetics, Leiden University Medical Center, S4-P, PO Box 9600, Albinusdreef 2, Leiden, 2333 ZA Leiden, Netherlands.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Nat Rev Nephrol</MedlineTA>
            <NlmUniqueID>101500081</NlmUniqueID>
            <ISSNLinking>1759-5061</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">nrneph.2014.137</ArticleId>
            <ArticleId IdType="doi">10.1038/nrneph.2014.137</ArticleId>
            <ArticleId IdType="pubmed">25137562</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137549</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1520-4804</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medicinal chemistry</Title>
                <ISOAbbreviation>J. Med. Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">New antimalarial agents that exhibit multi-stage activities against drug-resistant strains of malaria parasites represent good starting points for developing next generation antimalarial therapies. To facilitate the progression of such agents into the development phase, we developed an image-based parasitological screening method for defining drug effects on different asexual life cycle stages of P. falciparum. High-throughput screening of a newly assembled diversity-oriented synthetic library using this approach led to the identification of carbohybrid-based 2-aminopyrimidine compounds with fast-acting growth inhibitory activities against three laboratory strains of multidrug resistant P. falciparum. Our structure-activity relationship study led to the identification of two derivatives (8aA and 11aA) as the most promising antimalarial candidates (mean EC50 of 0.130 and 0.096 ??M against all three P. falciparum strains, selectivity indices &gt;600, microsomal stabilities &gt;80%, and mouse malaria ED50 values of 0.32 and 0.12 mg/kg/day, respectively) targeting all major blood stages of multi-drug-resistant P. falciparum parasites.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Sukjun</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Lim</LastName>
                    <ForeName>Donghyun</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Eunyoung</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Nakyung</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Hong-Gun</ForeName>
                    <Initials>HG</Initials>
                </Author>
                <Author>
                    <LastName>Cechetto</LastName>
                    <ForeName>Jonathan</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Liuzzi</LastName>
                    <ForeName>Michel</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Freitas-Junior</LastName>
                    <ForeName>Lucio H</ForeName>
                    <Initials>LH</Initials>
                </Author>
                <Author>
                    <LastName>Song</LastName>
                    <ForeName>Jin Sook</ForeName>
                    <Initials>JS</Initials>
                </Author>
                <Author>
                    <LastName>Bae</LastName>
                    <ForeName>Myung Ae</ForeName>
                    <Initials>MA</Initials>
                </Author>
                <Author>
                    <LastName>Oh</LastName>
                    <ForeName>Sangmi</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Ayong</LastName>
                    <ForeName>Lawrence</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Seung Bum</ForeName>
                    <Initials>SB</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Med Chem</MedlineTA>
            <NlmUniqueID>9716531</NlmUniqueID>
            <ISSNLinking>0022-2623</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jm5009693</ArticleId>
            <ArticleId IdType="pubmed">25137549</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137525</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>25</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1944-8252</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>ACS applied materials &amp; interfaces</Title>
                <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Surface-Initiated Hyperbranched Polyglycerol as an Ultralow-Fouling Coating on Glass, Silicon, and Porous Silicon Substrates.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Anionic ring-opening polymerization of glycidol was initiated from activated glass, silicon, and porous silicon substrates to yield thin, ultralow-fouling hyperbranched polyglycerol (HPG) graft polymer coatings. Substrates were activated by deprotonation of surface-bound silanol functionalities. HPG polymerization was initiated upon the addition of freshly distilled glycidol to yield films in the nanometer thickness range. X-ray photoelectron spectroscopy, contact angle measurements, and ellipsometry were used to characterize the resulting coatings. The antifouling properties of HPG-coated surfaces were evaluated in terms of protein adsorption and the attachment of mammalian cells. The adsorption of bovine serum albumin and collagen type I was found to be reduced by as much as 97 and 91%, respectively, in comparison to untreated surfaces. Human glioblastoma and mouse fibroblast attachment was reduced by 99 and 98%, respectively. HPG-grafted substrates outperformed polyethylene glycol (PEG) grafted substrates of comparable thickness under the same incubation conditions. Our results demonstrate the effectiveness of antifouling HPG graft polymer coatings on a selected range of substrate materials and open the door for their use in biomedical applications.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Moore</LastName>
                    <ForeName>Eli</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Mawson Institute, University of South Australia , GPO Box 2471, Adelaide, South Australia 5001, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Delalat</LastName>
                    <ForeName>Bahman</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Vasani</LastName>
                    <ForeName>Roshan</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>McPhee</LastName>
                    <ForeName>Gordon</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Thissen</LastName>
                    <ForeName>Helmut</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Voelcker</LastName>
                    <ForeName>Nicolas H</ForeName>
                    <Initials>NH</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
            <NlmUniqueID>101504991</NlmUniqueID>
            <ISSNLinking>1944-8244</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/am503570v</ArticleId>
            <ArticleId IdType="pubmed">25137525</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137423</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1945-7197</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of clinical endocrinology and metabolism</Title>
                <ISOAbbreviation>J. Clin. Endocrinol. Metab.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Elevated FGF21 Leads to Attenuated Postnatal Linear Growth in Preterm Infants Through GH Resistance in Chondrocytes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>jc20141566</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Context: The hormone fibroblast growth factor 21 (FGF21) is a key metabolic regulator in the adaptation to fasting. In food-restricted mice, inhibition of skeletal growth is mediated by the antagonistic effect of FGF21 on GH action in the liver and growth plate. Objective: The objective of the study was to assess the role of FGF21 in growth regulation in humans using postnatal growth failure of very preterm infants as a model. Design: FGF21 levels were measured serially in very preterm infants, and their linear growth evaluated from birth to term-equivalent age. Primary chondrocytes obtained from pediatric donors were used to test whether FGF21 can directly interfere with GH signaling. Results: A negative association (?? -.415, P &lt; .005, linear regression model) of FGF21 levels with the change in SD score for length was found. In primary chondrocytes, FGF21 upregulated basal and GH-induced SOCS2 expression and inhibited GH-induced STAT5 phosphorylation as well as GH-induced COLII and ALP expression. Finally, FGF21 inhibited GH-induced IGF-1 expression and cell proliferation, indicating GH resistance. However, FGF21 did not affect IGF-1-induced cell proliferation. Conclusions: Elevated FGF21 serum levels during the first weeks of life are independently associated with postnatal growth failure in preterm infants. Furthermore, our data provide mechanistic insights into GH resistance secondary to prematurity and may offer an explanation for the growth failure commonly seen in chronic conditions of childhood.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Guasti</LastName>
                    <ForeName>Leonardo</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Centre for Endocrinology (L.G., L.D.), William Harvey Research Institute, Barts and the London, Queen Mary University of London, London EC1M 6BQ, United Kingdom; Department of Pediatrics (S.S., U.S.), Kuopio University Hospital, Kuopio, Finland; Department of Plastic Surgery (N.W.B.), Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom; and Developmental Biology Unit (P.F.), University College London Institute of Child Health, London, United Kingdom.</Affiliation>
                </Author>
                <Author>
                    <LastName>Silvennoinen</LastName>
                    <ForeName>Sanna</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Bulstrode</LastName>
                    <ForeName>Neil W</ForeName>
                    <Initials>NW</Initials>
                </Author>
                <Author>
                    <LastName>Ferretti</LastName>
                    <ForeName>Patrizia</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Sankilampi</LastName>
                    <ForeName>Ulla</ForeName>
                    <Initials>U</Initials>
                </Author>
                <Author>
                    <LastName>Dunkel</LastName>
                    <ForeName>Leo</ForeName>
                    <Initials>L</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Clin Endocrinol Metab</MedlineTA>
            <NlmUniqueID>0375362</NlmUniqueID>
            <ISSNLinking>0021-972X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2014-1566</ArticleId>
            <ArticleId IdType="pubmed">25137423</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137396</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1535-4989</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of respiratory cell and molecular biology</Title>
                <ISOAbbreviation>Am. J. Respir. Cell Mol. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Wood Smoke Enhances Cigarette Smoke-Induced Inflammation by Inducing the Aryl Hydrocarbon Receptor Repressor in Airway Epithelial Cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Our previous studies showed that cigarette smokers who are exposed to wood smoke (WS) are at an increased risk for chronic bronchitis and reduced lung function. The present study was to determine the mechanisms for WS-induced adverse effects. We studied the effect of wood smoke exposure using 4 cohorts of mice. C57Bl/6 were exposed for 4 or 12 wk to filtered air (FA), to 10 mg/m3 wood smoke (WS) for 2h/d, to 250 mg/m3 cigarette smoke (CS) for 6 h/d, or to CS followed by WS (CW). Inflammation was absent in the FA and WS groups, but enhanced by 2-fold in the bronchoalveolar lavage (BAL) of the CW compared to CS group as measured by neutrophil numbers and levels of the neutrophil chemoattractant, KC. The levels of the anti-inflammatory lipoxin, LXA4, were reduced by 3-fold along with COX-2 and mPGES-1 in airway epithelial cells and PGE2 levels in the BAL of CW compared to CS mice. We replicated in primary human airway epithelial cells (HAECs) the changes observed in mice. Immunoprecipitations showed that WS blocked the interaction of AHR with ARNT to reduce expression of COX-2 and mPGES-1 by increasing expression of AHR repressor (AHRR). Collectively, these studies showed that exposure to low concentrations of WS enhanced CS-induced inflammation by inducing AHRR expression to suppress AHR, COX-2, and mPGES-1 expression, and levels of PGE2 and LXA4. Therefore, AHRR is a potential therapeutic target for wood smoke-associated exacerbations of CS-induced inflammation.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Awji</LastName>
                    <ForeName>Elias G</ForeName>
                    <Initials>EG</Initials>
                    <Affiliation>Lovelace Respiratory Research Institute, COPD Program, Albuqueque, New Mexico, United States ; eawji@lrri.org.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chand</LastName>
                    <ForeName>Hitendra</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Bruse</LastName>
                    <ForeName>Shannon</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Smith</LastName>
                    <ForeName>Kevin R</ForeName>
                    <Initials>KR</Initials>
                </Author>
                <Author>
                    <LastName>Colby</LastName>
                    <ForeName>Jennifer K</ForeName>
                    <Initials>JK</Initials>
                </Author>
                <Author>
                    <LastName>Mebratu</LastName>
                    <ForeName>Yohannes</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Levy</LastName>
                    <ForeName>Bruce D</ForeName>
                    <Initials>BD</Initials>
                </Author>
                <Author>
                    <LastName>Tesfaigzi</LastName>
                    <ForeName>Yohannes</ForeName>
                    <Initials>Y</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Am J Respir Cell Mol Biol</MedlineTA>
            <NlmUniqueID>8917225</NlmUniqueID>
            <ISSNLinking>1044-1549</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">air pollution</Keyword>
            <Keyword MajorTopicYN="N">arachidonic acid pathway</Keyword>
            <Keyword MajorTopicYN="N">exacerbation</Keyword>
            <Keyword MajorTopicYN="N">lipoxin</Keyword>
            <Keyword MajorTopicYN="N">neutrophilic inflammation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2014-0142OC</ArticleId>
            <ArticleId IdType="pubmed">25137396</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137390</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1470-8728</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Biochemical journal</Title>
                <ISOAbbreviation>Biochem. J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Crystal structure of the mouse interleukin-3 ??-receptor: insights into interleukin???3 binding and receptor activation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Interleukin-3 (IL-3) is a cytokine secreted by mast cells and activated T-cells known to be an important regulator of differentiation, survival, proliferation and activation of a range of hematopoietic lineages. The effects of IL-3 on target cells are mediated by a transmembrane receptor system composed of a cytokine-specific ??-subunit and a ??-subunit, the principal signalling entity. In the mouse, two ??-subunits have co-evolved: a common ??-subunit (??c) shared between IL-3 and the related cytokines, IL-5 and GM-CSF; and an IL-3-specific ??-subunit (??IL-3). ??IL???3 differs from ??c in its specificity for IL-3 and its capacity to bind IL-3 directly in the absence of an ??-subunit and, in the absence of structural information, the basis for these properties has remained enigmatic. Here, we present the crystal structure of the ??IL-3 ectodomain at 3.45 ?? resolution. This structure provides the first evidence that ??IL-3 adopts an arch-shaped, intertwined homodimer with similar topology to the paralogous ??c structure. In contrast to apo-??c, however, the ligand-binding interface of ??IL???3 appears to pre-exist in a conformation receptive to IL-3 engagement. Molecular modelling of the IL-3:??IL???3 interface, in conjunction with previous mutational studies, suggests that divergent evolution of both ??IL???3 and IL-3 underlies their unique capacity for direct interaction and specificity.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Carr</LastName>
                    <ForeName>Paul D</ForeName>
                    <Initials>PD</Initials>
                </Author>
                <Author>
                    <LastName>Ewens</LastName>
                    <ForeName>Cameron L</ForeName>
                    <Initials>CL</Initials>
                </Author>
                <Author>
                    <LastName>Dai</LastName>
                    <ForeName>Jin</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Ollis</LastName>
                    <ForeName>David L</ForeName>
                    <Initials>DL</Initials>
                </Author>
                <Author>
                    <LastName>Murphy</LastName>
                    <ForeName>James M</ForeName>
                    <Initials>JM</Initials>
                </Author>
                <Author>
                    <LastName>Jackson</LastName>
                    <ForeName>Colin J</ForeName>
                    <Initials>CJ</Initials>
                </Author>
                <Author>
                    <LastName>Young</LastName>
                    <ForeName>Ian G</ForeName>
                    <Initials>IG</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biochem J</MedlineTA>
            <NlmUniqueID>2984726R</NlmUniqueID>
            <ISSNLinking>0264-6021</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">BJ20140863</ArticleId>
            <ArticleId IdType="doi">10.1042/BJ20140863</ArticleId>
            <ArticleId IdType="pubmed">25137390</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137261</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1699-5198</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>30</Volume>
                    <Issue>n01</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Nutricion hospitalaria</Title>
                <ISOAbbreviation>Nutr Hosp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>GENOME-WIDE SCREEN OF PROMOTER METHYLATION IDENTIFIES NOVEL MARKERS IN DIET-INDUCED OBESE MICE.</ArticleTitle>
            <Pagination>
                <MedlinePgn>42-52</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the genome-wide promoter methylation and gene expression for the identification of methylation markers in obesity.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Using a high-fat, diet-induced obese mouse model, we performed comprehensive DNA methylation profiling of gene promoters to determine the differentially methylated genes using methylated DNA immunoprecipitation followed by hybridization to the NimbleGen MM8 CpG plus Promoter Microarray. We further integrated epigenomics data with gene expression profiling to identify promoters exhibiting an association between methylation status and the expression of downstream genes.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 24 hypermethylated promoters and 42 hypomethylated promoters in epididymal fat were selected as methylation markers, which were associated with downregulated and upregulated gene expression, respectively. The promoter methylation and differential gene expression of three markers (Mmp2, Foxj3 and Ube2q2) in the fat were validated by sequencing bisulfitemodified DNA and real-time reverse transcriptase PCR. The genes with these differentially methylated promoters and the associated transcriptional expression in the fat were primarily involved in biological activities in lipid metabolism and storage, cellular differentiation, immunity and the pathogenesis of obesity-related complications.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study represents the first effort to determine methylation markers in obese mice that may regulate gene transcription in obesity. Our approach has potential relevance for clinical applications by identifying markers useful in elucidating the mechanisms of obesity pathogenesis and its complications.</AbstractText>
                <CopyrightInformation>Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Fan</LastName>
                    <ForeName>Chaonan</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Nutrition Research Unit. Beijing Pediatric Research Institute. Beijing Children's Hospital. Capital Medical University. Beijing. China. These authors contributed equally to this work.. fanchaonan-2005@163.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dong</LastName>
                    <ForeName>Hua</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Laboratory Animal Center. Hospital 304 affiliated with the General Hospital of the People's Liberation Army. Beijing. China.. suifengzhiyou@126.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yan</LastName>
                    <ForeName>Kesong</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Nutrition Research Unit. Beijing Pediatric Research Institute. Beijing Children's Hospital. Capital Medical University. Beijing. China.. yankesong@163.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shen</LastName>
                    <ForeName>Wenwen</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Nutrition Research Unit. Beijing Pediatric Research Institute. Beijing Children's Hospital. Capital Medical University. Beijing. China.. shenwenwen210@yahoo.com.cn.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Cui</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Nutrition Research Unit. Beijing Pediatric Research Institute. Beijing Children's Hospital. Capital Medical University. Beijing. China.. wangcui0424@163.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xia</LastName>
                    <ForeName>Lulu</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Laboratory Animal Center. Hospital 304 affiliated with the General Hospital of the People's Liberation Army. Beijing. China. Address correspondence to Kemin Qi and Dawei Zhan.. xia4302668@126.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhan</LastName>
                    <ForeName>Dawei</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Nutrition Research Unit. Beijing Pediatric Research Institute. Beijing Children's Hospital. Capital Medical University. Beijing. China. Address correspondence to Kemin Qi and Dawei Zhan.. davidzhandoc@yahoo.com.cn.</Affiliation>
                </Author>
                <Author>
                    <LastName>Qi</LastName>
                    <ForeName>Kemin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Nutrition Research Unit. Beijing Pediatric Research Institute. Beijing Children's Hospital. Capital Medical University. Beijing. China. These authors contributed equally to this work.. qkm666@yahoo.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <VernacularTitle>EL CRIBADO PANGEN??MICO DE LA METILACI??N DEL PROMOTOR IDENTIFICA MARCADORES NUEVOS EN RATONES CON OBESIDAD INDUCIDA POR LA DIETA.</VernacularTitle>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Nutr Hosp</MedlineTA>
            <NlmUniqueID>9100365</NlmUniqueID>
            <ISSNLinking>0212-1611</ISSNLinking>
        </MedlineJournalInfo>
        <OtherAbstract Type="Publisher" Language="SPA">
            <AbstractText>Abstract available from the publisher.</AbstractText>
        </OtherAbstract>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3305/nh.2014.30.1.7521</ArticleId>
            <ArticleId IdType="pubmed">25137261</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137252</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1557-8534</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Stem cells and development</Title>
                <ISOAbbreviation>Stem Cells Dev.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long term engraftment in NSG mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Human cord blood (CB) hematopoietic stem (HSC) cell transplants demonstrate delayed early neutrophil and platelet recovery and delayed longer term immune reconstitution compared to bone marrow and mobilized peripheral blood transplants. Despite advances in enhancing early neutrophil engraftment, platelet recovery after CB transplantation is not significantly altered when compared to contemporaneous controls. Recent studies have identified a platelet biased murine HSC subset, maintained by thrombopoietin (TPO) which has enhanced capacity for short and long term platelet reconstitution, can self-renew, and can give rise to myeloid and lymphoid biased HSCs. In previous studies, we have shown that transplantation of human CB CD34+ cells pre-cultured in TPO as a single graft accelerates early platelet recovery as well as yielding long term repopulation in immune deficient mice. Here, using a double CB murine transplant model, we investigated whether TPO cultured human CB CD34+ cells have a competitive advantage or disadvantage over untreated human CB CD34+ cells in terms of i) short and longer term platelet recovery and ii) longer term hematological recovery. Our studies demonstrate that the TPO treated graft shows accelerated early platelet recovery without impairing the platelet engraftment of untreated CD34+ cells. Notably, this was followed by a dominant contribution to platelet production via the untreated CD34+ cell graft over the intermediate to longer term. Furthermore, although the contribution of the TPO treated graft to long term hematological engraftment was reduced, the TPO treated and untreated grafts both contributed significantly to long term chimerism in vivo.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>van der Garde</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Sanquin Blood Supply Foundation, Jon J van Rood Center for Clinical Transfusion Research, Netherlands, University of Oxford, Radcliffe Department of Medicine, United Kingdom, NHS Blood and Transplant, Stem Cell Research, United Kingdom ; mark.vandergarde@nhsbt.nhs.uk.</Affiliation>
                </Author>
                <Author>
                    <LastName>van Hensbergen</LastName>
                    <ForeName>Yvette</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Brand</LastName>
                    <ForeName>Anneke</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Slot</LastName>
                    <ForeName>Manon C</ForeName>
                    <Initials>MC</Initials>
                </Author>
                <Author>
                    <LastName>de Graaf-Dijkstra</LastName>
                    <ForeName>Alice</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Mulder</LastName>
                    <ForeName>Arend</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Watt</LastName>
                    <ForeName>Suzanne M</ForeName>
                    <Initials>SM</Initials>
                </Author>
                <Author>
                    <LastName>Zwaginga</LastName>
                    <ForeName>Jaap Jan</ForeName>
                    <Initials>JJ</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Stem Cells Dev</MedlineTA>
            <NlmUniqueID>101197107</NlmUniqueID>
            <ISSNLinking>1547-3287</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1089/scd.2014.0294</ArticleId>
            <ArticleId IdType="pubmed">25137252</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137224</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1537-6524</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Toxicology mechanisms and methods</Title>
                <ISOAbbreviation>Toxicol. Mech. Methods</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Protective effects of escin against indomethacin-induced gastric ulcer in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-26</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Abstract Escin, a natural mixture of triterpenoid saponin isolated from the seed of the horse chestnut, is reported to have a potent antiulcer activity against ethanol-induced gastric mucosal lesions. This study investigated the possible mechanisms underlying the gastroprotective effect of escin against indomethacin-induced gastric ulcer in mice. Gastric ulceration was induced by a single intragastric administration of indomethacin (18 mg/kg). One hour later, the mice underwent intragastric treatment with escin at doses of 0.45, 0.9, or 1.8 mg/kg. Gastric lesion was estimated morphometrically and histopathologically 4 h after the escin administration. The antioxidative parameters in gastric mucosa were measured. Moreover, the activity of myeloperoxidase and the contents of TNF-??, P-selectin, VCAM-1 in gastric tissues were determined. The results showed that escin protected gastric tissues against indomethacin-induced gastropathy as demonstrated from a reduction in the ulcer index and an attenuation of histopathological changes. Escin caused significant reductions of the contents of malondialdehyde, TNF-??, P-selectin, VCAM-1, and myeloperoxidase activity. The altered activities of superoxide dismutase, catalase, and glutathione peroxidase in the stomach tissues were also ameliorated by escin treatment. The present study demonstrated that escin had a protective effect against indomethacin-induced gastric ulcer in mice, not only by virtue of its antioxidant potential, but also due to its anti-inflammatory effect.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Tian</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Pharmacology, School of Pharmacy, Yantai University 30#, Qingquan Road, Yantai, 264005, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhao</LastName>
                    <ForeName>Shanshan</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Yucun</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Yujiao</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Yao</LastName>
                    <ForeName>Le</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Chu</LastName>
                    <ForeName>Liuxiang</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Du</LastName>
                    <ForeName>Hanhan</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Fu</LastName>
                    <ForeName>Fenghua</ForeName>
                    <Initials>F</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Toxicol Mech Methods</MedlineTA>
            <NlmUniqueID>101134521</NlmUniqueID>
            <ISSNLinking>1537-6516</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anti-inflammatory</Keyword>
            <Keyword MajorTopicYN="N">Antioxidant</Keyword>
            <Keyword MajorTopicYN="N">Escin</Keyword>
            <Keyword MajorTopicYN="N">Gastric ulcer</Keyword>
            <Keyword MajorTopicYN="N">Indomethacin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3109/15376516.2014.951815</ArticleId>
            <ArticleId IdType="pubmed">25137224</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25137139</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCompleted>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2162-2531</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>3</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular therapy. Nucleic acids</Title>
                <ISOAbbreviation>Mol Ther Nucleic Acids</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e186</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/mtna.2014.38</ELocationID>
            <Abstract>
                <AbstractText>Persistence of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) under current antiviral therapy is a major barrier to eradication of chronic hepatitis B (CHB). Curing CHB will require novel strategies for specific disruption of cccDNA. The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system is a newly developed tool for site-specific cleavage of DNA targets directed by a synthetic guide RNA (gRNA) base-paired to the target DNA sequence. To examine whether this system can cleave HBV genomes, we designed eight gRNAs against HBV of genotype A. With the HBV-specific gRNAs, the CRISPR/Cas9 system significantly reduced the production of HBV core and surface proteins in Huh-7 cells transfected with an HBV-expression vector. Among eight screened gRNAs, two effective ones were identified. Interestingly, one gRNA targeting the conserved HBV sequence acted against different genotypes. Using a hydrodynamics-HBV persistence mouse model, we further demonstrated that this system could cleave the intrahepatic HBV genome-containing plasmid and facilitate its clearance in vivo, resulting in reduction of serum surface antigen levels. These data suggest that the CRISPR/Cas9 system could disrupt the HBV-expressing templates both in vitro and in vivo, indicating its potential in eradicating persistent HBV infection.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Su-Ru</ForeName>
                    <Initials>SR</Initials>
                    <Affiliation>Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Hung-Chih</ForeName>
                    <Initials>HC</Initials>
                    <Affiliation>1] Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan [2] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan [3] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuo</LastName>
                    <ForeName>Yi-Ting</ForeName>
                    <Initials>YT</Initials>
                    <Affiliation>Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Chun-Jen</ForeName>
                    <Initials>CJ</Initials>
                    <Affiliation>1] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan [2] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [3] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Ta-Yu</ForeName>
                    <Initials>TY</Initials>
                    <Affiliation>Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sung</LastName>
                    <ForeName>Ku-Chun</ForeName>
                    <Initials>KC</Initials>
                    <Affiliation>Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>You-Yu</ForeName>
                    <Initials>YY</Initials>
                    <Affiliation>1] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan [2] Department of Life Science, National Taiwan University College of Life Science, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Hurng-Yi</ForeName>
                    <Initials>HY</Initials>
                    <Affiliation>Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Chih-Chiang</ForeName>
                    <Initials>CC</Initials>
                    <Affiliation>Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>Yueh-Chi</ForeName>
                    <Initials>YC</Initials>
                    <Affiliation>Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Fang-Yi</ForeName>
                    <Initials>FY</Initials>
                    <Affiliation>Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kao</LastName>
                    <ForeName>Jia-Horng</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>1] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan [2] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [3] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [4] Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Ding-Shinn</ForeName>
                    <Initials>DS</Initials>
                    <Affiliation>1] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan [2] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [3] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [4] Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Pei-Jer</ForeName>
                    <Initials>PJ</Initials>
                    <Affiliation>1] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan [2] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [3] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [4] Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Ther Nucleic Acids</MedlineTA>
            <NlmUniqueID>101581621</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">mtna201438</ArticleId>
            <ArticleId IdType="doi">10.1038/mtna.2014.38</ArticleId>
            <ArticleId IdType="pubmed">25137139</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137131</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2042-650X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Food &amp; function</Title>
                <ISOAbbreviation>Food Funct</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Grape seed extract improves epithelial structure and suppresses inflammation in ileum of IL-10-deficient mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Defect in intestinal epithelial structure is a critical etiological factor of several intestinal diseases such as inflammatory bowel disease. The objective of this study was to evaluate the effect of grape seed extract (GSE), which contains a mixture of polyphenols, on ileal mucosal structure and inflammation in interleukin (IL)-10-deficient mice, a common model for studying inflammatory bowel disease. Wild-type and IL-10-deficient mice were fed GSE at 0 or 1% (based on dry feed weight) for 16 weeks. GSE supplementation decreased crypt depth and increased (P &lt; 0.05) the ratio of villus/crypt length in the terminal ileum. Consistently, the dietary GSE decreased (P &lt; 0.05) proliferation and enhanced (P &lt; 0.05) differentiation of epithelial cells. These changes in gut epithelium were associated with the suppression of nuclear factor kappa-light-chain-enhancer of activated B-cell (NF-??B) signaling. Furthermore, compared with WT mice, IL-10 deletion promoted beclin-1 and AMPK expression, both of which were decreased to normal by GSE supplementation. These changes were associated with alterations in epithelial barrier function as indicated by reduced pore forming claudin-2 protein expression and increased barrier forming claudin-1 protein expression in the ileum of GSE supplemented mice. In summary, our data indicates that GSE exerts protective effects to the ileal epithelial structure in IL-10-deficient mice possibly through the suppression of inflammatory response.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Guan</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>School of Food Science, Washington State University, Pullman, WA 99164, USA. meijun.zhu@wsu.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Kang</LastName>
                    <ForeName>Yifei</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Mei-Jun</ForeName>
                    <Initials>MJ</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Food Funct</MedlineTA>
            <NlmUniqueID>101549033</NlmUniqueID>
            <ISSNLinking>2042-6496</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c4fo00451e</ArticleId>
            <ArticleId IdType="pubmed">25137131</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25137069</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hope for the best or prepare for the worst? Towards a spatial cognitive bias test for mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105431</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105431</ELocationID>
            <Abstract>
                <AbstractText>Cognitive bias, the altered information processing resulting from the background emotional state of an individual, has been suggested as a promising new indicator of animal emotion. Comparable to anxious or depressed humans, animals in a putatively negative emotional state are more likely to judge an ambiguous stimulus as if it predicts a negative event, than those in positive states. The present study aimed to establish a cognitive bias test for mice based on a spatial judgment task and to apply it in a pilot study to serotonin transporter (5-HTT) knockout mice, a well-established mouse model for the study of anxiety- and depression-related behavior. In a first step, we validated that our setup can assess different expectations about the outcome of an ambiguous stimulus: mice having learned to expect something positive within a maze differed significantly in their behavior towards an unfamiliar location than animals having learned to expect something negative. In a second step, the use of spatial location as a discriminatory stimulus was confirmed by showing that mice interpret an ambiguous stimulus depending on its spatial location, with a position exactly midway between a positive and a negative reference point provoking the highest level of ambiguity. Finally, the anxiety- and depression-like phenotype of the 5-HTT knockout mouse model manifested - comparable to human conditions - in a trend for a negatively distorted interpretation of ambiguous information, albeit this effect was not statistically significant. The results suggest that the present cognitive bias test provides a useful basis to study the emotional state in mice, which may not only increase the translational value of animal models in the study of human affective disorders, but which is also a central objective of animal welfare research.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kloke</LastName>
                    <ForeName>Vanessa</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Department of Behavioural Biology, University of M??nster, M??nster, Germany; Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience, University of M??nster, M??nster, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schreiber</LastName>
                    <ForeName>Rebecca S</ForeName>
                    <Initials>RS</Initials>
                    <Affiliation>Department of Behavioural Biology, University of M??nster, M??nster, Germany; Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience, University of M??nster, M??nster, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bodden</LastName>
                    <ForeName>Carina</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Behavioural Biology, University of M??nster, M??nster, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>M??llers</LastName>
                    <ForeName>Julian</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Behavioural Biology, University of M??nster, M??nster, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ruhmann</LastName>
                    <ForeName>Hanna</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Behavioural Biology, University of M??nster, M??nster, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaiser</LastName>
                    <ForeName>Sylvia</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Behavioural Biology, University of M??nster, M??nster, Germany; Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience, University of M??nster, M??nster, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lesch</LastName>
                    <ForeName>Klaus-Peter</ForeName>
                    <Initials>KP</Initials>
                    <Affiliation>Division of Molecular Psychiatry, Laboratory of Translational Neuroscience, Department of Psychiatry, Psychosomatics and Psychotherapy, University of W??rzburg, W??rzburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sachser</LastName>
                    <ForeName>Norbert</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Behavioural Biology, University of M??nster, M??nster, Germany; Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience, University of M??nster, M??nster, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lewejohann</LastName>
                    <ForeName>Lars</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Behavioural Biology, University of M??nster, M??nster, Germany; Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience, University of M??nster, M??nster, Germany; Behavioral Biology, University of Osnabr??ck, Osnabr??ck, Germany.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res Bull. 2001 Mar 15;54(5):559-63</RefSource>
                <PMID Version="1">11397548</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Brain Res. 2010 Feb 11;207(1):21-9</RefSource>
                <PMID Version="1">19782704</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2003 Nov 15;54(10):960-71</RefSource>
                <PMID Version="1">14625138</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2004 Jan 22;427(6972):312</RefSource>
                <PMID Version="1">14737158</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Physiol Psychol. 1979 Feb;93(1):74-104</RefSource>
                <PMID Version="1">221551</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol. 1989 May;256(5 Pt 2):R1121-6</RefSource>
                <PMID Version="1">2719154</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Abnorm Psychol. 1991 May;100(2):144-50</RefSource>
                <PMID Version="1">2040764</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Res Ther. 1995 Sep;33(7):755-70</RefSource>
                <PMID Version="1">7677713</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Abnorm Psychol. 1996 May;105(2):286-9</RefSource>
                <PMID Version="1">8723011</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Bull. 1996 Jul;120(1):3-24</RefSource>
                <PMID Version="1">8711015</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Methods. 1995 Nov;62(1-2):1-5</RefSource>
                <PMID Version="1">8750078</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Brain Res. 1996 May;77(1-2):211-3</RefSource>
                <PMID Version="1">8762172</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychoneuroendocrinology. 1996 May;21(4):391-400</RefSource>
                <PMID Version="1">8844877</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Pharmacol. 1998 Apr;53(4):649-55</RefSource>
                <PMID Version="1">9547354</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurobiol Learn Mem. 1998 Jul-Sep;70(1-2):44-61</RefSource>
                <PMID Version="1">9753586</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Methods. 1999 Feb 1;87(1):87-95</RefSource>
                <PMID Version="1">10065997</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 1999 Jun 4;284(5420):1670-2</RefSource>
                <PMID Version="1">10356397</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Biobehav Rev. 2005 May;29(3):469-91</RefSource>
                <PMID Version="1">15820551</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Drug Discov. 2005 Sep;4(9):775-90</RefSource>
                <PMID Version="1">16138108</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genes Brain Behav. 2006 Feb;5(1):64-72</RefSource>
                <PMID Version="1">16436190</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2007 Jan 17;27(3):684-91</RefSource>
                <PMID Version="1">17234600</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Pharmacol Sci. 2007 Mar;28(3):122-7</RefSource>
                <PMID Version="1">17275930</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genes Brain Behav. 2007 Jun;6(4):389-400</RefSource>
                <PMID Version="1">16939636</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Clin Psychol. 2005;1:167-95</RefSource>
                <PMID Version="1">17716086</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res. 2007 Sep 12;1169:87-97</RefSource>
                <PMID Version="1">17692295</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2008 May 1;63(9):840-6</RefSource>
                <PMID Version="1">17949690</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychol. 2010 Mar;83(3):269-71</RefSource>
                <PMID Version="1">19723555</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cogn Affect Behav Neurosci. 2010 Mar;10(1):8-20</RefSource>
                <PMID Version="1">20233952</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Psychiatry. 2010 May;167(5):509-27</RefSource>
                <PMID Version="1">20231323</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Anim Cogn. 2010 Sep;13(5):721-31</RefSource>
                <PMID Version="1">20464439</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroreport. 2010 Apr 21;21(6):422-6</RefSource>
                <PMID Version="1">20216333</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Biol. 2010 Oct 12;20(19):R839-40</RefSource>
                <PMID Version="1">20937467</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res. 2011 Feb 10;1373:124-30</RefSource>
                <PMID Version="1">21156165</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Biol. 2011 Jun 21;21(12):1070-3</RefSource>
                <PMID Version="1">21636277</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Biol. 2011 Jun 21;21(12):R463-5</RefSource>
                <PMID Version="1">21683898</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2011;6(8):e22715</RefSource>
                <PMID Version="1">21857948</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Methods. 2012 Feb 15;204(1):1-8</RefSource>
                <PMID Version="1">22074818</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropsychopharmacology. 2010 Mar;35(4):1008-15</RefSource>
                <PMID Version="1">20043002</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2012 Feb 15;71(4):373-9</RefSource>
                <PMID Version="1">22138391</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Brain Res. 2012 Jul 15;233(1):45-54</RefSource>
                <PMID Version="1">22562041</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cogn Affect Behav Neurosci. 2012 Sep;12(3):527-42</RefSource>
                <PMID Version="1">22644760</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2012 Oct 1;72(7):572-9</RefSource>
                <PMID Version="1">22579509</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Psychol Rev. 2012 Dec;32(8):704-23</RefSource>
                <PMID Version="1">23059623</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(12):e51959</RefSource>
                <PMID Version="1">23300582</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychopharmacology (Berl). 2013 Apr;226(3):601-13</RefSource>
                <PMID Version="1">23239131</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Drug Targets. 2013 May 1;14(5):549-70</RefSource>
                <PMID Version="1">23547810</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(10):e78238</RefSource>
                <PMID Version="1">24167611</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(11):e80355</RefSource>
                <PMID Version="1">24236177</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(12):e80556</RefSource>
                <PMID Version="1">24324609</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Brain Res. 2010 Aug 25;211(2):220-8</RefSource>
                <PMID Version="1">20347882</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Psychiatry. 2008 Aug;165(8):969-77</RefSource>
                <PMID Version="1">18628348</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Physiol Behav. 2009 Sep 7;98(3):345-50</RefSource>
                <PMID Version="1">19560479</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Abnorm Psychol. 2009 Aug;118(3):670-81</RefSource>
                <PMID Version="1">19685963</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2003 Jul 18;301(5631):386-9</RefSource>
                <PMID Version="1">12869766</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4138164</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105431</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-15163</ArticleId>
            <ArticleId IdType="pubmed">25137069</ArticleId>
            <ArticleId IdType="pmc">PMC4138164</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137067</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1555-8584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>RNA biology</Title>
                <ISOAbbreviation>RNA Biol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Recent genome-wide studies have revealed that the majority of the mouse genome is transcribed as non-coding RNAs (ncRNAs) and growing evidence supports the importance of ncRNAs in regulating gene expression and epigenetic processes. However, the low efficiency of conventional gene targeting strategies has hindered the functional study of ncRNAs in vivo, particularly in generating large fragment deletions of long non-coding RNAs (lncRNAs) with multiple expression variants. The bacterial clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) system has recently been applied as an efficient tool for engineering site-specific mutations of protein-coding genes in the genome. In this study, we explored the potential of using the CRISPR/Cas9 system to generate large genomic deletions of lncRNAs in mice. We developed an efficient one-step strategy to target the maternally expressed lncRNA, Rian, on chromosome 12 in mice. We showed that paired sgRNAs can precisely generate large deletions up to 23kb and the deletion efficiency can be further improved up to 33% by combining multiple sgRNAs. The deletion successfully abolished the expression of Rian from the maternally inherited allele, validating the biological relevance of the mutations in studying an imprinted locus. Mutation of Rian has differential effects on expression of nearby genes in different somatic tissues. Taken together, we have established a robust one-step method to engineer large deletions to knockout lncRNA genes with the CRISPR/Cas9 system. Our work will facilitate future functional studies of other lncRNAs in vivo.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Han</LastName>
                    <ForeName>Jinxiong</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>MOE Key Laboratory of Model Animal for Disease Study; Model Animal Research Center of Nanjing University; Nanjing, Jiangsu Province, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>MOE Key Laboratory of Model Animal for Disease Study; Model Animal Research Center of Nanjing University; Nanjing, Jiangsu Province, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>MOE Key Laboratory of Model Animal for Disease Study; Model Animal Research Center of Nanjing University; Nanjing, Jiangsu Province, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shen</LastName>
                    <ForeName>Bin</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>MOE Key Laboratory of Model Animal for Disease Study; Model Animal Research Center of Nanjing University; Nanjing, Jiangsu Province, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhou</LastName>
                    <ForeName>Jiankui</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>MOE Key Laboratory of Model Animal for Disease Study; Model Animal Research Center of Nanjing University; Nanjing, Jiangsu Province, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hu</LastName>
                    <ForeName>Bian</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>MOE Key Laboratory of Model Animal for Disease Study; Model Animal Research Center of Nanjing University; Nanjing, Jiangsu Province, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Du</LastName>
                    <ForeName>Yinan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>MOE Key Laboratory of Model Animal for Disease Study; Model Animal Research Center of Nanjing University; Nanjing, Jiangsu Province, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tate</LastName>
                    <ForeName>Peri H</ForeName>
                    <Initials>PH</Initials>
                    <Affiliation>Wellcome Trust Sanger Institute; Wellcome Trust Genome Campus; Hinxton, Cambridge, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Xingxu</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>MOE Key Laboratory of Model Animal for Disease Study; Model Animal Research Center of Nanjing University; Nanjing, Jiangsu Province, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Wensheng</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Cambridge Suda Genome Research Center; Soochow University; Soochow, Jiangsu Province, PR China; Wellcome Trust Sanger Institute; Wellcome Trust Genome Campus; Hinxton, Cambridge, UK.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>RNA Biol</MedlineTA>
            <NlmUniqueID>101235328</NlmUniqueID>
            <ISSNLinking>1547-6286</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword>
            <Keyword MajorTopicYN="N">Rian</Keyword>
            <Keyword MajorTopicYN="N">imprinting</Keyword>
            <Keyword MajorTopicYN="N">large fragment deletion</Keyword>
            <Keyword MajorTopicYN="N">lncRNA</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">29624</ArticleId>
            <ArticleId IdType="pubmed">25137067</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25137065</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1545-7885</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>12</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>PLoS biology</Title>
                <ISOAbbreviation>PLoS Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pyramidal Cells Make Specific Connections onto Smooth (GABAergic) Neurons in Mouse Visual Cortex.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1001932</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pbio.1001932</ELocationID>
            <Abstract>
                <AbstractText>One of the hallmarks of neocortical circuits is the predominance of recurrent excitation between pyramidal neurons, which is balanced by recurrent inhibition from smooth GABAergic neurons. It has been previously described that in layer 2/3 of primary visual cortex (V1) of cat and monkey, pyramidal cells filled with horseradish peroxidase connect approximately in proportion to the spiny (excitatory, 95% and 81%, respectively) and smooth (GABAergic, 5% and 19%, respectively) dendrites found in the neuropil. By contrast, a recent ultrastructural study of V1 in a single mouse found that smooth neurons formed 51% of the targets of the superficial layer pyramidal cells. This suggests that either the neuropil of this particular mouse V1 had a dramatically different composition to that of V1 in cat and monkey, or that smooth neurons were specifically targeted by the pyramidal cells in that mouse. We tested these hypotheses by examining similar cells filled with biocytin in a sample of five mice. We found that the average composition of the neuropil in V1 of these mice was similar to that described for cat and monkey V1, but that the superficial layer pyramidal cells do form proportionately more synapses with smooth dendrites than the equivalent neurons in cat or monkey. These distributions may underlie the distinct differences in functional architecture of V1 between rodent and higher mammals.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bopp</LastName>
                    <ForeName>Rita</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Institute for Neuroinformatics, University of Z??rich and ETH Z??rich, Z??rich, Switzerland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma??arico da Costa</LastName>
                    <ForeName>Nuno</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Institute for Neuroinformatics, University of Z??rich and ETH Z??rich, Z??rich, Switzerland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kampa</LastName>
                    <ForeName>Bj??rn M</ForeName>
                    <Initials>BM</Initials>
                    <Affiliation>Brain Research Institute, University of Z??rich, Z??rich, Switzerland; Institute de Neurosciences de la Timone, Marseille, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Martin</LastName>
                    <ForeName>Kevan A C</ForeName>
                    <Initials>KA</Initials>
                    <Affiliation>Institute for Neuroinformatics, University of Z??rich and ETH Z??rich, Z??rich, Switzerland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roth</LastName>
                    <ForeName>Morgane M</ForeName>
                    <Initials>MM</Initials>
                    <Affiliation>Brain Research Institute, University of Z??rich, Z??rich, Switzerland.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS Biol</MedlineTA>
            <NlmUniqueID>101183755</NlmUniqueID>
            <ISSNLinking>1544-9173</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Neurosci. 2004;27:419-51</RefSource>
                <PMID Version="1">15217339</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2013 Apr 4;496(7443):96-100</RefSource>
                <PMID Version="1">23552948</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Anat. 1967 Sep;101(Pt 4):639-54</RefSource>
                <PMID Version="1">4964696</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res. 1968 Jul;9(2):268-87</RefSource>
                <PMID Version="1">4175993</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 1979 Jul 12;280(5718):120-5</RefSource>
                <PMID Version="1">552600</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 1982 Sep 20;210(3):278-90</RefSource>
                <PMID Version="1">7142443</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 1983 Jul 1;217(3):337-44</RefSource>
                <PMID Version="1">6411777</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroscience. 1983 Oct;10(2):261-94</RefSource>
                <PMID Version="1">6633861</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Brain Res. 1983;50(2-3):193-200</RefSource>
                <PMID Version="1">6641854</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Microsc. 1984 May;134(Pt 2):127-36</RefSource>
                <PMID Version="1">6737468</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 1985 Jan 8;231(2):180-9</RefSource>
                <PMID Version="1">3968234</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 1985 Nov 8;241(2):111-37</RefSource>
                <PMID Version="1">4067011</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Brain Res. 1986;61(2):323-31</RefSource>
                <PMID Version="1">3005016</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Brain Res. 1986;64(3):541-52</RefSource>
                <PMID Version="1">3803491</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Microsc. 1987 Sep;147(Pt 3):229-63</RefSource>
                <PMID Version="1">3430576</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 1989 Aug 22;286(4):442-55</RefSource>
                <PMID Version="1">2778101</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 1991 Mar 15;305(3):370-92</RefSource>
                <PMID Version="1">1709953</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cereb Cortex. 1992 Jul-Aug;2(4):295-309</RefSource>
                <PMID Version="1">1330121</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res. 1993 Apr 23;609(1-2):284-92</RefSource>
                <PMID Version="1">8508310</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cereb Cortex. 1993 Sep-Oct;3(5):412-20</RefSource>
                <PMID Version="1">8260809</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 1995 Aug 18;269(5226):981-5</RefSource>
                <PMID Version="1">7638624</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 1997 Apr 7;380(2):230-42</RefSource>
                <PMID Version="1">9100134</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Methods. 1997 Aug 22;75(2):119-26</RefSource>
                <PMID Version="1">9288643</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurophysiol. 1999 Jul;82(1):301-11</RefSource>
                <PMID Version="1">10400959</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Physiol. 1962 Jan;160:106-54</RefSource>
                <PMID Version="1">14449617</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Anat. 1959 Oct;93:420-33</RefSource>
                <PMID Version="1">13829103</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2005 Feb 10;433(7026):597-603</RefSource>
                <PMID Version="1">15660108</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2005 Feb 24;433(7028):868-73</RefSource>
                <PMID Version="1">15729343</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Biol. 2005 Mar;3(3):e68</RefSource>
                <PMID Version="1">15737062</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2002 Jul 1;22(13):5639-51</RefSource>
                <PMID Version="1">12097515</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7319-24</RefSource>
                <PMID Version="1">12777621</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 2003 Dec;6(12):1300-8</RefSource>
                <PMID Version="1">14625553</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Methods. 2004 Oct;1(1):31-7</RefSource>
                <PMID Version="1">15782150</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2005 May 6;308(5723):863-6</RefSource>
                <PMID Version="1">15774725</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 2005 Nov;8(11):1552-9</RefSource>
                <PMID Version="1">16222228</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Physiol. 2006 Sep 1;575(Pt 2):583-602</RefSource>
                <PMID Version="1">16793907</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 2006 Dec;9(12):1472-3</RefSource>
                <PMID Version="1">17099707</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pflugers Arch. 2007 Jul;454(4):675-88</RefSource>
                <PMID Version="1">17334778</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2007 Sep 26;27(39):10333-44</RefSource>
                <PMID Version="1">17898205</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cereb Cortex. 2008 Jan;18(1):13-28</RefSource>
                <PMID Version="1">17420172</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2008 Jul 23;28(30):7520-36</RefSource>
                <PMID Version="1">18650330</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Methods. 2009 May 30;180(1):77-81</RefSource>
                <PMID Version="1">19427532</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroscience. 2009 Jun 30;161(2):561-71</RefSource>
                <PMID Version="1">19327388</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Bioinformatics. 2009 Aug 1;25(15):1984-6</RefSource>
                <PMID Version="1">19376822</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2009 Aug 26;29(34):10520-32</RefSource>
                <PMID Version="1">19710305</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2010 Sep 9;67(5):847-57</RefSource>
                <PMID Version="1">20826315</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2010 Sep 9;67(5):858-71</RefSource>
                <PMID Version="1">20826316</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2011 Mar 10;471(7337):177-82</RefSource>
                <PMID Version="1">21390124</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2011 May 5;473(7345):87-91</RefSource>
                <PMID Version="1">21478872</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 2011 Aug;14(8):1045-52</RefSource>
                <PMID Version="1">21765421</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(6):e38011</RefSource>
                <PMID Version="1">22723842</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2012 Jul 11;32(28):9716-26</RefSource>
                <PMID Version="1">22787057</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2004 Sep 29;24(39):8441-53</RefSource>
                <PMID Version="1">15456817</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4138028</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pbio.1001932</ArticleId>
            <ArticleId IdType="pii">PBIOLOGY-D-13-04179</ArticleId>
            <ArticleId IdType="pubmed">25137065</ArticleId>
            <ArticleId IdType="pmc">PMC4138028</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25137057</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Correction: The db/db Mouse: A Useful Model for the Study of Diabetic Retinal Neurodegeneration.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e106227</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0106227</ELocationID>
            <Abstract>
                <AbstractText>[This corrects the article DOI: 10.1371/journal.pone.0097302.].</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <CollectiveName>PLOS ONE Staff</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2014;9(5):e97302</RefSource>
                <PMID Version="1">24837086</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4138206</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0106227</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-35220</ArticleId>
            <ArticleId IdType="pubmed">25137057</ArticleId>
            <ArticleId IdType="pmc">PMC4138206</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25137049</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105429</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105429</ELocationID>
            <Abstract>
                <AbstractText>The MacBlue transgenic mouse uses the Csf1r promoter and first intron to drive expression of gal4-VP16, which in turn drives a cointegrated gal4-responsive UAS-ECFP cassette. The Csf1r promoter region used contains a deletion of a 150 bp conserved region covering trophoblast and osteoclast-specific transcription start sites. In this study, we examined expression of the transgene in embryos and adult mice. In embryos, ECFP was expressed in the large majority of macrophages derived from the yolk sac, and as the liver became a major site of monocytopoiesis. In adults, ECFP was detected at high levels in both Ly6C+ and Ly6C- monocytes and distinguished them from Ly6C+, F4/80+, CSF1R+ immature myeloid cells in peripheral blood. ECFP was also detected in the large majority of microglia and Langerhans cells. However, expression was lost from the majority of tissue macrophages, including Kupffer cells in the liver and F4/80+ macrophages of the lung, kidney, spleen and intestine. The small numbers of positive cells isolated from the liver resembled blood monocytes. In the gut, ECFP+ cells were identified primarily as classical dendritic cells or blood monocytes in disaggregated cell preparations. Immunohistochemistry showed large numbers of ECFP+ cells in the Peyer's patch and isolated lymphoid follicles. The MacBlue transgene was used to investigate the effect of treatment with CSF1-Fc, a form of the growth factor with longer half-life and efficacy. CSF1-Fc massively expanded both the immature myeloid cell (ECFP-) and Ly6C+ monocyte populations, but had a smaller effect on Ly6C- monocytes. There were proportional increases in ECFP+ cells detected in lung and liver, consistent with monocyte infiltration, but no generation of ECFP+ Kupffer cells. In the gut, there was selective infiltration of large numbers of cells into the lamina propria and Peyer's patches. We discuss the use of the MacBlue transgene as a marker of monocyte/macrophage/dendritic cell differentiation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sauter</LastName>
                    <ForeName>Kristin A</ForeName>
                    <Initials>KA</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pridans</LastName>
                    <ForeName>Clare</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sehgal</LastName>
                    <ForeName>Anuj</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bain</LastName>
                    <ForeName>Calum C</ForeName>
                    <Initials>CC</Initials>
                    <Affiliation>Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scott</LastName>
                    <ForeName>Charlotte</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moffat</LastName>
                    <ForeName>Lindsey</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rojo</LastName>
                    <ForeName>Roc??o</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stutchfield</LastName>
                    <ForeName>Ben M</ForeName>
                    <Initials>BM</Initials>
                    <Affiliation>MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Davies</LastName>
                    <ForeName>Claire L</ForeName>
                    <Initials>CL</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donaldson</LastName>
                    <ForeName>David S</ForeName>
                    <Initials>DS</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Renault</LastName>
                    <ForeName>Kathleen</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McColl</LastName>
                    <ForeName>Barry W</ForeName>
                    <Initials>BW</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mowat</LastName>
                    <ForeName>Alan M</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Serrels</LastName>
                    <ForeName>Alan</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frame</LastName>
                    <ForeName>Margaret C</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mabbott</LastName>
                    <ForeName>Neil A</ForeName>
                    <Initials>NA</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hume</LastName>
                    <ForeName>David A</ForeName>
                    <Initials>DA</Initials>
                    <Affiliation>The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2013 Jan 14;210(1):157-72</RefSource>
                <PMID Version="1">23296467</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2013 Jan 24;38(1):79-91</RefSource>
                <PMID Version="1">23273845</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cell Res. 2013 Mar;10(2):203-12</RefSource>
                <PMID Version="1">23314290</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(1):e54935</RefSource>
                <PMID Version="1">23383005</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mucosal Immunol. 2013 May;6(3):498-510</RefSource>
                <PMID Version="1">22990622</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2013 Apr 18;38(4):792-804</RefSource>
                <PMID Version="1">23601688</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2013 May 9;497(7448):239-43</RefSource>
                <PMID Version="1">23575636</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2013 Jul 1;191(1):17-23</RefSource>
                <PMID Version="1">23794702</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 1985 Mar 1;161(3):475-89</RefSource>
                <PMID Version="1">3973536</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroscience. 1985 Jun;15(2):313-26</RefSource>
                <PMID Version="1">3895031</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1987 Sep;84(17):6179-83</RefSource>
                <PMID Version="1">2819867</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 1988 Nov 15;141(10):3405-9</RefSource>
                <PMID Version="1">3053899</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell Biol. 1989 Mar;9(3):1336-41</RefSource>
                <PMID Version="1">2524648</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 1990 Feb 15;75(4):846-50</RefSource>
                <PMID Version="1">2405921</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunology. 1990 May;70(1):40-7</RefSource>
                <PMID Version="1">2141319</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 1994 Jun;120(6):1357-72</RefSource>
                <PMID Version="1">8050349</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell Biol. 1995 Jun;15(6):3430-41</RefSource>
                <PMID Version="1">7760840</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Oncogene. 1995 Oct 5;11(7):1371-81</RefSource>
                <PMID Version="1">7478559</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Leukoc Biol. 1999 Feb;65(2):217-31</RefSource>
                <PMID Version="1">10088605</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann N Y Acad Sci. 2004 Dec;1029:44-57</RefSource>
                <PMID Version="1">15681742</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2005 May 16;201(10):1615-25</RefSource>
                <PMID Version="1">15883173</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2005 Aug 1;175(3):1399-405</RefSource>
                <PMID Version="1">16034075</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Oncogene. 2005 Aug 11;24(34):5278-86</RefSource>
                <PMID Version="1">16007221</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2005 Nov 1;106(9):3004-11</RefSource>
                <PMID Version="1">16020514</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2006 Jan 15;176(2):803-10</RefSource>
                <PMID Version="1">16393963</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Immunol. 2006 Feb;18(1):39-48</RefSource>
                <PMID Version="1">16337366</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Immunol. 2006 Feb;18(1):49-53</RefSource>
                <PMID Version="1">16338128</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2006 Feb 15;176(4):2219-28</RefSource>
                <PMID Version="1">16455978</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell Biol. 2007 Apr;27(8):2919-33</RefSource>
                <PMID Version="1">17283046</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Leukoc Biol. 2007 Jul;82(1):111-23</RefSource>
                <PMID Version="1">17438263</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2007 Oct;8(10):1086-94</RefSource>
                <PMID Version="1">17873879</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Leukoc Biol. 2008 Feb;83(2):430-3</RefSource>
                <PMID Version="1">17971498</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mucosal Immunol. 2008 Nov;1(6):432-41</RefSource>
                <PMID Version="1">19079210</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2009 Apr;9(4):259-70</RefSource>
                <PMID Version="1">19282852</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2009 Aug;119(8):2330-42</RefSource>
                <PMID Version="1">19587445</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2009 Sep 18;31(3):513-25</RefSource>
                <PMID Version="1">19733489</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2009 Dec 21;206(13):3089-100</RefSource>
                <PMID Version="1">19995948</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2009 Dec 21;206(13):3115-30</RefSource>
                <PMID Version="1">20008528</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Pathol. 2010 Jan;176(1):369-80</RefSource>
                <PMID Version="1">20008135</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Leukoc Biol. 2010 May;87(5):815-22</RefSource>
                <PMID Version="1">20123678</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell. 2010 May 28;38(4):576-89</RefSource>
                <PMID Version="1">20513432</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2010 Nov 5;330(6005):841-5</RefSource>
                <PMID Version="1">20966214</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2010 Nov 11;116(19):3955-63</RefSource>
                <PMID Version="1">20682855</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Res. 2010 Nov 15;70(22):9413-22</RefSource>
                <PMID Version="1">21045155</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Tissue Res. 2011 Jan;343(1):33-41</RefSource>
                <PMID Version="1">20824287</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2011;6(1):e15723</RefSource>
                <PMID Version="1">21249125</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2011 Feb 25;34(2):237-46</RefSource>
                <PMID Version="1">21333554</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bone Miner Res. 2011 Jul;26(7):1517-32</RefSource>
                <PMID Version="1">21305607</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Pathol. 2011 Sep;179(3):1243-56</RefSource>
                <PMID Version="1">21762674</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2012 Feb 23;119(8):1810-20</RefSource>
                <PMID Version="1">22186992</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2012 Dec;13(12):1145-54</RefSource>
                <PMID Version="1">23160217</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2012 Dec;42(12):3150-66</RefSource>
                <PMID Version="1">22936024</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mucosal Immunol. 2013 Jan;6(1):104-13</RefSource>
                <PMID Version="1">22718260</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2012 Apr 6;336(6077):86-90</RefSource>
                <PMID Version="1">22442384</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunobiology. 2012 Jun;217(6):643-51</RefSource>
                <PMID Version="1">22204814</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Cancer. 2012 Jul 15;131(2):287-97</RefSource>
                <PMID Version="1">21823119</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2012 Jun 4;209(6):1167-81</RefSource>
                <PMID Version="1">22565823</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2012 Jun 4;209(6):1135-52</RefSource>
                <PMID Version="1">22615127</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Biol. 2012 Jul 15;367(2):100-13</RefSource>
                <PMID Version="1">22542597</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2012 Aug;13(8):753-60</RefSource>
                <PMID Version="1">22729249</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cytokine. 2012 Dec;60(3):793-805</RefSource>
                <PMID Version="1">22974529</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2013 Aug 1;122(5):674-83</RefSource>
                <PMID Version="1">23775714</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2013 Sep;14(9):937-48</RefSource>
                <PMID Version="1">23913046</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2013 Oct 21;210(11):2477-91</RefSource>
                <PMID Version="1">24101381</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2013 Aug;14(8):821-30</RefSource>
                <PMID Version="1">23812096</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2002 Jan 1;168(1):57-64</RefSource>
                <PMID Version="1">11751946</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genes Dev. 2002 Jul 1;16(13):1721-37</RefSource>
                <PMID Version="1">12101129</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Leukoc Biol. 2002 Oct;72(4):621-7</RefSource>
                <PMID Version="1">12377929</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2003 Feb 1;101(3):1155-63</RefSource>
                <PMID Version="1">12393599</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2003 Jul;19(1):71-82</RefSource>
                <PMID Version="1">12871640</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nucleic Acids Res. 2003 Oct 15;31(20):5805-16</RefSource>
                <PMID Version="1">14530429</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 1983 Jul;97(1):253-7</RefSource>
                <PMID Version="1">6345555</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4138162</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105429</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-26080</ArticleId>
            <ArticleId IdType="pubmed">25137049</ArticleId>
            <ArticleId IdType="pmc">PMC4138162</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137047</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1555-8584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>RNA biology</Title>
                <ISOAbbreviation>RNA Biol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Coupling of X-Chromosome reactivation with the pluripotent stem cell state.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">X-chromosome inactivation (XCI) in female mammals is a dramatic example of epigenetic gene regulation, which entails the silencing of an entire chromosome through a wide range of mechanisms involving noncoding RNAs, chromatin-modifications, and DNA-methylation. While XCI is associated with the differentiated cell state, it is reversed by X-chromosome reactivation (XCR) ex vivo in pluripotent stem cells and in vivo in the early mouse embryo and the germline. Critical in the regulation of XCI vs. XCR is the X-inactivation center, a multigene locus on the X-chromosome harboring several long noncoding RNA genes including, most prominently, Xist and Tsix. These genes, which sit at the top of the XCI hierarchy, are by themselves controlled by pluripotency factors, coupling XCR with the na??ve pluripotent stem cell state. In this point-of-view article we review the latest findings regarding this intricate relationship between cell differentiation state and epigenetic control of the X-chromosome. In particular, we discuss the emerging picture of complex multifactorial regulatory mechanisms, ensuring both a fine-tuned and robust X-reactivation process.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Payer</LastName>
                    <ForeName>Bernhard</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Howard Hughes Medical Institute; Department of Molecular Biology; Massachusetts General Hospital; Department of Genetics; Harvard Medical School; Boston, MA USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Jeannie T</ForeName>
                    <Initials>JT</Initials>
                    <Affiliation>Howard Hughes Medical Institute; Department of Molecular Biology; Massachusetts General Hospital; Department of Genetics; Harvard Medical School; Boston, MA USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>RNA Biol</MedlineTA>
            <NlmUniqueID>101235328</NlmUniqueID>
            <ISSNLinking>1547-6286</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">PRDM14</Keyword>
            <Keyword MajorTopicYN="N">Tsix</Keyword>
            <Keyword MajorTopicYN="N">X-chromosome reactivation</Keyword>
            <Keyword MajorTopicYN="N">Xist</Keyword>
            <Keyword MajorTopicYN="N">epigenetics</Keyword>
            <Keyword MajorTopicYN="N">long noncoding RNA</Keyword>
            <Keyword MajorTopicYN="N">pluripotency</Keyword>
            <Keyword MajorTopicYN="N">reprogramming</Keyword>
            <Keyword MajorTopicYN="N">stem cells</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">29779</ArticleId>
            <ArticleId IdType="pubmed">25137047</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25137044</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Glycoconjugate Vaccine Containing Escherichia coli O157:H7 O-Antigen Linked with Maltose-Binding Protein Elicits Humoral and Cellular Responses.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105215</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105215</ELocationID>
            <Abstract>
                <AbstractText>Glycoconjugate is one of the most efficacious and safest vaccines against bacterial pathogens. Previous studies of glycoconjugates against pathogen E. coli O157:H7 focused more on the humoral responses they elicited. However, little was known about their cellular responses. In this study, we exploited a novel approach based on bacterial protein N-linked glycosylation system to produce glycoconjugate containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein and examined its humoral and cellular responses in BALB/c mice. The transfer of E. coli O157:H7 O-antigen to MBP was confirmed by western blot and MALDI-TOF MS. Mice injected with glycoconjugate O-Ag-MBP elicited serum bactericidal antibodies including anti-E. coli O157:H7 O-antigen IgG and IgM. Interestingly, O-Ag-MBP also stimulated the secretion of anti-E. coli O157:H7 O-antigen IgA in intestine. In addition, O-Ag-MBP stimulated cellular responses by recruiting Th1-biased CD4+ T cells, CD8+ T cells. Meanwhile, O-Ag-MBP induced the upregulation of Th1-related IFN-?? and downregulation of Th2-related IL-4, and the upregulation of IFN-?? was stimulated by MBP in a dose-dependent manner. MBP showed TLR4 agonist-like properties to activate Th1 cells as carrier protein of O-Ag-MBP. Thus, glycoconjugate vaccine E. coli O157:H7-specific O-Ag-MBP produced by bacterial protein N-linked glycosylation system was able to elicit both humoral and Th1-biased cellular responses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Zhongrui</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>School of Life Sciences and The State Key Laboratory of Microbial Technology, National Glycoengineering Research Center, Shandong University, Jinan, Shandong, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Huajie</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>School of Life Sciences and The State Key Laboratory of Microbial Technology, National Glycoengineering Research Center, Shandong University, Jinan, Shandong, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shang</LastName>
                    <ForeName>Wenjing</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, Shandong, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Faliang</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Immunology, Shandong University School of Medicine, Jinan, Shandong, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Weiqing</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>College of Pharmacy and the State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Xueer</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>School of Life Sciences and The State Key Laboratory of Microbial Technology, National Glycoengineering Research Center, Shandong University, Jinan, Shandong, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Donglei</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>School of Life Sciences and The State Key Laboratory of Microbial Technology, National Glycoengineering Research Center, Shandong University, Jinan, Shandong, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Peng George</ForeName>
                    <Initials>PG</Initials>
                    <Affiliation>School of Life Sciences and The State Key Laboratory of Microbial Technology, National Glycoengineering Research Center, Shandong University, Jinan, Shandong, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>School of Life Sciences and The State Key Laboratory of Microbial Technology, National Glycoengineering Research Center, Shandong University, Jinan, Shandong, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 1999 Nov;67(11):6191-3</RefSource>
                <PMID Version="1">10531288</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2014 Jan 3;343(6166):1235681</RefSource>
                <PMID Version="1">24385630</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Can J Microbiol. 2000 Mar;46(3):283-90</RefSource>
                <PMID Version="1">10749542</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 2000 Jun 29;342(26):1930-6</RefSource>
                <PMID Version="1">10874060</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Biotechnol. 2000 May;15(1):51-63</RefSource>
                <PMID Version="1">10911622</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Protein Sci. 2001 Mar;10(3):622-30</RefSource>
                <PMID Version="1">11344330</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2002 Mar 1;168(5):2240-6</RefSource>
                <PMID Version="1">11859111</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Carbohydr Res. 2003 Nov 14;338(23):2539-47</RefSource>
                <PMID Version="1">14670715</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Expert Rev Vaccines. 2003 Oct;2(5):633-48</RefSource>
                <PMID Version="1">14711325</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br Med J. 1978 Jun 10;1(6126):1518-21</RefSource>
                <PMID Version="1">350345</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Immunol. 1986;4:389-417</RefSource>
                <PMID Version="1">3518747</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Basic Microbiol. 1988;28(7):437-44</RefSource>
                <PMID Version="1">3065478</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Microbiol. 1991 Aug;5(8):1873-81</RefSource>
                <PMID Version="1">1722557</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann Intern Med. 1995 Nov 1;123(9):698-714</RefSource>
                <PMID Version="1">7574226</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Infect Dis. 1997 Mar;175(3):611-20</RefSource>
                <PMID Version="1">9041333</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Infect Dis. 1998 Feb;177(2):383-7</RefSource>
                <PMID Version="1">9466525</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 1998 Aug;66(8):3545-51</RefSource>
                <PMID Version="1">9673232</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Can J Microbiol. 1999 Apr;45(4):279-86</RefSource>
                <PMID Version="1">10420579</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3016-21</RefSource>
                <PMID Version="1">15703289</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Res. 2005 Nov 15;65(22):10555-61</RefSource>
                <PMID Version="1">16288048</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2006 Dec 1;177(11):7980-9</RefSource>
                <PMID Version="1">17114471</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2007 Mar;75(3):1359-63</RefSource>
                <PMID Version="1">17220311</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microb Cell Fact. 2010;9:61</RefSource>
                <PMID Version="1">20701771</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Appl Environ Microbiol. 2011 Feb;77(3):871-81</RefSource>
                <PMID Version="1">21131519</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vaccine. 2011 Jul 12;29(31):4881-90</RefSource>
                <PMID Version="1">21549783</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Med. 2012;10:12</RefSource>
                <PMID Version="1">22300510</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microb Cell Fact. 2012;11:13</RefSource>
                <PMID Version="1">22276812</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Expert Opin Biol Ther. 2013 Jan;13(1):11-33</RefSource>
                <PMID Version="1">22992106</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Open Biol. 2013 May;3(5):130002</RefSource>
                <PMID Version="1">23697804</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Glycoconj J. 2013 Jul;30(5):511-22</RefSource>
                <PMID Version="1">23053636</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 1999 Dec 3;274(49):35129-38</RefSource>
                <PMID Version="1">10574995</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4138118</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105215</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-15106</ArticleId>
            <ArticleId IdType="pubmed">25137044</ArticleId>
            <ArticleId IdType="pmc">PMC4138118</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25137043</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Molecular Signatures of the Evolving Immune Response in Mice following a Bordetella pertussis Infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e104548</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0104548</ELocationID>
            <Abstract>
                <AbstractText>Worldwide resurgence of pertussis necessitates the need for improvement of pertussis vaccines and vaccination strategies. Since natural infections induce a longer-lasting immunity than vaccinations, detailed knowledge of the immune responses following natural infection can provide important clues for such improvement. The purpose was to elucidate the kinetics of the protective immune response evolving after experimental Bordetella pertussis (B. pertussis) infection in mice. Data were collected from (i) individual analyses, i.e. microarray, flow cytometry, multiplex immunoassays, and bacterial clearance; (ii) twelve time points during the infection; and (iii) different tissues involved in the immune responses, i.e. lungs, spleen and blood. Combined data revealed detailed insight in molecular and cellular sequence of events connecting different phases (innate, bridging and adaptive) of the immune response following the infection. We detected a prolonged acute phase response, broad pathogen recognition, and early gene signatures of subsequent T-cell recruitment in the lungs. Activation of particular transcription factors and specific cell markers provided insight into the time course of the transition from innate towards adaptive immune responses, which resulted in a broad spectrum of systemic antibody subclasses and splenic Th1/Th17 memory cells against B. pertussis. In addition, signatures preceding the local generation of Th1 and Th17 cells as well as IgA in the lungs, considered key elements in protection against B. pertussis, were established. In conclusion, molecular and cellular immunological processes in response to live B. pertussis infection were unraveled, which may provide guidance in selecting new vaccine candidates that should evoke local and prolonged protective immune responses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Raeven</LastName>
                    <ForeName>Ren?? H M</ForeName>
                    <Initials>RH</Initials>
                    <Affiliation>Intravacc, Bilthoven, The Netherlands; Division of Drug Delivery Technology, Leiden Academic Centre for Drug Research, Leiden, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brummelman</LastName>
                    <ForeName>Jolanda</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pennings</LastName>
                    <ForeName>Jeroen L A</ForeName>
                    <Initials>JL</Initials>
                    <Affiliation>Centre for Health Protection (GZB), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nijst</LastName>
                    <ForeName>Olaf E M</ForeName>
                    <Initials>OE</Initials>
                    <Affiliation>Intravacc, Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuipers</LastName>
                    <ForeName>Betsy</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Blok</LastName>
                    <ForeName>Laura E R</ForeName>
                    <Initials>LE</Initials>
                    <Affiliation>Intravacc, Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Helm</LastName>
                    <ForeName>Kina</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>van Riet</LastName>
                    <ForeName>Elly</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Intravacc, Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiskoot</LastName>
                    <ForeName>Wim</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Division of Drug Delivery Technology, Leiden Academic Centre for Drug Research, Leiden, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>van Els</LastName>
                    <ForeName>Cecile A C M</ForeName>
                    <Initials>CA</Initials>
                    <Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Wanda G H</ForeName>
                    <Initials>WG</Initials>
                    <Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kersten</LastName>
                    <ForeName>Gideon F A</ForeName>
                    <Initials>GF</Initials>
                    <Affiliation>Intravacc, Bilthoven, The Netherlands; Division of Drug Delivery Technology, Leiden Academic Centre for Drug Research, Leiden, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Metz</LastName>
                    <ForeName>Bernard</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Intravacc, Bilthoven, The Netherlands.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genes Dev. 2005 Nov 15;19(22):2645-55</RefSource>
                <PMID Version="1">16291643</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2005 Dec;115(12):3594-601</RefSource>
                <PMID Version="1">16294220</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2006 Feb 15;176(4):2069-73</RefSource>
                <PMID Version="1">16455961</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2006 May;74(5):2596-605</RefSource>
                <PMID Version="1">16622195</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Pathog. 2006 Jul;2(7):e65</RefSource>
                <PMID Version="1">16839199</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2006 Jul 21;281(29):20440-9</RefSource>
                <PMID Version="1">16682406</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2006 Aug 15;177(4):2051-5</RefSource>
                <PMID Version="1">16887962</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Pharmacol. 2007 Jun;7(3):272-8</RefSource>
                <PMID Version="1">17418639</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mucosal Immunol. 2009 Sep;2(5):403-11</RefSource>
                <PMID Version="1">19587639</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genome Biol. 2009;10(11):R130</RefSource>
                <PMID Version="1">19919682</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Physiol. 2010;72:413-35</RefSource>
                <PMID Version="1">20148683</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMJ. 2013;347:f4249</RefSource>
                <PMID Version="1">23873919</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Autoimmun Rev. 2013 Sep;12(11):1091-100</RefSource>
                <PMID Version="1">23792703</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microbes Infect. 2013 Sep-Oct;15(10-11):708-18</RefSource>
                <PMID Version="1">23811096</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):787-92</RefSource>
                <PMID Version="1">24277828</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Epidemiol Infect. 2014 Apr;142(4):685-94</RefSource>
                <PMID Version="1">23406868</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Leukoc Biol. 2013 Sep;94(3):439-48</RefSource>
                <PMID Version="1">23794711</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2004 May;72(5):2477-83</RefSource>
                <PMID Version="1">15102754</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 1990 Aug;20(8):1709-15</RefSource>
                <PMID Version="1">2120063</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 1993 Feb;61(2):399-410</RefSource>
                <PMID Version="1">8423070</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 1994 Mar 1;179(3):881-7</RefSource>
                <PMID Version="1">7509365</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 1995 Mar;25(3):823-9</RefSource>
                <PMID Version="1">7705414</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 1995 Jun 1;154(11):6048-57</RefSource>
                <PMID Version="1">7751647</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Infect Dis. 1997 May;175(5):1246-50</RefSource>
                <PMID Version="1">9129097</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 1997 Jun;65(6):2168-74</RefSource>
                <PMID Version="1">9169747</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Vaccine Immunol. 2011 Apr;18(4):595-603</RefSource>
                <PMID Version="1">21325488</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2011 May 1;186(9):5388-96</RefSource>
                <PMID Version="1">21430219</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2011;6(4):e18866</RefSource>
                <PMID Version="1">21533146</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Genet. 2011 Jun;7(6):e1002097</RefSource>
                <PMID Version="1">21731497</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2011 Aug 1;208(8):1661-71</RefSource>
                <PMID Version="1">21727189</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2007 Jun;8(6):639-46</RefSource>
                <PMID Version="1">17486092</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunogenetics. 2007 Jul;59(7):555-64</RefSource>
                <PMID Version="1">17487483</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2007 Jul 26;448(7152):501-5</RefSource>
                <PMID Version="1">17618271</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Adv Immunol. 2007;96:179-204</RefSource>
                <PMID Version="1">17981207</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2007 Dec 1;179(11):7791-9</RefSource>
                <PMID Version="1">18025225</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2008 Feb 1;319(5863):624-7</RefSource>
                <PMID Version="1">18239127</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2008 Mar 15;180(6):4032-9</RefSource>
                <PMID Version="1">18322212</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2008 Nov;76(11):5139-48</RefSource>
                <PMID Version="1">18765723</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2008 Dec;9(12):1341-6</RefSource>
                <PMID Version="1">18931678</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Soc Trans. 2008 Dec;36(Pt 6):1478-81</RefSource>
                <PMID Version="1">19021579</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2008 Dec 15;181(12):8521-7</RefSource>
                <PMID Version="1">19050270</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Protoc. 2009;4(1):44-57</RefSource>
                <PMID Version="1">19131956</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Hematol. 2009 Feb;37(2):266-75</RefSource>
                <PMID Version="1">19100676</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2009 Apr 15;182(8):4507-11</RefSource>
                <PMID Version="1">19342622</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Immunol Immunother. 2009 Jul;58(7):1149-57</RefSource>
                <PMID Version="1">18998127</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Immunol. 2009 May;30(5):209-17</RefSource>
                <PMID Version="1">19359216</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Leukoc Biol. 2009 Aug;86(2):251-9</RefSource>
                <PMID Version="1">19401396</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2009 Aug 3;206(8):1653-60</RefSource>
                <PMID Version="1">19596803</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2009 Aug 15;183(4):2513-21</RefSource>
                <PMID Version="1">19625643</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microbiol Mol Biol Rev. 2010 Mar;74(1):81-94</RefSource>
                <PMID Version="1">20197500</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2010 May 14;285(20):15268-77</RefSource>
                <PMID Version="1">20231290</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Med. 2010 Jun;7(6):e1000291</RefSource>
                <PMID Version="1">20585374</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14292-7</RefSource>
                <PMID Version="1">20660725</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2010 Aug 19;466(7309):973-7</RefSource>
                <PMID Version="1">20725040</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2010 Nov;238(1):63-75</RefSource>
                <PMID Version="1">20969585</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Genomics. 2010;11:627</RefSource>
                <PMID Version="1">21070624</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Cell Res. 2011 Mar 10;317(5):613-9</RefSource>
                <PMID Version="1">21376174</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2011 Dec 23;35(6):958-71</RefSource>
                <PMID Version="1">22177923</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2012 Feb 1;188(3):1421-30</RefSource>
                <PMID Version="1">22219321</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Immunol. 2012 Feb;33(2):98-102</RefSource>
                <PMID Version="1">22075207</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Dev Immunol. 2012;2012:795958</RefSource>
                <PMID Version="1">22550536</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2012 Jun 15;188(12):6399-406</RefSource>
                <PMID Version="1">22611239</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Host Microbe. 2012 Jul 19;12(1):34-46</RefSource>
                <PMID Version="1">22817986</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12123-8</RefSource>
                <PMID Version="1">22783014</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 2012 Aug 30;367(9):785-7</RefSource>
                <PMID Version="1">22894554</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Biophys Res Commun. 2012 Sep 7;425(4):918-23</RefSource>
                <PMID Version="1">22906740</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18529-34</RefSource>
                <PMID Version="1">23091043</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Expert Rev Vaccines. 2012 Sep;11(9):1121-37</RefSource>
                <PMID Version="1">23151168</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2012 Dec;42(12):3346-57</RefSource>
                <PMID Version="1">22965758</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2013 Mar 14;121(11):1951-60</RefSource>
                <PMID Version="1">23293083</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Syst Biol. 2013;9:659</RefSource>
                <PMID Version="1">23591775</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Pathog. 2013;9(4):e1003264</RefSource>
                <PMID Version="1">23592988</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2013 Jul;81(7):2371-8</RefSource>
                <PMID Version="1">23630952</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mucosal Immunol. 2013 Jul;6(4):787-96</RefSource>
                <PMID Version="1">23187316</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2013 Jul 3;154(1):197-212</RefSource>
                <PMID Version="1">23827683</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2013 Jul 3;154(1):213-27</RefSource>
                <PMID Version="1">23827684</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Immunol Ther Exp (Warsz). 2011 Dec;59(6):431-40</RefSource>
                <PMID Version="1">21972017</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2011;6(11):e27384</RefSource>
                <PMID Version="1">22096565</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2011;6(11):e27681</RefSource>
                <PMID Version="1">22110718</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Crit Rev Immunol. 1999;19(5-6):481-508</RefSource>
                <PMID Version="1">10647747</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2000 Mar;68(3):1235-42</RefSource>
                <PMID Version="1">10678932</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2000 Jun 5;191(11):1841-52</RefSource>
                <PMID Version="1">10839801</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pac Symp Biocomput. 2000;:455-66</RefSource>
                <PMID Version="1">10902193</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vaccine. 2000 Nov 8;19(6):637-43</RefSource>
                <PMID Version="1">11090715</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2001 Aug;69(8):4846-50</RefSource>
                <PMID Version="1">11447159</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Endotoxin Res. 2000;6(5):389-91</RefSource>
                <PMID Version="1">11521060</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2001 Dec 1;167(11):6545-51</RefSource>
                <PMID Version="1">11714823</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2002 Jan 21;195(2):221-31</RefSource>
                <PMID Version="1">11805149</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2002 Jun;3(6):549-57</RefSource>
                <PMID Version="1">12006974</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2003 Jan 3;278(1):289-95</RefSource>
                <PMID Version="1">12417585</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2003 Feb;3(2):159-67</RefSource>
                <PMID Version="1">12563299</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2003 Apr;71(4):1719-24</RefSource>
                <PMID Version="1">12654784</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Respir Cell Mol Biol. 2003 Jun;28(6):648-54</RefSource>
                <PMID Version="1">12760962</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microb Pathog. 2003 Jul;35(1):19-29</RefSource>
                <PMID Version="1">12860455</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Infect Dis. 2004 Mar 1;189(5):833-6</RefSource>
                <PMID Version="1">14976600</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 1997 Sep 26;277(5334):2005-7</RefSource>
                <PMID Version="1">9302298</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 1997 Dec;65(12):4904-8</RefSource>
                <PMID Version="1">9393774</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 1998 Feb;66(2):594-602</RefSource>
                <PMID Version="1">9453614</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 1998 Jan;28(1):153-63</RefSource>
                <PMID Version="1">9485195</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 1999 Jan 1;162(1):186-94</RefSource>
                <PMID Version="1">9886385</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Microbiol. 1999 May;38(5):273-8</RefSource>
                <PMID Version="1">10355115</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2004 Dec 1;173(11):6592-602</RefSource>
                <PMID Version="1">15557149</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2005 Mar;22(3):285-94</RefSource>
                <PMID Version="1">15780986</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Protein Expr Purif. 2005 May;41(1):106-12</RefSource>
                <PMID Version="1">15802227</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Microbiol Rev. 2005 Apr;18(2):326-82</RefSource>
                <PMID Version="1">15831828</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pediatr Infect Dis J. 2005 May;24(5 Suppl):S58-61</RefSource>
                <PMID Version="1">15876927</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Immunol. 2005 Jun;17(3):290-7</RefSource>
                <PMID Version="1">15886119</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Respir Cell Mol Biol. 2005 Jun;32(6):531-9</RefSource>
                <PMID Version="1">15778492</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Res. 2005 Jun;15(6):407-22</RefSource>
                <PMID Version="1">15987599</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2005 Jul 15;175(2):730-8</RefSource>
                <PMID Version="1">16002668</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Growth Factors. 2005 Mar;23(1):33-41</RefSource>
                <PMID Version="1">16019425</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2005 Aug;206:83-99</RefSource>
                <PMID Version="1">16048543</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pediatr Infect Dis J. 2005 Sep;24(9):761-5</RefSource>
                <PMID Version="1">16148840</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4138111</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0104548</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-11579</ArticleId>
            <ArticleId IdType="pubmed">25137043</ArticleId>
            <ArticleId IdType="pmc">PMC4138111</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25137039</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Enhanced Cross-Presentation and Improved CD8+ T Cell Responses after Mannosylation of Synthetic Long Peptides in Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e103755</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0103755</ELocationID>
            <Abstract>
                <AbstractText>The use of synthetic long peptides (SLP) has been proven to be a promising approach to induce adaptive immune responses in vaccination strategies. Here, we analyzed whether the efficiency to activate cytotoxic T cells by SLP-based vaccinations can be increased by conjugating SLPs to mannose residues. We could demonstrate that mannosylation of SLPs results in increased internalization by the mannose receptor (MR) on murine antigen-presenting cells. MR-mediated internalization targeted the mannosylated SLPs into early endosomes, from where they were cross-presented very efficiently compared to non-mannosylated SLPs. The influence of SLP mannosylation was specific for cross-presentation, as no influence on MHC II-restricted presentation was observed. Additionally, we showed that vaccination of mice with mannosylated SLPs containing epitopes from either ovalbumin or HPV E7 resulted in enhanced proliferation and activation of antigen-specific CD8+ T cells. These findings demonstrate that mannosylation of SLPs augments the induction of a cytotoxic T cell response in vitro and in vivo and might be a promising approach to induce cytotoxic T cell responses in e.g. cancer therapy and anti-viral immunity.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rauen</LastName>
                    <ForeName>Judith</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kreer</LastName>
                    <ForeName>Christoph</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paillard</LastName>
                    <ForeName>Arlette</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>van Duikeren</LastName>
                    <ForeName>Suzanne</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Benckhuijsen</LastName>
                    <ForeName>Willemien E</ForeName>
                    <Initials>WE</Initials>
                    <Affiliation>Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Camps</LastName>
                    <ForeName>Marcel G</ForeName>
                    <Initials>MG</Initials>
                    <Affiliation>Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Valentijn</LastName>
                    <ForeName>A Rob P M</ForeName>
                    <Initials>AR</Initials>
                    <Affiliation>Department of Bio-organic Synthesis, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ossendorp</LastName>
                    <ForeName>Ferry</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Drijfhout</LastName>
                    <ForeName>Jan W</ForeName>
                    <Initials>JW</Initials>
                    <Affiliation>Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arens</LastName>
                    <ForeName>Ramon</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Burgdorf</LastName>
                    <ForeName>Sven</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Life and Medical Sciences Institute, University of Bonn, Bonn, Germany; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 1990 Dec 1;172(6):1785-94</RefSource>
                <PMID Version="1">2258707</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Adv Immunol. 2012;114:51-76</RefSource>
                <PMID Version="1">22449778</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vaccine. 1996 Jun;14(9):930-8</RefSource>
                <PMID Version="1">8843637</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 1997 Sep;27(9):2417-25</RefSource>
                <PMID Version="1">9341788</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 1997 Sep;27(9):2426-35</RefSource>
                <PMID Version="1">9341789</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 1999 Feb;29(2):571-80</RefSource>
                <PMID Version="1">10064073</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Expert Opin Biol Ther. 2004 Dec;4(12):1953-62</RefSource>
                <PMID Version="1">15571457</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2004 Dec 15;104(13):4038-45</RefSource>
                <PMID Version="1">15304394</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neuroimmunol. 2005 Mar;160(1-2):178-87</RefSource>
                <PMID Version="1">15710471</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2006 Jun 1;176(11):6770-6</RefSource>
                <PMID Version="1">16709836</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Adv Immunol. 2012;114:177-201</RefSource>
                <PMID Version="1">22449782</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Adv Immunol. 2012;114:217-43</RefSource>
                <PMID Version="1">22449784</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2012 Sep 6;120(10):2011-20</RefSource>
                <PMID Version="1">22791285</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2012 Oct 1;189(7):3397-403</RefSource>
                <PMID Version="1">22914049</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Semin Immunol. 2013 Apr;25(2):182-90</RefSource>
                <PMID Version="1">23706598</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Soc Mass Spectrom. 2000 Jun;11(6):564-71</RefSource>
                <PMID Version="1">10833030</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2000 Jun;30(6):1714-23</RefSource>
                <PMID Version="1">10898509</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2001 Aug 3;276(31):28939-45</RefSource>
                <PMID Version="1">11384997</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2002 Mar 1;168(5):2118-26</RefSource>
                <PMID Version="1">11859097</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2002 Jul 1;169(1):350-8</RefSource>
                <PMID Version="1">12077264</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2002 Aug;17(2):211-20</RefSource>
                <PMID Version="1">12196292</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2003 Nov 1;171(9):4552-60</RefSource>
                <PMID Version="1">14568928</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Cell Res. 2006 Jul 15;312(12):2238-51</RefSource>
                <PMID Version="1">16650848</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2006 Jul 14;126(1):205-18</RefSource>
                <PMID Version="1">16839887</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Pathol. 2007 Jan;170(1):272-80</RefSource>
                <PMID Version="1">17200200</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vaccine. 2007 Feb 9;25(8):1379-89</RefSource>
                <PMID Version="1">17123670</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2007 Apr 15;178(8):4975-83</RefSource>
                <PMID Version="1">17404279</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2007 Apr 27;316(5824):612-6</RefSource>
                <PMID Version="1">17463291</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2007 May 15;178(10):6259-67</RefSource>
                <PMID Version="1">17475854</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2007 Oct 15;179(8):5033-40</RefSource>
                <PMID Version="1">17911588</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int Immunol. 2008 Jan;20(1):117-27</RefSource>
                <PMID Version="1">18024466</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2008 May;9(5):558-66</RefSource>
                <PMID Version="1">18376402</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Cancer. 2008 May;8(5):351-60</RefSource>
                <PMID Version="1">18418403</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2009 Feb;39(2):380-90</RefSource>
                <PMID Version="1">19130478</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6730-5</RefSource>
                <PMID Version="1">19346487</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 2009 Nov 5;361(19):1838-47</RefSource>
                <PMID Version="1">19890126</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9933-8</RefSource>
                <PMID Version="1">21628571</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2011 Aug 1;187(3):1201-6</RefSource>
                <PMID Version="1">21709154</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2011 Dec 9;147(6):1355-68</RefSource>
                <PMID Version="1">22153078</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microb Biotechnol. 2012 Mar;5(2):149-55</RefSource>
                <PMID Version="1">21880117</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7855-60</RefSource>
                <PMID Version="1">8755566</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4138033</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0103755</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-14530</ArticleId>
            <ArticleId IdType="pubmed">25137039</ArticleId>
            <ArticleId IdType="pmc">PMC4138033</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137029</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1945-7170</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Endocrinology</Title>
                <ISOAbbreviation>Endocrinology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In Vivo Fluorescence Imaging and Urinary Monoamines as Surrogate Biomarkers of Disease Progression in a Mouse Model of Pheochromocytoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>en20141431</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Pheochromocytoma is a rare but potentially lethal neuroendocrine tumor arising from catecholamine producing chromaffin cells. Especially for metastatic pheochromocytoma, the availability of animal models is essential for developing novel therapies. For evaluating therapeutic outcome in rodent pheochromocytoma models reliable quantification of multiple organ lesions depends on dedicated small animal in vivo imaging, which is still challenging and only available at specialized research facilities. Here, we investigated whether whole-body fluorescence imaging and monitoring of urinary free monoamines provide suitable parameters for measuring tumor progression in a murine allograft model of pheochromocytoma. We generated an mCherry-expressing mouse pheochromocytoma cell line by lentiviral gene transfer. These cells were injected subcutaneously into nude mice to perform whole-body fluorescence imaging of tumor development. Urinary free monoamines were measured by liquid chromatography with tandem mass spectrometry. Tumor fluorescence intensity and urinary outputs of monoamines showed tumor growth-dependent increases ( &lt; 0.001) over the 30 days of monitoring post tumor engraftment. Concomitantly, systolic blood pressure was increased significantly during tumor growth. Tumor volume correlated significantly ( &lt; 0.001) and strongly with tumor fluorescence intensity (= 0.946) and urinary outputs of dopamine ( = 0.952), methoxytyramine ( = 0.947), norepinephrine ( = 0.756) and normetanephrine ( = 0.949). Dopamine and methoxytyramine outputs allowed for detection of lesions at diameters below 2.3 mm. Our results demonstrate that MPC-mCherry cell tumors are functionally similar to human pheochromocytoma. Both tumor fluorescence intensity and urinary outputs of free monoamines provide precise parameters of tumor progression in this subcutaneous mouse model of pheochromocytoma. This animal model will allow for testing new treatment strategies for chromaffin cell tumors.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ullrich</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Dept. of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany;</Affiliation>
                </Author>
                <Author>
                    <LastName>Bergmann</LastName>
                    <ForeName>Ralf</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Peitzsch</LastName>
                    <ForeName>Mirko</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Cartellieri</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Qin</LastName>
                    <ForeName>Nan</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Ehrhart-Bornstein</LastName>
                    <ForeName>Monika</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Block</LastName>
                    <ForeName>Norman L</ForeName>
                    <Initials>NL</Initials>
                </Author>
                <Author>
                    <LastName>Schally</LastName>
                    <ForeName>Andrew V</ForeName>
                    <Initials>AV</Initials>
                </Author>
                <Author>
                    <LastName>Pietzsch</LastName>
                    <ForeName>Jens</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Eisenhofer</LastName>
                    <ForeName>Graeme</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Bornstein</LastName>
                    <ForeName>Stefan R</ForeName>
                    <Initials>SR</Initials>
                </Author>
                <Author>
                    <LastName>Ziegler</LastName>
                    <ForeName>Christian G</ForeName>
                    <Initials>CG</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Endocrinology</MedlineTA>
            <NlmUniqueID>0375040</NlmUniqueID>
            <ISSNLinking>0013-7227</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2014-1431</ArticleId>
            <ArticleId IdType="pubmed">25137029</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137027</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1945-7170</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Endocrinology</Title>
                <ISOAbbreviation>Endocrinology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Role of Melanocortin Signaling in Neuroendocrine and Metabolic Actions of Leptin in Male Rats with Uncontrolled Diabetes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>en20141169</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Although the antidiabetic effects of leptin require intact neuronal melanocortin signaling in rodents with uncontrolled diabetes (uDM), increased melanocortin signaling is not sufficient to mimic leptin's glucose-lowering effects. The current studies were undertaken to clarify the role of melanocortin signaling in leptin's ability to correct metabolic and neuroendocrine disturbances associated with uDM. To accomplish this, bilateral cannulae were implanted in the lateral ventricle of rats with streptozotocin-induced diabetes, and leptin was coinfused with varying doses of the melanocortin 3/4 receptor (MC3/4R) antagonist, SHU9119. An additional cohort of streptozotocin-induced diabetes rats received intracerebroventricular administration of either the MC3/4R agonist, melanotan-II, or its vehicle. Consistent with previous findings, leptin's glucose-lowering effects were blocked by intracerebroventricular SHU9119. In contrast, leptin-mediated suppression of hyperglucagonemia involves both melanocortin dependent and independent mechanisms, and the degree of glucagon inhibition was a associated with reduced plasma ketone body levels. Increased CNS melanocortin signaling alone fails to mimic leptin's ability to correct any of the metabolic or neuroendocrine disturbances associated with uDM. Moreover, the inability of increased melanocortin signaling to lower diabetic hyperglycemia does not appear to be secondary to release of the endogenous MC3/4R inverse agonist, Agouti-related peptide (AgRP), because AgRP knockout mice did not show increased susceptibility to the antidiabetic effects of increased MC3/4R signaling. Overall, these data suggest that 1) AgRP is not a major driver of diabetic hyperglycemia, 2) mechanisms independent of melanocortin signaling contribute to leptin's antidiabetic effects, and 3) melanocortin receptor blockade dissociates leptin's glucose-lowering effect from its action on other features of uDM, including reversal of hyperglucagonemia and ketosis, suggesting that brain control of ketosis, but not blood glucose levels, is glucagon dependent.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Meek</LastName>
                    <ForeName>Thomas H</ForeName>
                    <Initials>TH</Initials>
                    <Affiliation>Diabetes and Obesity Center of Excellence (T.H.M., M.E.M.,. V.D., A.C., G.J.M.), Department of Medicine, University of Washington, Seattle, Washington 98109; and Division of Endocrinology (S.C.C.), Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.</Affiliation>
                </Author>
                <Author>
                    <LastName>Matsen</LastName>
                    <ForeName>Miles E</ForeName>
                    <Initials>ME</Initials>
                </Author>
                <Author>
                    <LastName>Damian</LastName>
                    <ForeName>Vincent</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author>
                    <LastName>Cubelo</LastName>
                    <ForeName>Alex</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Chua</LastName>
                    <ForeName>Streamson C</ForeName>
                    <Initials>SC</Initials>
                    <Suffix>Jr</Suffix>
                </Author>
                <Author>
                    <LastName>Morton</LastName>
                    <ForeName>Gregory J</ForeName>
                    <Initials>GJ</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Endocrinology</MedlineTA>
            <NlmUniqueID>0375040</NlmUniqueID>
            <ISSNLinking>0013-7227</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2014-1169</ArticleId>
            <ArticleId IdType="pubmed">25137027</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25137025</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1945-7170</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Endocrinology</Title>
                <ISOAbbreviation>Endocrinology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Somatotropinomas, But Not Nonfunctioning Pituitary Adenomas, Maintain a Functional Apoptotic RET/Pit1/ARF/p53 Pathway That Is Blocked by Excess GDNF.</ArticleTitle>
            <Pagination>
                <MedlinePgn>en20141034</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Acromegaly is caused by somatotroph cell adenomas (somatotropinomas [ACROs]), which secrete GH. Human and rodent somatotroph cells express the RET receptor. In rodents, when normal somatotrophs are deprived of the RET ligand, GDNF, RET is processed intracellularly to induce overexpression of Pit1, which in turn leads to p19Arf/p53-dependent apoptosis. Our purpose was to ascertain whether human ACROs maintain the RET/Pit1/p14ARF/p53/apoptosis pathway, relative to nonfunctioning pituitary adenomas (NFPAs). Apoptosis in the absence and presence of GDNF was studied in primary cultures of 7 ACROs and 3 NFPAs. Parallel protein extracts were analyzed for expression of RET, Pit1, p14Arf, p53, and phospho-Akt. When GDNF deprived, ACRO cells, but not NFPAs, presented marked level of apoptosis that was prevented in the presence of GDNF. Apoptosis was accompanied by RET processing, Pit1 accumulation, and p14ARF and p53 induction. GDNF prevented all these effects via activation of phospho-AKT. Overexpression of human Pit1 (hPit1) directly induced p14Arf/p53 and apoptosis in a pituitary cell line. Using in silico studies, 2 cEBP?? consensus-binding sites were found to be 100% conserved in mouse, rat, and hPit1 promoters. Deletion of 1 cEBP?? site prevented the RET-induced increase in hPit1 promoter expression. TaqMan qRT-PCR for RET, Pit1, Arf, TP53, GDNF, SF-1, and GH was performed in RNA from whole ACRO and NFPA tumors. ACRO but not NFPA adenomas express RET and Pit1. GDNF expression in the tumors was positively correlated with RET and negatively correlated with p53. In conclusion, ACROs maintain an active RET/Pit1/p14Arf/p53/apoptosis pathway that is inhibited by GDNF. Disruption of GDNF's survival function might constitute a new therapeutic route in acromegaly.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Diaz-Rodriguez</LastName>
                    <ForeName>Esther</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>CIMUS (E.D.-R., A.R.G.-G., M.G.-L., C.D., C.V.A.), University of Santiago de Compostela, and Department of Endocrinology (I.B.), University Hospital (CHUS), IDIS, Santiago de Compostela, Spain; Departments of Cell Biology, Physiology, and Immunology (A.I.-C., E.G.-P., R.M.L., J.P.C.), and Morphological Sciences (L.J.-R.), University of Cordoba, and Reina Sofia University Hospital (P.B., M.A.G.), Maimonides Institute for Research in Biomedicine of Cordoba, C??rdoba, Spain; Departments of Endocrinology and Pathology (A.L., M.A.J., A.S., E.V.), Hospital Universitario Virgen del Roc??o, IBIS-CSIC, University of Sevilla, Sevilla, Spain; Department of Endocrinology (F.J.T.), Hospital Virgen de la Victoria, and Department of Endocrinology (J.A.G.-A.), Hospital Carlos Haya, Malaga, Spain; and CIBERObn Network (A.I.-C., A.L., F.J.T., P.B., L.J.-R., I.B., C.D., R.M.L., J.P.C., C.V.A.).</Affiliation>
                </Author>
                <Author>
                    <LastName>Garcia-Rendueles</LastName>
                    <ForeName>Angela R</ForeName>
                    <Initials>AR</Initials>
                </Author>
                <Author>
                    <LastName>Ib????ez-Costa</LastName>
                    <ForeName>Alejandro</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Gutierrez-Pascual</LastName>
                    <ForeName>Ester</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Garcia-Lavandeira</LastName>
                    <ForeName>Montserrat</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Leal</LastName>
                    <ForeName>Alfonso</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Japon</LastName>
                    <ForeName>Miguel A</ForeName>
                    <Initials>MA</Initials>
                </Author>
                <Author>
                    <LastName>Soto</LastName>
                    <ForeName>Alfonso</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Venegas</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Tinahones</LastName>
                    <ForeName>Francisco J</ForeName>
                    <Initials>FJ</Initials>
                </Author>
                <Author>
                    <LastName>Garcia-Arnes</LastName>
                    <ForeName>Juan A</ForeName>
                    <Initials>JA</Initials>
                </Author>
                <Author>
                    <LastName>Benito</LastName>
                    <ForeName>Pedro</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Angeles Galvez</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Jimenez-Reina</LastName>
                    <ForeName>Luis</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Bernabeu</LastName>
                    <ForeName>Ignacio</ForeName>
                    <Initials>I</Initials>
                </Author>
                <Author>
                    <LastName>Dieguez</LastName>
                    <ForeName>Carlos</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Luque</LastName>
                    <ForeName>Raul M</ForeName>
                    <Initials>RM</Initials>
                </Author>
                <Author>
                    <LastName>Casta??o</LastName>
                    <ForeName>Justo P</ForeName>
                    <Initials>JP</Initials>
                </Author>
                <Author>
                    <LastName>Alvarez</LastName>
                    <ForeName>Clara V</ForeName>
                    <Initials>CV</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Endocrinology</MedlineTA>
            <NlmUniqueID>0375040</NlmUniqueID>
            <ISSNLinking>0013-7227</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2014-1034</ArticleId>
            <ArticleId IdType="pubmed">25137025</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136982</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-8259</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Computer methods in biomechanics and biomedical engineering</Title>
                <ISOAbbreviation>Comput Methods Biomech Biomed Engin</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Registration of 2D histological sections with 3D micro-CT datasets from small animal vertebrae and tibiae.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-16</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The aim of this study was the registration of digitized thin 2D sections of mouse vertebrae and tibiae used for histomorphometry of trabecular bone structure into 3D micro computed tomography (??CT) datasets of the samples from which the sections were prepared. Intensity-based and segmentation-based registrations (SegRegs) of 2D sections and 3D ??CT datasets were applied. As the 2D sections were deformed during their preparation, affine registration for the vertebrae was used instead of rigid registration. Tibiae sections were additionally cut on the distal end, which subsequently undergone more deformation so that elastic registration was necessary. The Jaccard distance was used as registration quality measure. The quality of intensity-based registrations and SegRegs was practically equal, although precision errors of the elastic registration of segmentation masks in tibiae were lower, while those in vertebrae were lower for the intensity-based registration. Results of SegReg significantly depended on the segmentation of the ??CT datasets. Accuracy errors were reduced from approximately 64% to 42% when applying affine instead of rigid transformations for the vertebrae and from about 43% to 24% when using B-spline instead of rigid transformations for the tibiae. Accuracy errors can also be caused by the difference in spatial resolution between the thin sections (pixel size: 7.25????m) and the ??CT data (voxel size: 15????m). In the vertebrae, average deformations amounted to a 6.7% shortening along the direction of sectioning and a 4% extension along the perpendicular direction corresponding to 0.13-0.17??mm. Maximum offsets in the mouse tibiae were 0.16??mm on average.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Museyko</LastName>
                    <ForeName>Oleg</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>a Institute of Medical Physics, University of Erlangen-Nuremberg , Henkestr. 91, 91052 Erlangen , Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Marshall</LastName>
                    <ForeName>Robert Percy</ForeName>
                    <Initials>RP</Initials>
                </Author>
                <Author>
                    <LastName>Lu</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Hess</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Schett</LastName>
                    <ForeName>Georg</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Amling</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Kalender</LastName>
                    <ForeName>Willi A</ForeName>
                    <Initials>WA</Initials>
                </Author>
                <Author>
                    <LastName>Engelke</LastName>
                    <ForeName>Klaus</ForeName>
                    <Initials>K</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Comput Methods Biomech Biomed Engin</MedlineTA>
            <NlmUniqueID>9802899</NlmUniqueID>
            <ISSNLinking>1025-5842</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">2D???3D image registration</Keyword>
            <Keyword MajorTopicYN="N">deformation quantification</Keyword>
            <Keyword MajorTopicYN="N">histological sections</Keyword>
            <Keyword MajorTopicYN="N">trabecular structure</Keyword>
            <Keyword MajorTopicYN="N">??CT</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10255842.2014.941824</ArticleId>
            <ArticleId IdType="pubmed">25136982</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136890</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2158-3188</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>4</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Translational psychiatry</Title>
                <ISOAbbreviation>Transl Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dysfunctional dopaminergic neurotransmission in asocial BTBR mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e427</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/tp.2014.69</ELocationID>
            <Abstract>
                <AbstractText>Autism spectrum disorders (ASD) are neurodevelopmental conditions characterized by pronounced social and communication deficits and stereotyped behaviours. Recent psychosocial and neuroimaging studies have highlighted reward-processing deficits and reduced dopamine (DA) mesolimbic circuit reactivity in ASD patients. However, the neurobiological and molecular determinants of these deficits remain undetermined. Mouse models recapitulating ASD-like phenotypes could help generate hypotheses about the origin and neurophysiological underpinnings of clinically relevant traits. Here we used functional magnetic resonance imaging (fMRI), behavioural and molecular readouts to probe dopamine neurotransmission responsivity in BTBR T(+) Itpr3(tf)/J mice (BTBR), an inbred mouse line widely used to model ASD-like symptoms owing to its robust social and communication deficits, and high level of repetitive stereotyped behaviours. C57BL/6J (B6) mice were used as normosocial reference comparators. DA reuptake inhibition with GBR 12909 produced significant striatal DA release in both strains, but failed to elicit fMRI activation in widespread forebrain areas of BTBR mice, including mesolimbic reward and striatal terminals. In addition, BTBR mice exhibited no appreciable motor responses to GBR 12909. DA D1 receptor-dependent behavioural and signalling responses were found to be unaltered in BTBR mice, whereas dramatic reductions in pre- and postsynaptic DA D2 and adenosine A2A receptor function was observed in these animals. Overall these results document profoundly compromised DA D2-mediated neurotransmission in BTBR mice, a finding that is likely to have a role in the distinctive social and behavioural deficits exhibited by these mice. Our results call for a deeper investigation of the role of dopaminergic dysfunction in mouse lines exhibiting ASD-like phenotypes, and possibly in ASD patient populations.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Squillace</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Ceinge Biotecnologie Avanzate, Naples, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dodero</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>1] Istituto Italiano di Tecnologia, Center for Neuroscience and Cognitive Systems, Rovereto, Italy [2] Istituto Italiano di Tecnologia, Pavis, Genoa, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Federici</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>1] Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy [2] Laboratorio di Neurologia Sperimentale, IRCCS Fondazione Santa Lucia, Rome, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Migliarini</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Biology, Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Errico</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>1] Ceinge Biotecnologie Avanzate, Naples, Italy [2] Department of Molecular Medicine and Medical Biotechnology, University of Naples 'Federico II', Naples, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Napolitano</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>1] Ceinge Biotecnologie Avanzate, Naples, Italy [2] Department of Molecular Medicine and Medical Biotechnology, University of Naples 'Federico II', Naples, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krashia</LastName>
                    <ForeName>P</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Maio</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Ceinge Biotecnologie Avanzate, Naples, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galbusera</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Istituto Italiano di Tecnologia, Center for Neuroscience and Cognitive Systems, Rovereto, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bifone</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Istituto Italiano di Tecnologia, Center for Neuroscience and Cognitive Systems, Rovereto, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scattoni</LastName>
                    <ForeName>M L</ForeName>
                    <Initials>ML</Initials>
                    <Affiliation>Neurotoxicology and Neuroendocrinology Section, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanit??, Rome, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pasqualetti</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Biology, Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mercuri</LastName>
                    <ForeName>N B</ForeName>
                    <Initials>NB</Initials>
                    <Affiliation>1] Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy [2] Laboratorio di Neurologia Sperimentale, IRCCS Fondazione Santa Lucia, Rome, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Usiello</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>1] Ceinge Biotecnologie Avanzate, Naples, Italy [2] Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples (SUN), Caserta, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gozzi</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Istituto Italiano di Tecnologia, Center for Neuroscience and Cognitive Systems, Rovereto, Italy.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Transl Psychiatry</MedlineTA>
            <NlmUniqueID>101562664</NlmUniqueID>
            <ISSNLinking>2158-3188</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">tp201469</ArticleId>
            <ArticleId IdType="doi">10.1038/tp.2014.69</ArticleId>
            <ArticleId IdType="pubmed">25136890</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136832</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Transient Receptor Potential Vanilloid 2 Cation Channel Is Abundant in Macrophages Accumulating at the Peri-Infarct Zone and May Enhance Their Migration Capacity towards Injured Cardiomyocytes following Myocardial Infarction.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105055</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105055</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">A novel family of transient receptor potential (TRP) channels, that may hold a role in calcium homeostasis, has recently been described. By employing a GeneChip array analysis we have demonstrated a clear and specific upregulation of the TRP vanilloid 2 (TRPV2) mRNA in the left ventricles (LV) 3-5 days post-acute myocardial infarction (MI) compared to sham-operated controls, both in rats and in mice. We sought to characterize the cardiac cellular subpopulations in which TRPV2 is overexpressed upon acute MI.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Lewis rats underwent an acute MI by ligation of the left anterior descending artery or chest opening only (sham). The animals were terminated at various time points and an immunohistochemical (IHC) and immunofloerescent (IFC) staining of the LV sections as well as a flow cytometry analysis of LV-derived cells were carried out, using anti-TRPV2 and anti-monocyte/macrophage antibodies. Rat alveolar macrophage cells, NR8383, transiently transfected with TRPV2 siRNA were allowed to migrate towards hypoxic conditioned media of the rat cardiac myoblast line H9C2 using a trans-well migration assay. The macrophage cells migrating to the bottom side of the inserts were counted.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The IHC and IFC staining as well as the flow cytometry data demonstrated a substantial expression of TRPV2 in infiltrating macrophages in the peri-infarct region 3-5 days post-acute MI. The in vitro migration assay data demonstrated that following inhibition of the TRPV2 channel, the number of migrating macrophages towards conditioned medium of hypoxic cardiomyocytes was significantly reduced.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">TRPV2 is highly expressed on the peri-infarct infiltrating macrophages and may play an important role in post-MI phagocytosis. Better characterization of this channel may pave the way for identifying a new target for modulating the dramatic post-MI immune reactions.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Entin-Meer</LastName>
                    <ForeName>Michal</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Laboratory of Cardiovascular Research, Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Levy</LastName>
                    <ForeName>Ran</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Laboratory of Cardiovascular Research, Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goryainov</LastName>
                    <ForeName>Pavel</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Laboratory of Cardiovascular Research, Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Landa</LastName>
                    <ForeName>Natalie</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Neufeld Cardiac Research Institute, Sheba Medical Center, Ramat Gan, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barshack</LastName>
                    <ForeName>Iris</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Department of Pathology, Sheba Medical Center, Ramat Gan, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Avivi</LastName>
                    <ForeName>Camila</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Pathology, Sheba Medical Center, Ramat Gan, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Semo</LastName>
                    <ForeName>Jonathan</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Laboratory of Cardiovascular Research, Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keren</LastName>
                    <ForeName>Gad</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Laboratory of Cardiovascular Research, Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Endocrinol. 1999 Dec;163(3):433-45</RefSource>
                <PMID Version="1">10588817</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Commun. 2014;5:3932</RefSource>
                <PMID Version="1">24874017</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur Heart J. 1995 Dec;16 Suppl N:37-45</RefSource>
                <PMID Version="1">8682060</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Biophys Res Commun. 1998 Nov 9;252(1):151-5</RefSource>
                <PMID Version="1">9813161</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 1999 Apr 1;398(6726):436-41</RefSource>
                <PMID Version="1">10201375</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Immunol. 2004 Dec;25(12):677-86</RefSource>
                <PMID Version="1">15530839</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Calcium. 2006 Sep;40(3):261-75</RefSource>
                <PMID Version="1">16806461</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Physiol. 2007 Mar;210(3):692-702</RefSource>
                <PMID Version="1">17154364</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hypertension. 2009 Feb;53(2):243-50</RefSource>
                <PMID Version="1">19114647</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Thromb Haemost. 2010 Jan;103(1):188-97</RefSource>
                <PMID Version="1">20062933</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2010 Mar;11(3):232-9</RefSource>
                <PMID Version="1">20118928</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Pharmacol. 2010 Apr;10(2):127-32</RefSource>
                <PMID Version="1">20060363</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 2010 Apr;113(2):313-28</RefSource>
                <PMID Version="1">20132470</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Surg. 2010 Apr;23(2):79-86</RefSource>
                <PMID Version="1">20497009</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cardiovasc Transl Res. 2010 Oct;3(5):516-24</RefSource>
                <PMID Version="1">20652467</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Adv Exp Med Biol. 2011;704:929-45</RefSource>
                <PMID Version="1">21290334</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Endocr Metab Immune Disord Drug Targets. 2011 Mar;11(1):54-67</RefSource>
                <PMID Version="1">21348820</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Physiol. 2011 Apr 1;589(Pt 7):1527-34</RefSource>
                <PMID Version="1">21173080</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Calcium. 2012 Feb;51(2):186-93</RefSource>
                <PMID Version="1">22226146</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Mol Cell Cardiol. 2012 Jul;53(1):134-44</RefSource>
                <PMID Version="1">22561103</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Growth Horm IGF Res. 2012 Dec;22(6):206-11</RefSource>
                <PMID Version="1">23102937</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Mol Cell Cardiol. 2013 Sep;62:24-35</RefSource>
                <PMID Version="1">23644221</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cardiovasc Res. 2013 Sep 1;99(4):760-8</RefSource>
                <PMID Version="1">23786999</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FEBS J. 2013 Nov;280(21):5471-87</RefSource>
                <PMID Version="1">23615321</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biostatistics. 2003 Apr;4(2):249-64</RefSource>
                <PMID Version="1">12925520</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4138115</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105055</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-05696</ArticleId>
            <ArticleId IdType="pubmed">25136832</ArticleId>
            <ArticleId IdType="pmc">PMC4138115</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136821</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-1004</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Human mutation</Title>
                <ISOAbbreviation>Hum. Mutat.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Instability of Trinucleotidic Repeats During Chromatin Remodeling in Spermatids.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/humu.22637</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Transient DNA breaks and evidence of DNA damage response have recently been reported during the chromatin remodeling process in haploid spermatids, creating a potential window of enhanced genetic instability. We used flow cytometry to achieve separation of differentiating spermatids into four highly purified populations using transgenic mice harboring 160 CAG repeats within exon 1 of the human Huntington disease gene (HTT). Trinucleotic repeat expansion was found to occur immediately following the chromatin remodeling steps, confirming the genetic instability of the process and pointing to the origin of paternal anticipation observed in some TNR diseases. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Simard</LastName>
                    <ForeName>Olivier</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Department of Biochemistry, Universit?? de Sherbrooke, Sherbrooke, J1E 4K8, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gr??goire</LastName>
                    <ForeName>Marie-Chantal</ForeName>
                    <Initials>MC</Initials>
                </Author>
                <Author>
                    <LastName>Arguin</LastName>
                    <ForeName>M??lina</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Brazeau</LastName>
                    <ForeName>Marc-Andr??</ForeName>
                    <Initials>MA</Initials>
                </Author>
                <Author>
                    <LastName>Leduc</LastName>
                    <ForeName>Fr??d??ric</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Marois</LastName>
                    <ForeName>Isabelle</ForeName>
                    <Initials>I</Initials>
                </Author>
                <Author>
                    <LastName>Richter</LastName>
                    <ForeName>Martin V</ForeName>
                    <Initials>MV</Initials>
                </Author>
                <Author>
                    <LastName>Boissonneault</LastName>
                    <ForeName>Guylain</ForeName>
                    <Initials>G</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Hum Mutat</MedlineTA>
            <NlmUniqueID>9215429</NlmUniqueID>
            <ISSNLinking>1059-7794</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Double-strand break</Keyword>
            <Keyword MajorTopicYN="N">Genetic instability</Keyword>
            <Keyword MajorTopicYN="N">HTT</Keyword>
            <Keyword MajorTopicYN="N">Huntington</Keyword>
            <Keyword MajorTopicYN="N">Huntington disease</Keyword>
            <Keyword MajorTopicYN="N">Spermatid chromatin remodeling</Keyword>
            <Keyword MajorTopicYN="N">Trinucleotide expansion</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/humu.22637</ArticleId>
            <ArticleId IdType="pubmed">25136821</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136812</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Snail Transcription Factor Regulates the Numbers of Neural Precursor Cells and Newborn Neurons throughout Mammalian Life.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e104767</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0104767</ELocationID>
            <Abstract>
                <AbstractText>The Snail transcription factor regulates diverse aspects of stem cell biology in organisms ranging from Drosophila to mammals. Here we have asked whether it regulates the biology of neural precursor cells (NPCs) in the forebrain of postnatal and adult mice, taking advantage of a mouse containing a floxed Snail allele (Snailfl/fl mice). We show that when Snail is inducibly ablated in the embryonic cortex, this has long-term consequences for cortical organization. In particular, when Snailfl/fl mice are crossed to Nestin-cre mice that express Cre recombinase in embryonic neural precursors, this causes inducible ablation of Snail expression throughout the postnatal cortex. This loss of Snail causes a decrease in proliferation of neonatal cortical neural precursors and mislocalization and misspecification of cortical neurons. Moreover, these precursor phenotypes persist into adulthood. Adult neural precursor cell proliferation is decreased in the forebrain subventricular zone and in the hippocampal dentate gyrus, and this is coincident with a decrease in the number of adult-born olfactory and hippocampal neurons. Thus, Snail is a key regulator of the numbers of neural precursors and newborn neurons throughout life.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zander</LastName>
                    <ForeName>Mark A</ForeName>
                    <Initials>MA</Initials>
                    <Affiliation>Program in Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada; Institute for Medical Sciences, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cancino</LastName>
                    <ForeName>Gonzalo I</ForeName>
                    <Initials>GI</Initials>
                    <Affiliation>Program in Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gridley</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Maine Medical Center Research Institute, University of Maine, Scarborough, Maine, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaplan</LastName>
                    <ForeName>David R</ForeName>
                    <Initials>DR</Initials>
                    <Affiliation>Program in Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada; Institute for Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miller</LastName>
                    <ForeName>Freda D</ForeName>
                    <Initials>FD</Initials>
                    <Affiliation>Program in Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada; Institute for Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada; Department of Physiology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Cell Biol. 2000 Feb;2(2):84-9</RefSource>
                <PMID Version="1">10655587</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2013 Nov 7;13(5):564-76</RefSource>
                <PMID Version="1">24209760</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 2001 Dec;128(23):4757-67</RefSource>
                <PMID Version="1">11731456</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Cell. 2002 Oct;2(4):279-88</RefSource>
                <PMID Version="1">12398892</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 2003 Sep;130(17):4057-71</RefSource>
                <PMID Version="1">12874127</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 1991 Feb;11(2):519-33</RefSource>
                <PMID Version="1">1992014</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Neurol. 1992 Jan;115(1):121-6</RefSource>
                <PMID Version="1">1728557</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Genet. 1999 Sep;23(1):99-103</RefSource>
                <PMID Version="1">10471508</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2005 Oct 20;48(2):253-65</RefSource>
                <PMID Version="1">16242406</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2005 Nov 18;123(4):641-53</RefSource>
                <PMID Version="1">16286009</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 2006 Jan;133(2):363-9</RefSource>
                <PMID Version="1">16368933</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genesis. 2006 Jan;44(1):7-11</RefSource>
                <PMID Version="1">16397867</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2006 Jan 25;26(4):1107-16</RefSource>
                <PMID Version="1">16436596</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Neurosci. 2006 Nov;7(11):883-90</RefSource>
                <PMID Version="1">17033683</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2007 Apr 19;54(2):245-62</RefSource>
                <PMID Version="1">17442246</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2007 Aug 16;1(2):230-6</RefSource>
                <PMID Version="1">18371353</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Biol. 2008 Apr 8;6(4):e84</RefSource>
                <PMID Version="1">18399720</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2009 Mar 6;136(5):913-25</RefSource>
                <PMID Version="1">19269368</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2009 May 20;29(20):6710-21</RefSource>
                <PMID Version="1">19458240</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2009 Jun;119(6):1438-49</RefSource>
                <PMID Version="1">19487820</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2009 Jun 5;4(6):507-10</RefSource>
                <PMID Version="1">19497279</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2009 Jun 17;29(24):7694-705</RefSource>
                <PMID Version="1">19535581</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Neurosci. 2009;32:149-84</RefSource>
                <PMID Version="1">19555289</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 2009 Jun;12(6):735-44</RefSource>
                <PMID Version="1">19448628</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Cell. 2010 Jan 19;18(1):114-25</RefSource>
                <PMID Version="1">20152182</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Biol. 2014 Jan 15;385(2):230-41</RefSource>
                <PMID Version="1">24247009</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genes Dev. 2014 Jan 15;28(2):167-81</RefSource>
                <PMID Version="1">24402316</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2014 Apr 9;34(15):5164-75</RefSource>
                <PMID Version="1">24719096</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Biol. 2010 Nov 23;20(22):2058-65</RefSource>
                <PMID Version="1">21074438</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2011 Mar 24;69(6):1069-84</RefSource>
                <PMID Version="1">21435554</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2011 Oct 20;72(2):269-84</RefSource>
                <PMID Version="1">22017987</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2012 Jul 6;11(1):23-35</RefSource>
                <PMID Version="1">22770240</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2012 Oct 5;11(4):517-28</RefSource>
                <PMID Version="1">22902294</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2012 Oct 5;11(4):505-16</RefSource>
                <PMID Version="1">22902295</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Cell. 2012 Oct 16;23(4):849-57</RefSource>
                <PMID Version="1">23079601</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2013 Jan 2;33(1):244-58</RefSource>
                <PMID Version="1">23283338</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 2013 Apr;16(4):416-25</RefSource>
                <PMID Version="1">23434913</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2013 Jul 31;33(31):12569-85</RefSource>
                <PMID Version="1">23904595</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>EMBO J. 2001 Apr 2;20(7):1704-14</RefSource>
                <PMID Version="1">11285234</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4138084</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0104767</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-24549</ArticleId>
            <ArticleId IdType="pubmed">25136812</ArticleId>
            <ArticleId IdType="pmc">PMC4138084</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136803</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1554-8635</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Autophagy</Title>
                <ISOAbbreviation>Autophagy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An alteration in ATG16L1 stability in Crohn disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Individuals who harbor a common coding polymorphism (Thr300Ala) within a structurally unclassified region of ATG16L1 are at increased risk for the development of Crohn disease. Recently, we reported on the generation and characterization of knockin mice carrying the ATG16L1 T300A variant. We demonstrate that multiple cell types from T300A knock-in mice exhibit reduced selective autophagy, and we mechanistically link this phenotype with an increased susceptibility of ATG16L1 T300A to CASP3- and CASP7-mediated cleavage. These findings demonstrate how a single polymorphism can result in cell type- and pathway-specific disruptions of selective autophagy and alterations in the inflammatory milieu that can contribute to disease.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lassen</LastName>
                    <ForeName>Kara G</ForeName>
                    <Initials>KG</Initials>
                    <Affiliation>Broad Institute; Cambridge, MA USA; Center for Computational and Integrative Biology; Massachusetts General Hospital; Boston, MA USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xavier</LastName>
                    <ForeName>Ramnik J</ForeName>
                    <Initials>RJ</Initials>
                    <Affiliation>Broad Institute; Cambridge, MA USA; Center for Computational and Integrative Biology; Massachusetts General Hospital; Boston, MA USA; Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease; Massachusetts General Hospital; Harvard Medical School; Boston, MA USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>REVIEW</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Autophagy</MedlineTA>
            <NlmUniqueID>101265188</NlmUniqueID>
            <ISSNLinking>1554-8627</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ATG16L1</Keyword>
            <Keyword MajorTopicYN="N">Crohn disease</Keyword>
            <Keyword MajorTopicYN="N">IL1B</Keyword>
            <Keyword MajorTopicYN="N">antibacterial autophagy</Keyword>
            <Keyword MajorTopicYN="N">caspase cleavage</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">29963</ArticleId>
            <ArticleId IdType="pubmed">25136803</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136780</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1540-0514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Shock (Augusta, Ga.)</Title>
                <ISOAbbreviation>Shock</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Macrophage-Derived Chemokine (MDC/CCL22) is a Novel Mediator of Lung Inflammation Following Hemorrhage and Resuscitation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Resuscitation of patients after hemorrhage often results in pulmonary inflammation and places them at risk for the development of acute respiratory distress syndrome. Our previous data indicate that macrophage-derived chemokine (MDC/CCL22) is elevated after resuscitation, but its direct role in this inflammatory response is unknown. MDC signaling through the C-C chemokine receptor type 4 (CCR4) is implicated in other pulmonary proinflammatory conditions, leading us to hypothesize that MDC may also play a role in the pathogenesis of lung inflammation following hemorrhage and resuscitation. To test this, C57BL/6 mice underwent pressure-controlled hemorrhage followed by resuscitation with lactated Ringer's solution. Pulmonary inflammation and inflammatory cell recruitment were analyzed with histological staining, and serum- and tissue-level cytokines were measured by ELISA. Pulmonary inflammation and cell recruitment following hemorrhage and resuscitation were associated with systemic MDC levels. Inhibition of MDC via injection of a specific neutralizing antibody prior to hemorrhage and resuscitation significantly reduced pulmonary levels of the chemotactic cytokines KC, MIP-2, and MIP-1?? as well as inflammatory cell recruitment to the lungs. Intravenous administration of recombinant MDC prior to resuscitation augmented pulmonary inflammation and cell recruitment. Histological evaluation revealed the expression of CCR4 within the bronchial epithelium, and in vitro treatment of activated bronchial epithelial cells with MDC resulted in production and secretion of neutrophil chemokines. The present study identifies MDC as a novel mediator of lung inflammation after hemorrhage and resuscitation. MDC neutralization may provide a therapeutic strategy to mitigate this inflammatory response.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Richter</LastName>
                    <ForeName>Jillian R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Department of Surgery and Institute for Military Medicine, University of Cincinnati, Cincinnati, OH.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sutton</LastName>
                    <ForeName>Jeffrey M</ForeName>
                    <Initials>JM</Initials>
                </Author>
                <Author>
                    <LastName>Belizaire</LastName>
                    <ForeName>Ritha M</ForeName>
                    <Initials>RM</Initials>
                </Author>
                <Author>
                    <LastName>Friend</LastName>
                    <ForeName>Lou Ann</ForeName>
                    <Initials>LA</Initials>
                </Author>
                <Author>
                    <LastName>Schuster</LastName>
                    <ForeName>Rebecca M</ForeName>
                    <Initials>RM</Initials>
                </Author>
                <Author>
                    <LastName>Johannigman</LastName>
                    <ForeName>Taylor A</ForeName>
                    <Initials>TA</Initials>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>Steven G</ForeName>
                    <Initials>SG</Initials>
                </Author>
                <Author>
                    <LastName>Lentsch</LastName>
                    <ForeName>Alex B</ForeName>
                    <Initials>AB</Initials>
                </Author>
                <Author>
                    <LastName>Pritts</LastName>
                    <ForeName>Timothy A</ForeName>
                    <Initials>TA</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Shock</MedlineTA>
            <NlmUniqueID>9421564</NlmUniqueID>
            <ISSNLinking>1073-2322</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1097/SHK.0000000000000253</ArticleId>
            <ArticleId IdType="pubmed">25136780</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136779</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7077</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>38</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Environmental toxicology and pharmacology</Title>
                <ISOAbbreviation>Environ. Toxicol. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>All-trans-retinoid acid (ATRA) suppresses chondrogenesis of rat primary hind limb bud mesenchymal cells by downregulating p63 and cartilage-specific molecules.</ArticleTitle>
            <Pagination>
                <MedlinePgn>460-468</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii">S1382-6689(14)00162-8</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.etap.2014.07.008</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">P63 null mice have no or truncated limbs and mutations in human p63 cause several skeletal syndromes that also show limb and digit abnormalities, suggesting its essential role in bone development. In the current study, we investigated the effect of ATRA on chondrogenesis using mesenchymal cells from rat hind limb bud and further examined the mRNA and protein expression of Sox9 and Col2a1 and p63 in rat hind limb bud cells. Limb buds were isolated from embryos from euthanized female rats. Growth of hind limb bud mesenchymal cells was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assays. Formation of cartilage nodules was examined by Alcian blue-nuclear fast red staining. The expression of Sox9, Col2al and p63 was determined by Real-time RT-PCR and immunoblotting assays, respectively. Our MTT assays revealed that ATRA at 1 and 10??M significantly suppressed the growth of mesenchymal cells from rat hind limb bud at 24 and 48h (P&lt;0.01 vs. controls). Alcian blue staining further showed that ATRA caused a significant dose-dependent reduction in the area of cartilage nodules (P&lt;0.05 in all vs. controls). At 1??M ATRA, the area of cartilage nodules from hind limb bud cells was reduced to 0.05??0.03mm from 0.15??0.01mm in controls. Real-time RT-PCR assays further indicated that 1 and 10??M ATRA markedly reduced the mRNA expression of Sox9, Col2al and p63 in hind limb bud cells (P&lt;0.05 in all vs. controls). In addition, ATRA time-dependently inhibits the mRNA expression of p63, Sox9 and Col2al. Western blotting assays additionally showed that ATRA dose-dependently reduced the expression of Sox9, Col2al and p63 (P&lt;0.05 in all vs. controls). Together, our results suggest that ATRA suppresses chondrogenesis by modulating the expression of Sox9, Col2al and p63 in primary hind limb bud mesenchymal cells.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Yun-Guo</ForeName>
                    <Initials>YG</Initials>
                    <Affiliation>Department of Orthopedics, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xie</LastName>
                    <ForeName>Peng</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Orthopedics, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Yun-Gong</ForeName>
                    <Initials>YG</Initials>
                    <Affiliation>Wang Chuanshan College, University of South China, Hengyang, Hunan, 421001, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Xue-Dong</ForeName>
                    <Initials>XD</Initials>
                    <Affiliation>Department of Orthopedics, the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515041, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Tao-Gen</ForeName>
                    <Initials>TG</Initials>
                    <Affiliation>Department of Orthopedics, the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515041, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Zhao-Yong</ForeName>
                    <Initials>ZY</Initials>
                    <Affiliation>Department of Orthopedics, the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515041, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hong</LastName>
                    <ForeName>Quan</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Department of Orthopedics, the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515041, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Du</LastName>
                    <ForeName>Shi-Xin</ForeName>
                    <Initials>SX</Initials>
                    <Affiliation>Department of Orthopedics, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China. Electronic address: 8760715@163.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Environ Toxicol Pharmacol</MedlineTA>
            <NlmUniqueID>9612020</NlmUniqueID>
            <ISSNLinking>1382-6689</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chondrogenesis</Keyword>
            <Keyword MajorTopicYN="N">Col2a1</Keyword>
            <Keyword MajorTopicYN="N">Hind limb bud mesenchymal cells</Keyword>
            <Keyword MajorTopicYN="N">Retinoic acid</Keyword>
            <Keyword MajorTopicYN="N">Sox9</Keyword>
            <Keyword MajorTopicYN="N">p63</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1382-6689(14)00162-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.etap.2014.07.008</ArticleId>
            <ArticleId IdType="pubmed">25136779</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136763</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1557-7600</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medicinal food</Title>
                <ISOAbbreviation>J Med Food</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Anti-Inflammatory Effects of Wild Irish Mushroom Extracts in RAW264.7 Mouse Macrophage Cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Abstract Mushrooms and mushroom extracts have traditionally been used as therapies for a wide variety of ailments, including allergy, arthritis, and other inflammatory disorders. However, more evidence is required on the mechanism by which mushrooms exert these effects. In the present study, the anti-inflammatory properties of ethanol and hot water extracts prepared from 27 fungal samples collected between October and November 2011 at various forest locations in the southwest of Ireland were investigated using the lipopolysaccharide (LPS)-stimulated mouse macrophage (RAW264.7 cells) model of inflammation. LPS-stimulated cells were incubated in the presence of mushroom extracts at nontoxic concentrations for 24???h and the production of interleukin-6 (IL-6) was quantified by ELISA. Seven ethanolic and one hot water extract that decreased IL-6 production were selected for further study. The extracts were then incubated with LPS-stimulated cells for 24???h and the production of IL-6, tumor necrosis factor-alpha (TNF-??), and nitric oxide (NO) was measured. Ethanolic extracts prepared from Russula mairei, Lactarius blennius, Craterellus tubaeformis, Russula fellea, and Craterellus cornucopioides demonstrated selective anti-inflammatory activity by decreasing the production of NO and IL-6 but not TNF-?? in LPS-stimulated RAW264.7 cells. These findings support existing evidence of the anti-inflammatory potential of mushroom extracts.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>O'Callaghan</LastName>
                    <ForeName>Yvonne C</ForeName>
                    <Initials>YC</Initials>
                    <Affiliation>1 School of Food and Nutritional Sciences, University College Cork , Cork, Ireland .</Affiliation>
                </Author>
                <Author>
                    <LastName>O'Brien</LastName>
                    <ForeName>Nora M</ForeName>
                    <Initials>NM</Initials>
                </Author>
                <Author>
                    <LastName>Kenny</LastName>
                    <ForeName>Owen</ForeName>
                    <Initials>O</Initials>
                </Author>
                <Author>
                    <LastName>Harrington</LastName>
                    <ForeName>Tom</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Brunton</LastName>
                    <ForeName>Nigel</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Smyth</LastName>
                    <ForeName>Thomas J</ForeName>
                    <Initials>TJ</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Med Food</MedlineTA>
            <NlmUniqueID>9812512</NlmUniqueID>
            <ISSNLinking>1096-620X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">RAW264.7</Keyword>
            <Keyword MajorTopicYN="N">anti-inflammatory</Keyword>
            <Keyword MajorTopicYN="N">fungi</Keyword>
            <Keyword MajorTopicYN="N">wild mushrooms</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1089/jmf.2014.0012</ArticleId>
            <ArticleId IdType="pubmed">25136763</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136646</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-7156</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of immunology research</Title>
                <ISOAbbreviation>J Immunol Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of pristane alone or combined with chloroquine on macrophage activation, oxidative stress, and TH1/TH2 skewness.</ArticleTitle>
            <Pagination>
                <MedlinePgn>613136</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/613136</ELocationID>
            <Abstract>
                <AbstractText>We investigated the protective role of chloroquine against pristane-induced macrophage activation, oxidative stress, and Th1/Th2 skewness in C57BL/6J mice. Those mice were treated with pristane alone or combined with chloroquine. Hematological and biochemical parameters, macrophage phagocytic function, the oxidant/antioxidant index, cytokine for IFN-??, TNF-??, IL-4, and IL-6, and the isotypes of IgG2a and IgG1 were determined. And the expression of T-bet/GATA-3 and IL-12/IL-10 mRNA in spleen were analyzed by real-time PCR. We found that pristane treatment for a period of 12 or 24 weeks triggered macrophage activation syndrome, characterized by hemophagocytosis in spleen and peripheral blood, enhanced lipid phagocytosis by peritoneal macrophages in vitro, erythropenia and leucopenia, increased anti-Smith, lactic dehydrogenase, triglyceride, and ferritin, as well as hypercytokinemia of IFN-??, TNF-??, IL-4, and IL-6. In parallel, a significant increase in lipid peroxidation and a decrease in superoxide dismutase, glutathione, and catalase activity, as well as a skewed Th1/Th2 balance in spleen, were observed. However, chloroquine supplementation showed a remarkable amelioration of these abnormalities. Our data indicate that pristane administration induces macrophage activation, oxidative stress, and Th1/Th2 skewness, which can be attenuated by chloroquine.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ouyang</LastName>
                    <ForeName>Qiufang</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Cardiovascular Department, Second Affiliated Hospital and Second Clinical Medical College, Fujian Medical University, Zhongshan North Road 34, Quanzhou, Fujian 362000, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Ziyang</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Cardiovascular Department, Second Affiliated Hospital and Second Clinical Medical College, Fujian Medical University, Zhongshan North Road 34, Quanzhou, Fujian 362000, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Zhenhua</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Cardiovascular Department, Second Affiliated Hospital and Second Clinical Medical College, Fujian Medical University, Zhongshan North Road 34, Quanzhou, Fujian 362000, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xiaoqing</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Rheumatism Department, Second Affiliated Hospital and Second Clinical Medical College, Fujian Medical University, Zhongshan North Road 34, Quanzhou, Fujian 362000, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ni</LastName>
                    <ForeName>Jingqin</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Cardiovascular Department, Second Affiliated Hospital and Second Clinical Medical College, Fujian Medical University, Zhongshan North Road 34, Quanzhou, Fujian 362000, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Rheumatism Department, Second Affiliated Hospital and Second Clinical Medical College, Fujian Medical University, Zhongshan North Road 34, Quanzhou, Fujian 362000, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Immunol Res</MedlineTA>
            <NlmUniqueID>101627166</NlmUniqueID>
            <ISSNLinking>2314-7156</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vet Pathol. 2010 Jul;47(4):664-76</RefSource>
                <PMID Version="1">20448279</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10154-9</RefSource>
                <PMID Version="1">20479222</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Assoc Lab Anim Sci. 2011 Sep;50(5):680-5</RefSource>
                <PMID Version="1">22330715</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2012 Jun;42(6):1477-87</RefSource>
                <PMID Version="1">22678902</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arthritis Res Ther. 2012;14(3):R155</RefSource>
                <PMID Version="1">22734582</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Clin Pathol. 2013 Jun;139(6):713-27</RefSource>
                <PMID Version="1">23690113</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Pharmacol. 2013 Aug 1;86(3):410-8</RefSource>
                <PMID Version="1">23707973</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arthritis Rheumatol. 2014 Jan;66(1):140-51</RefSource>
                <PMID Version="1">24449581</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Diagn Lab Immunol. 2000 May;7(3):366-70</RefSource>
                <PMID Version="1">10799447</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arthritis Res. 2001;3(3):136-41</RefSource>
                <PMID Version="1">11299053</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pediatr Hematol Oncol. 2002 May;24(4):330-2</RefSource>
                <PMID Version="1">11972108</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Autoimmun Rev. 2004 Feb;3(2):69-75</RefSource>
                <PMID Version="1">15003190</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2004 Sep;34(9):2541-50</RefSource>
                <PMID Version="1">15307186</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann Rheum Dis. 2006 Feb;65(2):144-8</RefSource>
                <PMID Version="1">16079164</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2004 Nov 5;306(5698):990-5</RefSource>
                <PMID Version="1">15528435</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 1996 Apr 1;97(7):1597-604</RefSource>
                <PMID Version="1">8601623</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Immunopathol Pharmacol. 2008 Jul-Sep;21(3):577-84</RefSource>
                <PMID Version="1">18831924</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Isr Med Assoc J. 2009 Oct;11(10):633-4</RefSource>
                <PMID Version="1">20077953</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Lett. 2010 Mar 10;129(1):7-12</RefSource>
                <PMID Version="1">20105444</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lupus. 2011 Nov;20(13):1421-5</RefSource>
                <PMID Version="1">22095888</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4127244</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/613136</ArticleId>
            <ArticleId IdType="pubmed">25136646</ArticleId>
            <ArticleId IdType="pmc">PMC4127244</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136627</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Abarema cochliacarpos Extract Decreases the Inflammatory Process and Skeletal Muscle Injury Induced by Bothrops leucurus Venom.</ArticleTitle>
            <Pagination>
                <MedlinePgn>820761</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/820761</ELocationID>
            <Abstract>
                <AbstractText>Snakebites are a public health problem, especially in tropical countries. However, treatment with antivenom has limited effectiveness against venoms' local effects. Here, we investigated the ability of Abarema cochliacarpos hydroethanolic extract (EAc) to protect mice against injection of Bothrops leucurus venom. Swiss mice received perimuscular venom injection and were subsequently treated orally with EAc in different doses. Treatment with EAc 100, 200, and 400???mg/kg reduced the edema induced by B. leucurus in 1%, 13%, and 39%, respectively. Although lower doses showed no antihypernociceptive effect in the Von Frey test, the higher dose significantly reduced hyperalgesia induced by the venom. Antimyotoxic activity of EAc was also observed by microscopy assessment, with treated muscles presenting preserved structures, decreased edema, and inflammatory infiltrate as compared to untreated ones. Finally, on the rotarod test, the treated mice showed better motor function, once muscle fibers were preserved and there were less edema and pain. Treated mice could stand four times more time on the rotating rod than untreated ones. Our results have shown that EAc presented relevant activities against injection of B. leucurus venom in mice, suggesting that it can be considered as an adjuvant in the treatment of envenomation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Saturnino-Oliveira</LastName>
                    <ForeName>Jeison</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Departamento de Fisiologia, Laboratorio de Farmacologia Pr??-Clinica, Universidade Federal de Sergipe, SE, Brazil ; Departamento de Morfologia, Laborat??rio de Biologia Celular e Estrutura, Universidade Federal de Sergipe, SE, Brazil ; Programa de P??s-Gradua????o em Biotecnologia (RENORBIO), Universidade Federal de Sergipe, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Santos</LastName>
                    <ForeName>Daiana Do Carmo</ForeName>
                    <Initials>Ddo C</Initials>
                    <Affiliation>Departamento de Fisiologia, Laboratorio de Farmacologia Pr??-Clinica, Universidade Federal de Sergipe, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guimar??es</LastName>
                    <ForeName>Adriana Gibara</ForeName>
                    <Initials>AG</Initials>
                    <Affiliation>Departamento de Fisiologia, Laboratorio de Farmacologia Pr??-Clinica, Universidade Federal de Sergipe, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Santos Dias</LastName>
                    <ForeName>Ant??nio</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Departamento de Fisiologia, Laborat??rio de Bioqu??mica e Qu??mica de Produtos Naturais, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomaz</LastName>
                    <ForeName>Marcelo Amorim</ForeName>
                    <Initials>MA</Initials>
                    <Affiliation>Laborat??rio de Farmacologia das Toxinas, ICB, UFRJ, Universidade Federal do Rio de Janeiro, RJ, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Monteiro-Machado</LastName>
                    <ForeName>Marcos</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Laborat??rio de Farmacologia das Toxinas, ICB, UFRJ, Universidade Federal do Rio de Janeiro, RJ, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Estevam</LastName>
                    <ForeName>Charles Santos</ForeName>
                    <Initials>CS</Initials>
                    <Affiliation>Departamento de Fisiologia, Laborat??rio de Bioqu??mica e Qu??mica de Produtos Naturais, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lucca J??nior</LastName>
                    <ForeName>Waldecy De</ForeName>
                    <Initials>WD</Initials>
                    <Affiliation>Departamento de Morfologia, Laborat??rio de Biologia Celular e Estrutura, Universidade Federal de Sergipe, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maria</LastName>
                    <ForeName>Durvanei Augusto</ForeName>
                    <Initials>DA</Initials>
                    <Affiliation>Instituto Butantan, Laborat??rio de Ci??ncias Fisiol??gicas e Qu??mica, S??o Paulo, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Melo</LastName>
                    <ForeName>Paulo A</ForeName>
                    <Initials>PA</Initials>
                    <Affiliation>Laborat??rio de Farmacologia das Toxinas, ICB, UFRJ, Universidade Federal do Rio de Janeiro, RJ, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ara??jo</LastName>
                    <ForeName>Adriano Antunes de Souza</ForeName>
                    <Initials>AA</Initials>
                    <Affiliation>Departamento de Farm??cia, Laborat??rio de Ensaios e de Toxicidade Farmac??utica, Universidade Federal de Sergipe, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Santos</LastName>
                    <ForeName>M??rcio Roberto Viana</ForeName>
                    <Initials>MR</Initials>
                    <Affiliation>Departamento de Fisiologia, Laboratorio de Farmacologia Pr??-Clinica, Universidade Federal de Sergipe, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Almeida</LastName>
                    <ForeName>Jackson Roberto Guedes da Silva</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Colegiado de Ci??ncias Farmac??uticas, Universidade Federal do Vale do S??o Francisco, PE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oliveira</LastName>
                    <ForeName>Rita de C??ssia Meneses</ForeName>
                    <Initials>Rde C</Initials>
                    <Affiliation>Departamento de Biof??sica e Fisiologia, Universidade Federal do Piaui, Teresina, PI, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pereira de Oliveira</LastName>
                    <ForeName>Aldeidia</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Departamento de Biof??sica e Fisiologia, Universidade Federal do Piaui, Teresina, PI, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Quintans J??nior</LastName>
                    <ForeName>Lucindo Jos??</ForeName>
                    <Initials>LJ</Initials>
                    <Affiliation>Departamento de Fisiologia, Laboratorio de Farmacologia Pr??-Clinica, Universidade Federal de Sergipe, SE, Brazil ; Programa de P??s-Gradua????o em Biotecnologia (RENORBIO), Universidade Federal de Sergipe, SE, Brazil ; Laboratory Preclinical Pharmacology of Natural Products, Department of Physiology, Federal University of Sergipe, S/N Marechal Rondon Avenue, 49.100-000 S??o Cristov??o, SE, Brazil.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 2001 Aug;39(8):1173-81</RefSource>
                <PMID Version="1">11306127</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Biochem Biophys. 2007 Dec 15;468(2):193-204</RefSource>
                <PMID Version="1">17963685</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Braz J Med Biol Res. 2002 Oct;35(10):1233-5</RefSource>
                <PMID Version="1">12424498</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 2003 Feb;41(2):251-5</RefSource>
                <PMID Version="1">12565745</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cad Saude Publica. 2003 Jan-Feb;19(1):7-16</RefSource>
                <PMID Version="1">12700779</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Mol Life Sci. 2008 Sep;65(18):2897-912</RefSource>
                <PMID Version="1">18563294</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2010 Mar 24;128(2):467-75</RefSource>
                <PMID Version="1">20083187</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2010 Oct 28;132(1):134-42</RefSource>
                <PMID Version="1">20696232</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Acad Orthop Surg. 2010 Dec;18(12):749-59</RefSource>
                <PMID Version="1">21119141</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):290-300</RefSource>
                <PMID Version="1">21130897</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Comp Biochem Physiol C Toxicol Pharmacol. 2011 Sep;154(3):226-33</RefSource>
                <PMID Version="1">21699995</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Braz J Med Biol Res. 2012 Jun;45(6):488-96</RefSource>
                <PMID Version="1">22415117</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2013 Jan 9;145(1):50-8</RefSource>
                <PMID Version="1">23123799</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biomed Res Int. 2013;2013:941467</RefSource>
                <PMID Version="1">23509815</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 2013 Jul;69:55-64</RefSource>
                <PMID Version="1">23416798</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2013 Aug 26;149(1):140-7</RefSource>
                <PMID Version="1">23792124</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Prod Res. 2013;27(16):1479-83</RefSource>
                <PMID Version="1">22963455</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 2003 Dec 15;42(8):885-901</RefSource>
                <PMID Version="1">15019489</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 2003 Dec 15;42(8):915-31</RefSource>
                <PMID Version="1">15019491</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Exp Pathol. 1971 Oct;52(5):538-42</RefSource>
                <PMID Version="1">5125267</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 1984;22(3):339-46</RefSource>
                <PMID Version="1">6474488</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 1988;26(1):87-95</RefSource>
                <PMID Version="1">3347934</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 1988;26(7):615-27</RefSource>
                <PMID Version="1">3176051</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Braz J Med Biol Res. 1988;21(3):545-8</RefSource>
                <PMID Version="1">3228636</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 1989;27(9):1003-9</RefSource>
                <PMID Version="1">2799833</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 1993 Mar;31(3):285-91</RefSource>
                <PMID Version="1">8470133</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 1993 Jun;13(6):2273-86</RefSource>
                <PMID Version="1">8501507</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Pharmacol. 1993 Nov;110(3):1227-31</RefSource>
                <PMID Version="1">8298813</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 1994 May;32(5):595-603</RefSource>
                <PMID Version="1">8079371</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Pharmacol. 1997 Jul;121(5):883-8</RefSource>
                <PMID Version="1">9222544</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 1998 May;36(5):771-80</RefSource>
                <PMID Version="1">9655637</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Acta Trop. 2005 Jan;93(1):85-95</RefSource>
                <PMID Version="1">15589801</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochimie. 2007 Mar;89(3):319-28</RefSource>
                <PMID Version="1">17110015</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 2007 Jul;50(1):120-34</RefSource>
                <PMID Version="1">17482228</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicon. 2007 Aug;50(2):196-205</RefSource>
                <PMID Version="1">17466354</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Inflamm Res. 2007 Oct;56(10):409-13</RefSource>
                <PMID Version="1">18026697</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Braz J Med Biol Res. 2002 Oct;35(10):1221-8</RefSource>
                <PMID Version="1">12424496</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4127289</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/820761</ArticleId>
            <ArticleId IdType="pubmed">25136627</ArticleId>
            <ArticleId IdType="pmc">PMC4127289</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136611</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Alternative Splicing Generates Different Parkin Protein Isoforms: Evidences in Human, Rat, and Mouse Brain.</ArticleTitle>
            <Pagination>
                <MedlinePgn>690796</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Parkinson protein 2, E3 ubiquitin protein ligase (PARK2) gene mutations are the most frequent causes of autosomal recessive early onset Parkinson's disease and juvenile Parkinson disease. Parkin deficiency has also been linked to other human pathologies, for example, sporadic Parkinson disease, Alzheimer disease, autism, and cancer. PARK2 primary transcript undergoes an extensive alternative splicing, which enhances transcriptomic diversification. To date several PARK2 splice variants have been identified; however, the expression and distribution of parkin isoforms have not been deeply investigated yet. Here, the currently known PARK2 gene transcripts and relative predicted encoded proteins in human, rat, and mouse are reviewed. By analyzing the literature, we highlight the existing data showing the presence of multiple parkin isoforms in the brain. Their expression emerges from conflicting results regarding the electrophoretic mobility of the protein, but it is also assumed from discrepant observations on the cellular and tissue distribution of parkin. Although the characterization of each predicted isoforms is complex, since they often diverge only for few amino acids, analysis of their expression patterns in the brain might account for the different pathogenetic effects linked to PARK2 gene mutations.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Scuderi</LastName>
                    <ForeName>Soraya</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0001-5126-2009</Identifier>
                    <Affiliation>Department of Bio-Medical Sciences, Section of Anatomy and Histology, University of Catania, Via S. Sofia, No. 87, 95123 Catania, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>La Cognata</LastName>
                    <ForeName>Valentina</ForeName>
                    <Initials>V</Initials>
                    <Identifier Source="ORCID">0000-0003-4066-0655</Identifier>
                    <Affiliation>Functional Genomics Center, Institute of Neurological Sciences, Italian National Research Council, Via Paolo Gaifami, No. 18, 95125 Catania, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Drago</LastName>
                    <ForeName>Filippo</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cavallaro</LastName>
                    <ForeName>Sebastiano</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0001-7590-1792</Identifier>
                    <Affiliation>Functional Genomics Center, Institute of Neurological Sciences, Italian National Research Council, Via Paolo Gaifami, No. 18, 95125 Catania, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>D'Agata</LastName>
                    <ForeName>Velia</ForeName>
                    <Initials>V</Initials>
                    <Identifier Source="ORCID">0000-0003-1114-8265</Identifier>
                    <Affiliation>Department of Bio-Medical Sciences, Section of Anatomy and Histology, University of Catania, Via S. Sofia, No. 87, 95123 Catania, Italy.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>REVIEW</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/690796</ArticleId>
            <ArticleId IdType="pubmed">25136611</ArticleId>
            <ArticleId IdType="pmc">PMC4124806</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136599</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Recombinant Lysostaphin Protects Mice from Methicillin-Resistant Staphylococcus aureus Pneumonia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>602185</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/602185</ELocationID>
            <Abstract>
                <AbstractText>The advent of methicillin-resistant Staphylococcus aureus (MRSA) and the frequent and excessive abuse of ventilators have made MRSA pneumonia an inordinate threat to human health. Appropriate antibacterial therapies are crucial, including the use of lysostaphin as an alternative to antibiotics. To explore the potential use of lysostaphin as a therapeutic agent for MRSA pneumonia, mice were intranasally infected with MRSA and then treated with recombinant lysostaphin (rLys; 45???mg/kg in the high-dose group and 1???mg/kg in the low-dose group) (0.33???mg/mL, 15???mg/mL), vancomycin (120???mg/kg) (40???mg/mL), or phosphate-buffered saline (PBS, negative control) 4???h after infection. Therapeutic efficacy was assessed by mouse survival, lung histopathology, bacterial density in the lungs, bodyweight, lung weight, temperature, white blood cells counts, lymphocytes counts, granulocytes counts, and monocytes counts. The mice treated with rLys showed lower mortality, less lung parenchymal damage, and lower bacterial density at metastatic tissue sites than mice treated with PBS or vancomycin. The overall mortality was 100%, 60%, 40%, and 60% for the control, vancomycin, high-dose rLys, and low-dose rLys groups, respectively. These findings indicate that, as a therapeutic agent for MRSA pneumonia, lysostaphin exerts profound protective effects in mice against the morbidity and mortality associated with S. aureus pneumonia.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Chen</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">0000-0002-3943-184X</Identifier>
                    <Affiliation>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing 100071, China ; Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, 27 Taiping Road, Haidian District, Beijing 100850, China ; Anhui Medical University, Hefei 230032, China ; Laboratory of Gene Regulation, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fan</LastName>
                    <ForeName>Huahao</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">0000-0001-5007-2158</Identifier>
                    <Affiliation>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing 100071, China ; Department of Microbiology, Peking University Health Science Center, Beijing 100191, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Yong</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing 100071, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peng</LastName>
                    <ForeName>Fan</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">0000-0001-9264-8469</Identifier>
                    <Affiliation>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing 100071, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fan</LastName>
                    <ForeName>Hang</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">0000-0002-7927-1684</Identifier>
                    <Affiliation>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing 100071, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yuan</LastName>
                    <ForeName>Shoujun</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, 27 Taiping Road, Haidian District, Beijing 100850, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tong</LastName>
                    <ForeName>Yigang</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">0000-0002-8503-8045</Identifier>
                    <Affiliation>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing 100071, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bacteriol. 2000 May;182(9):2635-8</RefSource>
                <PMID Version="1">10762270</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prog Drug Res. 1972;16:309-33</RefSource>
                <PMID Version="1">4265118</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Antimicrob Agents Chemother. 2002 Aug;46(8):2723-6</RefSource>
                <PMID Version="1">12121967</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Invest Ophthalmol Vis Sci. 2002 Dec;43(12):3712-6</RefSource>
                <PMID Version="1">12454041</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Infect Dis. 2003 Jan 1;36(1):53-9</RefSource>
                <PMID Version="1">12491202</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Chest. 2003 Nov;124(5):1789-97</RefSource>
                <PMID Version="1">14605050</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Infect Dis. 2003 Dec 1;37(11):1453-60</RefSource>
                <PMID Version="1">14614667</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Infect Dis. 2004 May 1;38(9):1328-30</RefSource>
                <PMID Version="1">15127350</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Yale J Biol Med. 1967 Feb;39(4):215-29</RefSource>
                <PMID Version="1">5182857</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bacteriol. 1991 Jun;173(11):3507-13</RefSource>
                <PMID Version="1">2045371</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bacteriol. 1993 May;175(9):2779-82</RefSource>
                <PMID Version="1">8478340</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bacteriol. 1997 Jan;179(1):9-16</RefSource>
                <PMID Version="1">8981974</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microb Drug Resist. 1996 Spring;2(1):29-41</RefSource>
                <PMID Version="1">9158720</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 1998 Aug 20;339(8):520-32</RefSource>
                <PMID Version="1">9709046</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Infect Dis. 1999 Nov;29(5):1128-32</RefSource>
                <PMID Version="1">10524952</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bacteriol. 1964 Sep;88:815-6</RefSource>
                <PMID Version="1">14208531</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Infect Dis. 2005 Jan 1;40(1):100-7</RefSource>
                <PMID Version="1">15614698</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 2005 Sep 22;353(12):1245-51</RefSource>
                <PMID Version="1">16177250</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lancet Infect Dis. 2005 Dec;5(12):751-62</RefSource>
                <PMID Version="1">16310147</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lancet. 2006 Sep 2;368(9538):874-85</RefSource>
                <PMID Version="1">16950365</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Antimicrob Agents Chemother. 2007 Feb;51(2):475-82</RefSource>
                <PMID Version="1">17101683</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Control Hosp Epidemiol. 2007 Mar;28(3):273-9</RefSource>
                <PMID Version="1">17326017</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Infect Dis. 2007 Aug 1;45(3):315-21</RefSource>
                <PMID Version="1">17599308</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur Respir J. 2008 Mar;31(3):625-32</RefSource>
                <PMID Version="1">18310398</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Appl Microbiol Biotechnol. 2008 Sep;80(4):555-61</RefSource>
                <PMID Version="1">18607587</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Antimicrob Chemother. 2008 Oct;62(4):773-5</RefSource>
                <PMID Version="1">18552338</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Emerg Infect Dis. 2008 Nov;14(11):1722-30</RefSource>
                <PMID Version="1">18976555</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Drugs Dermatol. 2009 Mar;8(3):281-6</RefSource>
                <PMID Version="1">19271378</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Invest Ophthalmol Vis Sci. 2000 May;41(6):1432-7</RefSource>
                <PMID Version="1">10798659</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4124205</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/602185</ArticleId>
            <ArticleId IdType="pubmed">25136599</ArticleId>
            <ArticleId IdType="pmc">PMC4124205</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136593</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>534969</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The tyrosine kinase human epidermal growth factor receptor 2 (HER2) gene is amplified in approximately 20% of human breast cancers and is associated with an aggressive clinical course and the early development of metastasis. Its crucial role in tumor growth and progression makes HER2 a prototypic oncoantigen, the targeting of which may be critical for the development of effective anticancer therapies. The setup of anti-HER2 targeting strategies has revolutionized the clinical outcome of HER2(+) breast cancer. However, their initial success has been overshadowed by the onset of pharmacological resistance that renders them ineffective. Since the tumor microenvironment (TME) plays a crucial role in drug resistance, the design of more effective anticancer therapies should depend on the targeting of both cancer cells and their TME as a whole. In this review, starting from the successful know-how obtained with a HER2(+) mouse model of mammary carcinogenesis, the BALB-neuT mice, we discuss the role of TME in mammary tumor development. Indeed, a deeper knowledge of antigens critical for cancer outbreak and progression and of the mechanisms that regulate the interplay between cancer and stromal cell populations could advise promising ways for the development of the best anticancer strategy.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Conti</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ruiu</LastName>
                    <ForeName>Roberto</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Barutello</LastName>
                    <ForeName>Giuseppina</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Macagno</LastName>
                    <ForeName>Marco</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bandini</LastName>
                    <ForeName>Silvio</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cavallo</LastName>
                    <ForeName>Federica</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lanzardo</LastName>
                    <ForeName>Stefania</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>REVIEW</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>3</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/534969</ArticleId>
            <ArticleId IdType="pubmed">25136593</ArticleId>
            <ArticleId IdType="pmc">PMC4065702</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136592</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Automated synthesis of (18) f-fluoropropoxytryptophan for amino Acid transporter system imaging.</ArticleTitle>
            <Pagination>
                <MedlinePgn>492545</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/492545</ELocationID>
            <Abstract>
                <AbstractText>Objective. This study was to develop a cGMP grade of [(18)F]fluoropropoxytryptophan ((18)F-FTP) to assess tryptophan transporters using an automated synthesizer. Methods. Tosylpropoxytryptophan (Ts-TP) was reacted with K(18)F/kryptofix complex. After column purification, solvent evaporation, and hydrolysis, the identity and purity of the product were validated by radio-TLC (1M-ammonium acetate???:???methanol = 4???:???1) and HPLC (C-18 column, methanol???:???water = 7???:???3) analyses. In vitro cellular uptake of (18)F-FTP and (18)F-FDG was performed in human prostate cancer cells. PET imaging studies were performed with (18)F-FTP and (18)F-FDG in prostate and small cell lung tumor-bearing mice (3.7???MBq/mouse, iv). Results. Radio-TLC and HPLC analyses of (18)F-FTP showed that the Rf and Rt values were 0.9 and 9???min, respectively. Radiochemical purity was &gt;99%. The radiochemical yield was 37.7% (EOS 90???min, decay corrected). Cellular uptake of (18)F-FTP and (18)F-FDG showed enhanced uptake as a function of incubation time. PET imaging studies showed that (18)F-FTP had less tumor uptake than (18)F-FDG in prostate cancer model. However, (18)F-FTP had more uptake than (18)F-FDG in small cell lung cancer model. Conclusion. (18)F-FTP could be synthesized with high radiochemical yield. Assessment of upregulated transporters activity by (18)F-FTP may provide potential applications in differential diagnosis and prediction of early treatment response.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shih</LastName>
                    <ForeName>I-Hong</ForeName>
                    <Initials>IH</Initials>
                    <Affiliation>Department of Cancer Systems Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duan</LastName>
                    <ForeName>Xu-Dong</ForeName>
                    <Initials>XD</Initials>
                    <Affiliation>Department of Cancer Systems Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kong</LastName>
                    <ForeName>Fan-Lin</ForeName>
                    <Initials>FL</Initials>
                    <Affiliation>Department of Cancer Systems Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williams</LastName>
                    <ForeName>Michael D</ForeName>
                    <Initials>MD</Initials>
                    <Affiliation>Department of Cancer Systems Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Kevin</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">0000-0003-3672-4222</Identifier>
                    <Affiliation>Department of Cancer Systems Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Yin-Han</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Department of Cancer Systems Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>David J</ForeName>
                    <Initials>DJ</Initials>
                    <Affiliation>Department of Cancer Systems Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pathol. 2006 Dec;210(4):420-30</RefSource>
                <PMID Version="1">17054309</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nucl Med. 2006 May;47(5):885-95</RefSource>
                <PMID Version="1">16644760</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pathol Res Pract. 2008;204(8):553-61</RefSource>
                <PMID Version="1">18440724</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Pharm Sci. 2008 Oct 2;35(3):161-74</RefSource>
                <PMID Version="1">18656534</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Metastasis Rev. 2008 Dec;27(4):545-54</RefSource>
                <PMID Version="1">18523732</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Sci. 2008 Dec;99(12):2380-6</RefSource>
                <PMID Version="1">19018776</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nucl Med Biol. 2009 Apr;36(3):295-303</RefSource>
                <PMID Version="1">19324275</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Histopathology. 2009 Jun;54(7):804-13</RefSource>
                <PMID Version="1">19635099</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Pharmacol. 2010 Sep 15;80(6):811-8</RefSource>
                <PMID Version="1">20510678</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Isr J Psychiatry Relat Sci. 2010;47(1):56-63</RefSource>
                <PMID Version="1">20686200</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nucl Med. 2012 Mar;53(3):434-42</RefSource>
                <PMID Version="1">22331220</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nucl Med Biol. 2012 Oct;39(7):926-32</RefSource>
                <PMID Version="1">22444239</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Thorac Oncol. 2013 Feb;8(2):140-6</RefSource>
                <PMID Version="1">23328546</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Pharm. 2013 Feb 25;443(1-2):245-53</RefSource>
                <PMID Version="1">23270998</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nucl Med Biol. 2013 Aug;40(6):801-7</RefSource>
                <PMID Version="1">23791401</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Can J Neurol Sci. 2013 Sep;40(5):657-62</RefSource>
                <PMID Version="1">23968938</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1876-83</RefSource>
                <PMID Version="1">23903666</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurol Clin. 2014 Feb;32(1):59-93</RefSource>
                <PMID Version="1">24287385</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Epilepsia. 2013 Dec;54(12):2143-50</RefSource>
                <PMID Version="1">24304437</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Pharmacol. 2002 Apr;61(4):729-37</RefSource>
                <PMID Version="1">11901210</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochim Biophys Acta. 2003 Apr 1;1611(1-2):81-90</RefSource>
                <PMID Version="1">12659948</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochim Biophys Acta. 2004 Feb 10;1661(1):106-12</RefSource>
                <PMID Version="1">14967480</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Leuk Lymphoma. 2004 Jan;45(1):85-92</RefSource>
                <PMID Version="1">15061202</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cereb Blood Flow Metab. 1998 May;18(5):500-9</RefSource>
                <PMID Version="1">9591842</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Korean J Radiol. 2006 Jan-Mar;7(1):57-69</RefSource>
                <PMID Version="1">16549957</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur Radiol. 2006 May;16(5):1054-65</RefSource>
                <PMID Version="1">16365730</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Cancer Res. 2007 Nov 1;13(21):6369-78</RefSource>
                <PMID Version="1">17975149</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4127279</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/492545</ArticleId>
            <ArticleId IdType="pubmed">25136592</ArticleId>
            <ArticleId IdType="pmc">PMC4127279</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136584</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effect of Exercise Intensity on Isoform-Specific Expressions of NT-PGC-1 ?? mRNA in Mouse Skeletal Muscle.</ArticleTitle>
            <Pagination>
                <MedlinePgn>402175</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/402175</ELocationID>
            <Abstract>
                <AbstractText>PGC-1?? is an inducible transcriptional coactivator that regulates mitochondrial biogenesis and cellular energy metabolism in skeletal muscle. Recent studies have identified two additional PGC-1?? transcripts that are derived from an alternative exon 1 (exon 1b) and induced by exercise. Given that the PGC-1?? gene also produces NT-PGC-1?? transcript by alternative 3(') splicing between exon 6 and exon 7, we have investigated isoform-specific expression of NT-PGC-1?? mRNA in mouse skeletal muscle during physical exercise with different intensities. We report here that NT-PGC-1??-a mRNA expression derived from a canonical exon 1 (exon 1a) is increased by high-intensity exercise and AMPK activator AICAR in mouse skeletal muscle but not altered by low- and medium-intensity exercise and ?? 2-adrenergic receptor agonist clenbuterol. In contrast, the alternative exon 1b-driven NT-PGC-1??-b (PGC-1??4) and NT-PGC-1??-c are highly induced by low-, medium-, and high-intensity exercise, AICAR, and clenbuterol. Ectopic expression of NT-PGC-1??-a in C2C12 myotube cells upregulates myosin heavy chain (MHC I, MHC II a) and Glut4, which represent oxidative fibers, and promotes the expression of mitochondrial genes (Cyc1, COX5B, and ATP5B). In line with gene expression data, citrate synthase activity was significantly increased by NT-PGC-1??-a in C2C12 myotube cells. Our results indicate the regulatory role for NT-PGC-1??-a in mitochondrial biogenesis and adaptation of skeletal muscle to endurance exercise.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wen</LastName>
                    <ForeName>Xingyuan</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>Ji Suk</ForeName>
                    <Initials>JS</Initials>
                    <Identifier Source="ORCID">0000-0002-0706-1960</Identifier>
                    <Affiliation>Laboratory of Nutrient Sensing and Adipocyte Signaling, Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Pengcheng</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">0000-0001-9514-0345</Identifier>
                    <Affiliation>State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jianzhu</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Nanjing University of Chinese Medicine, Nanjing 210023, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Yaliang</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gettys</LastName>
                    <ForeName>Thomas W</ForeName>
                    <Initials>TW</Initials>
                    <Affiliation>Laboratory of Nutrient Sensing and Adipocyte Signaling, Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Yubin</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">0000-0002-9947-0891</Identifier>
                    <Affiliation>State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2000 Dec 22;275(51):40235-43</RefSource>
                <PMID Version="1">10976104</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(5):e63778</RefSource>
                <PMID Version="1">23675505</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2002 Aug 15;418(6899):797-801</RefSource>
                <PMID Version="1">12181572</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FASEB J. 2002 Dec;16(14):1879-86</RefSource>
                <PMID Version="1">12468452</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Appl Physiol (1985). 2003 Feb;94(2):555-60</RefSource>
                <PMID Version="1">12531911</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Endocr Rev. 1996 Oct;17(5):481-517</RefSource>
                <PMID Version="1">8897022</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 1998 Mar 20;92(6):829-39</RefSource>
                <PMID Version="1">9529258</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Metab. 2005 Jun;1(6):361-70</RefSource>
                <PMID Version="1">16054085</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Metab. 2007 Jan;5(1):35-46</RefSource>
                <PMID Version="1">17189205</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Endocrinology. 2007 Jul;148(7):3441-8</RefSource>
                <PMID Version="1">17446185</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12017-22</RefSource>
                <PMID Version="1">17609368</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2008 Jul 24;454(7203):463-9</RefSource>
                <PMID Version="1">18650917</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Endocrinology. 2008 Sep;149(9):4527-33</RefSource>
                <PMID Version="1">18511502</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Biophys Res Commun. 2009 Apr 17;381(4):537-43</RefSource>
                <PMID Version="1">19233136</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2009 Nov 20;284(47):32813-26</RefSource>
                <PMID Version="1">19773550</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2010 Jun 4;285(23):18039-50</RefSource>
                <PMID Version="1">20351112</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Physiol. 2010 Sep 15;588(Pt 18):3551-66</RefSource>
                <PMID Version="1">20643772</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Appl Physiol. 2010 Nov;110(4):665-94</RefSource>
                <PMID Version="1">20602111</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E341-9</RefSource>
                <PMID Version="1">21098736</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurodegener Dis. 2011;8(6):496-503</RefSource>
                <PMID Version="1">21757867</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2011;6(12):e28290</RefSource>
                <PMID Version="1">22174785</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2012 Jan 26;481(7382):463-8</RefSource>
                <PMID Version="1">22237023</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2012 Mar 16;287(12):9100-11</RefSource>
                <PMID Version="1">22282499</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann N Y Acad Sci. 2012 Oct;1271:110-7</RefSource>
                <PMID Version="1">23050972</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2012 Dec 7;151(6):1319-31</RefSource>
                <PMID Version="1">23217713</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Metab. 2014 Jan 7;19(1):96-108</RefSource>
                <PMID Version="1">24411942</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Mol Biol. 2012;13:29</RefSource>
                <PMID Version="1">22989091</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pflugers Arch. 2001 Oct;443(1):6-17</RefSource>
                <PMID Version="1">11692261</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4106048</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/402175</ArticleId>
            <ArticleId IdType="pubmed">25136584</ArticleId>
            <ArticleId IdType="pmc">PMC4106048</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136578</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Potassium Channel Ether ?? go-go1 Is Aberrantly Expressed in Human Liposarcoma and Promotes Tumorigenesis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>345678</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/345678</ELocationID>
            <Abstract>
                <AbstractText>The ether ?? go-go1 (Eag1) channel is overexpressed in a variety of cancers. However, the expression and function of Eag1 in liposarcoma are poorly understood. In the present study, the mRNA expression of Eag1 in different adipose tissue samples was examined by real-time PCR. Then, the protein expression of Eag1 in 131 different adipose tissues from 109 patients was detected by immunohistochemistry. Next, the associations between Eag1 expression and clinicopathological features of liposarcoma were analyzed. In addition, the effects of Eag1 on liposarcoma cell proliferation and cycle were evaluated by CCK-8, colony formation, xenograft mouse model, and flow cytometry, respectively. Finally, the activation of p38 mitogen-activated protein kinase (MAPK) was detected by Western blot analysis to explain the detailed mechanisms of oncogenic potential of Eag1 in liposarcoma. It was found that Eag1 was aberrantly expressed in over 67% liposarcomas, with a higher frequency than in lipoma, hyperplasia, inflammation, and normal adipose tissues. However, Eag1 expression was not correlated with clinicopathological features of liposarcoma. Eag1 inhibitor imipramine or Eag1-shRNA significantly suppressed the proliferation of liposarcoma cells in vitro and in vivo, accompanying with accumulation of cells in the G1 phase. These results suggest that Eag1 plays an important role in regulating the proliferation and cell cycle of liposarcoma cells and might be a potential therapeutic target for liposarcoma.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Jin</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Orthopaedics, the Affiliated Southeast Hospital of Xiamen University, Orthopaedic Center of People's Liberation Army, Zhanghua Road 269, Zhangzhou 363000, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhong</LastName>
                    <ForeName>Daixing</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Thoracic Surgery, the Affiliated Tangdu Hospital of Fourth Military Medical University, Xi'an 710038, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wei</LastName>
                    <ForeName>Yujian</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>School of Basic Medical College, Nanjing Medical University, Nanjing 210000, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Xinyu</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Neurology, the Affiliated Southeast Hospital of Xiamen University, Zhangzhou 363000, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Liangqi</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Orthopaedics, the Affiliated Southeast Hospital of Xiamen University, Orthopaedic Center of People's Liberation Army, Zhanghua Road 269, Zhangzhou 363000, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ding</LastName>
                    <ForeName>Zhenqi</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Orthopaedics, the Affiliated Southeast Hospital of Xiamen University, Orthopaedic Center of People's Liberation Army, Zhanghua Road 269, Zhangzhou 363000, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann Diagn Pathol. 2000 Aug;4(4):252-66</RefSource>
                <PMID Version="1">10982304</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biomed Res Int. 2014;2014:187684</RefSource>
                <PMID Version="1">24527437</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Cell. 2001 Sep;93(1-2):47-51</RefSource>
                <PMID Version="1">11730321</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Membr Biol. 2002 Jul 15;188(2):137-49</RefSource>
                <PMID Version="1">12172639</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Skeletal Radiol. 2003 Sep;32(9):493-503</RefSource>
                <PMID Version="1">12802520</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann Surg. 2003 Sep;238(3):358-70; discussion 370-1</RefSource>
                <PMID Version="1">14501502</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Radiol. 2003 Oct;76(910):750-2</RefSource>
                <PMID Version="1">14512338</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Lett. 2004 Sep 30;368(3):249-53</RefSource>
                <PMID Version="1">15364405</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Orthop Relat Res. 1993 Apr;(289):50-7</RefSource>
                <PMID Version="1">8472432</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 1998 Nov 2;143(3):767-75</RefSource>
                <PMID Version="1">9813096</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>EMBO J. 1999 Oct 15;18(20):5540-7</RefSource>
                <PMID Version="1">10523298</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Invest. 2005;23(2):105-18</RefSource>
                <PMID Version="1">15813502</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Radiographics. 2005 Sep-Oct;25(5):1371-95</RefSource>
                <PMID Version="1">16160117</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Membr Biol. 2005 Jun;205(3):115-24</RefSource>
                <PMID Version="1">16362499</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Lett. 2006 Feb 20;233(1):1-9</RefSource>
                <PMID Version="1">16473665</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2886-91</RefSource>
                <PMID Version="1">16477030</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2006 May 12;281(19):13030-7</RefSource>
                <PMID Version="1">16537547</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann Surg. 2006 Sep;244(3):381-91</RefSource>
                <PMID Version="1">16926564</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cancer. 2006;5:42</RefSource>
                <PMID Version="1">17022811</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cancer. 2006;5:41</RefSource>
                <PMID Version="1">17022810</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Res. 2008 Mar 15;68(6):1611-3</RefSource>
                <PMID Version="1">18339837</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2008 Dec 26;283(52):36234-40</RefSource>
                <PMID Version="1">18927085</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Cancer. 2009 Aug;9(8):537-49</RefSource>
                <PMID Version="1">19629069</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cancer. 2010;9:18</RefSource>
                <PMID Version="1">20105281</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>World J Surg Oncol. 2010;8:113</RefSource>
                <PMID Version="1">21190577</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Anticancer Res. 2011 Apr;31(4):1265-70</RefSource>
                <PMID Version="1">21508374</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Clin Cancer Res. 2012;31:5</RefSource>
                <PMID Version="1">22243975</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Sensors (Basel). 2012;12(5):5986-95</RefSource>
                <PMID Version="1">22778627</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Discov. 2012 Dec;2(12):1109-17</RefSource>
                <PMID Version="1">23230188</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Philos Trans R Soc Lond B Biol Sci. 2014 Mar 19;369(1638):20130094</RefSource>
                <PMID Version="1">24493742</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann Oncol. 2001 Jan;12(1):75-80</RefSource>
                <PMID Version="1">11249053</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4127296</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/345678</ArticleId>
            <ArticleId IdType="pubmed">25136578</ArticleId>
            <ArticleId IdType="pmc">PMC4127296</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136556</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>miRNA Signature in Mouse Spermatogonial Stem Cells Revealed by High-Throughput Sequencing.</ArticleTitle>
            <Pagination>
                <MedlinePgn>154251</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/154251</ELocationID>
            <Abstract>
                <AbstractText>Spermatogonial stem cells (SSCs) play fundamental roles in spermatogenesis. Although a handful of genes have been discovered as key regulators of SSC self-renewal and differentiation, the regulatory network responsible for SSC function remains unclear. In particular, small RNA signatures during mouse spermatogenesis are not yet systematically investigated. Here, using next generation sequencing, we compared small RNA signatures of in vitro expanded SSCs, testis-derived somatic cells (Sertoli cells), developing germ cells, mouse embryonic stem cells (ESCs), and mouse mesenchymal stem cells among mouse embryonic stem cells (ESCs) to address small RNA transition during mouse spermatogenesis. The results manifest that small RNA transition during mouse spermatogenesis displays overall declined expression profiles of miRNAs and endo-siRNAs, in parallel with elevated expression profiles of piRNAs, resulting in the normal biogenesis of sperms. Meanwhile, several novel miRNAs were preferentially expressed in mouse SSCs, and further investigation of their functional annotation will allow insights into the mechanisms involved in the regulation of SSC activities. We also demonstrated the similarity of miRNA signatures between SSCs and ESCs, thereby providing a new clue to understanding the molecular basis underlying the easy conversion of SSCs to ESCs.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Tao</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Yunnan Key Laboratory of Primate Biomedical Research, No. 1 Boda Road, Yuhua Area, Chenggong District, Kunming, Yunnan 650500, China ; State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China ; Kunming Biomed International and National Engineering Research Center of Biomedicine and Animal Science, Kunming, Yunnan 650500, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Yanfeng</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Yunnan Key Laboratory of Primate Biomedical Research, No. 1 Boda Road, Yuhua Area, Chenggong District, Kunming, Yunnan 650500, China ; Department of Medicine, School of Medicine, Vanderbilt University, Nashville, TN 37203, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ji</LastName>
                    <ForeName>Weizhi</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Yunnan Key Laboratory of Primate Biomedical Research, No. 1 Boda Road, Yuhua Area, Chenggong District, Kunming, Yunnan 650500, China ; Kunming Biomed International and National Engineering Research Center of Biomedicine and Animal Science, Kunming, Yunnan 650500, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Ping</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2003 Aug;69(2):612-6</RefSource>
                <PMID Version="1">12700182</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13159-64</RefSource>
                <PMID Version="1">21788498</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Cell Res. 2004 May 1;295(2):395-406</RefSource>
                <PMID Version="1">15093739</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Genet. 2004 Jun;36(6):653-9</RefSource>
                <PMID Version="1">15156143</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16489-94</RefSource>
                <PMID Version="1">15520394</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2004 Dec 29;119(7):1001-12</RefSource>
                <PMID Version="1">15620358</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2005 Aug 18;436(7053):1030-4</RefSource>
                <PMID Version="1">16107850</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2006 Apr 27;440(7088):1199-203</RefSource>
                <PMID Version="1">16565704</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Biol. 2006 Jun 1;294(1):161-7</RefSource>
                <PMID Version="1">16564520</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2006 Jun;24(6):1505-11</RefSource>
                <PMID Version="1">16456131</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9524-9</RefSource>
                <PMID Version="1">16740658</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2006 Jul 21;313(5785):363-7</RefSource>
                <PMID Version="1">16778019</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2006 Aug 25;126(4):663-76</RefSource>
                <PMID Version="1">16904174</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Clin Pract Endocrinol Metab. 2006 Feb;2(2):99-108</RefSource>
                <PMID Version="1">16932264</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>EMBO J. 2006 Dec 13;25(24):5816-25</RefSource>
                <PMID Version="1">17124491</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Biophys Res Commun. 2007 Feb 9;353(2):259-67</RefSource>
                <PMID Version="1">17188235</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arthritis Res Ther. 2007;9(1):204</RefSource>
                <PMID Version="1">17316462</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 2007 May;134(10):1853-9</RefSource>
                <PMID Version="1">17428826</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2007 Jun 29;129(7):1401-14</RefSource>
                <PMID Version="1">17604727</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2007 Sep 20;449(7160):346-50</RefSource>
                <PMID Version="1">17882221</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2007 Nov 30;131(5):861-72</RefSource>
                <PMID Version="1">18035408</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2008 Apr;78(4):681-7</RefSource>
                <PMID Version="1">18199882</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genome Res. 2008 Apr;18(4):610-21</RefSource>
                <PMID Version="1">18285502</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2008 Jun;26(6):1506-16</RefSource>
                <PMID Version="1">18403753</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genes Dev. 2008 Aug 1;22(15):1987-97</RefSource>
                <PMID Version="1">18676805</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Hum Reprod. 2008 Sep;14(9):521-9</RefSource>
                <PMID Version="1">18697907</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2008 Nov 6;3(5):471-2</RefSource>
                <PMID Version="1">18983960</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2008 Nov 20;456(7220):344-9</RefSource>
                <PMID Version="1">18849962</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Cycle. 2008 Nov 15;7(22):3491-2</RefSource>
                <PMID Version="1">19001853</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Regen Med. 2009 Jan;4(1):3-5</RefSource>
                <PMID Version="1">19105611</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2009 Jan 23;136(2):215-33</RefSource>
                <PMID Version="1">19167326</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Genet. 2009 Apr;41(4):488-93</RefSource>
                <PMID Version="1">19305411</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Birth Defects Res C Embryo Today. 2009 Mar;87(1):1-26</RefSource>
                <PMID Version="1">19306346</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2009 Jan;27(1):138-49</RefSource>
                <PMID Version="1">18927477</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2009 Jul 2;5(1):87-96</RefSource>
                <PMID Version="1">19570517</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Bioinformatics. 2009 Aug 1;25(15):1966-7</RefSource>
                <PMID Version="1">19497933</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>RNA. 2010 Apr;16(4):720-31</RefSource>
                <PMID Version="1">20150330</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Endocrinol. 2010 May;205(2):133-45</RefSource>
                <PMID Version="1">20147357</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Philos Trans R Soc Lond B Biol Sci. 2010 May 27;365(1546):1663-78</RefSource>
                <PMID Version="1">20403877</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nucleic Acids Res. 2011 Aug;39(15):6596-607</RefSource>
                <PMID Version="1">21546553</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biotechniques. 2011 Nov;51(5):341-2, 344</RefSource>
                <PMID Version="1">22054547</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Genet. 2011;45:447-69</RefSource>
                <PMID Version="1">21942366</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Reprod Update. 2012 Jan-Feb;18(1):44-59</RefSource>
                <PMID Version="1">21989172</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2012 Jun 22;287(26):21686-98</RefSource>
                <PMID Version="1">22570483</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2012 Dec 21;151(7):1617-32</RefSource>
                <PMID Version="1">23260147</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Growth Differ. 2012 Jan;54(1):78-92</RefSource>
                <PMID Version="1">22221002</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell Endocrinol. 2014 Jan 25;382(1):498-508</RefSource>
                <PMID Version="1">23632103</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Protoc. 2010 May;5(5):921-8</RefSource>
                <PMID Version="1">20431537</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Biomed Eng. 2010 Aug 15;12:1-27</RefSource>
                <PMID Version="1">20415587</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2010;5(12):e15317</RefSource>
                <PMID Version="1">21206922</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2011 May 13;286(19):17359-64</RefSource>
                <PMID Version="1">21454525</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Biotechnol. 2011 May;29(5):443-8</RefSource>
                <PMID Version="1">21490602</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Genet. 2011 May;7(5):e1002054</RefSource>
                <PMID Version="1">21573140</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>RNA. 2011 Jul;17(7):1191-203</RefSource>
                <PMID Version="1">21602304</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Genomics. 2011;12(1):276</RefSource>
                <PMID Version="1">21627802</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12740-5</RefSource>
                <PMID Version="1">21768389</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2004 Mar 1;103(5):1662-8</RefSource>
                <PMID Version="1">14592819</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4124761</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/154251</ArticleId>
            <ArticleId IdType="pubmed">25136556</ArticleId>
            <ArticleId IdType="pmc">PMC4124761</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136513</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2234-943X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>4</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in oncology</Title>
                <ISOAbbreviation>Front Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetically engineered mouse models of pituitary tumors.</ArticleTitle>
            <Pagination>
                <MedlinePgn>203</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fonc.2014.00203</ELocationID>
            <Abstract>
                <AbstractText>Animal models constitute valuable tools for investigating the pathogenesis of cancer as well as for preclinical testing of novel therapeutics approaches. However, the pathogenic mechanisms of pituitary-tumor formation remain poorly understood, particularly in sporadic adenomas, thus, making it a challenge to model pituitary tumors in mice. Nevertheless, genetically engineered mouse models (GEMMs) of pituitary tumors have provided important insight into pituitary tumor biology. In this paper, we review various GEMMs of pituitary tumors, highlighting their contributions and limitations, and discuss opportunities for research in the field.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cano</LastName>
                    <ForeName>David A</ForeName>
                    <Initials>DA</Initials>
                    <Affiliation>Unidad de Gesti??n Cl??nica de Endocrinolog??a y Nutrici??n, Hospital Universitario Virgen del Roc??o , Seville , Spain ; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Roc??o/Consejo Superior de Investigaciones Cient??ficas/Universidad de Sevilla , Seville , Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soto-Moreno</LastName>
                    <ForeName>Alfonso</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Unidad de Gesti??n Cl??nica de Endocrinolog??a y Nutrici??n, Hospital Universitario Virgen del Roc??o , Seville , Spain ; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Roc??o/Consejo Superior de Investigaciones Cient??ficas/Universidad de Sevilla , Seville , Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leal-Cerro</LastName>
                    <ForeName>Alfonso</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Roc??o/Consejo Superior de Investigaciones Cient??ficas/Universidad de Sevilla , Seville , Spain.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
                <PublicationType>Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Oncol</MedlineTA>
            <NlmUniqueID>101568867</NlmUniqueID>
            <ISSNLinking>2234-943X</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4117927</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">GEMMs</Keyword>
            <Keyword MajorTopicYN="N">adenoma</Keyword>
            <Keyword MajorTopicYN="N">mouse models</Keyword>
            <Keyword MajorTopicYN="N">pituitary</Keyword>
            <Keyword MajorTopicYN="N">transgenic mice</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2014.00203</ArticleId>
            <ArticleId IdType="pubmed">25136513</ArticleId>
            <ArticleId IdType="pmc">PMC4117927</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136508</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2156-7085</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedical optics express</Title>
                <ISOAbbreviation>Biomed Opt Express</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The potential of photoacoustic microscopy as a tool to characterize the in vivo degradation of surgical sutures.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2856-69</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1364/BOE.5.002856</ELocationID>
            <Abstract>
                <AbstractText>The ex vivo and in vivo imaging, and quantitative characterization of the degradation of surgical sutures (???500 ??m diameter) up to ???1cm depth is demonstrated using a custom dark-field photo-acoustic microscope (PAM). A practical algorithm is developed to accurately measure the suture diameter during the degradation process. The results from tissue simulating phantoms and mice are compared to ex vivo measurements with an optical microscope demonstrating that PAM has a great deal of potential to characterize the degradation process of surgical sutures. The implications of this work for industrial applications are discussed.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Aguirre</LastName>
                    <ForeName>Juan</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>ICFO-Insitut de Ci??nces Fot??niques, 08860, Castelldefels, Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morales-Dalmau</LastName>
                    <ForeName>Jordi</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>ICFO-Insitut de Ci??nces Fot??niques, 08860, Castelldefels, Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Funk</LastName>
                    <ForeName>Lutz</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>B.Braun Surgical S.A., 08191, Rub??, Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jara</LastName>
                    <ForeName>Francesc</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>B.Braun Surgical S.A., 08191, Rub??, Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Turon</LastName>
                    <ForeName>Pau</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>B.Braun Surgical S.A., 08191, Rub??, Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Durduran</LastName>
                    <ForeName>Turgut</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>ICFO-Insitut de Ci??nces Fot??niques, 08860, Castelldefels, Barcelona, Spain.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Opt Express</MedlineTA>
            <NlmUniqueID>101540630</NlmUniqueID>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4133012</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">(110.5120) Photoacoustic imaging</Keyword>
            <Keyword MajorTopicYN="N">(170.0170) Medical optics and biotechnology</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1364/BOE.5.002856</ArticleId>
            <ArticleId IdType="pii">211843</ArticleId>
            <ArticleId IdType="pubmed">25136508</ArticleId>
            <ArticleId IdType="pmc">PMC4133012</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136507</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2156-7085</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedical optics express</Title>
                <ISOAbbreviation>Biomed Opt Express</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Histology validation of mapping depth-resolved cardiac fiber orientation in fresh mouse heart using optical polarization tractography.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2843-55</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1364/BOE.5.002843</ELocationID>
            <Abstract>
                <AbstractText>Myofiber organization in cardiac muscle plays an important role in achieving normal mechanical and electrical heart functions. An imaging tool that can reveal microstructural details of myofiber organization is valuable for both basic research and clinical applications. A high-resolution optical polarization tractography (OPT) was recently developed based on Jones matrix optical coherence tomography (JMOCT). In this study, we validated the accuracy of using OPT for measuring depth-resolved fiber orientation in fresh heart samples by comparing directly with histology images. Systematic image processing algorithms were developed to register OPT with histology images. The pixel-wise differences between the two tractographic results were analyzed in details. The results indicate that OPT can accurately image depth-resolved fiber orientation in fresh heart tissues and reveal microstructural details at the histological level.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Bioengineering, University of Missouri, Columbia, MO 65211 USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>K</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Molecular Microbiology &amp; Immunology, University of Missouri, Columbia, MO 65211 USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wasala</LastName>
                    <ForeName>N B</ForeName>
                    <Initials>NB</Initials>
                    <Affiliation>Department of Molecular Microbiology &amp; Immunology, University of Missouri, Columbia, MO 65211 USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yao</LastName>
                    <ForeName>X</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Bioengineering, University of Missouri, Columbia, MO 65211 USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duan</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Molecular Microbiology &amp; Immunology, University of Missouri, Columbia, MO 65211 USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yao</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Bioengineering, University of Missouri, Columbia, MO 65211 USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Opt Express</MedlineTA>
            <NlmUniqueID>101540630</NlmUniqueID>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4133011</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">(110.4500) Optical coherence tomography</Keyword>
            <Keyword MajorTopicYN="N">(170.6935) Tissue characterization</Keyword>
            <Keyword MajorTopicYN="N">(230.5440) Polarization-selective devices</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1364/BOE.5.002843</ArticleId>
            <ArticleId IdType="pii">213714</ArticleId>
            <ArticleId IdType="pubmed">25136507</ArticleId>
            <ArticleId IdType="pmc">PMC4133011</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136505</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2156-7085</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedical optics express</Title>
                <ISOAbbreviation>Biomed Opt Express</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Longitudinal vascular dynamics following cranial window and electrode implantation measured with speckle variance optical coherence angiography.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2823-36</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1364/BOE.5.002823</ELocationID>
            <Abstract>
                <AbstractText>Speckle variance optical coherence angiography (OCA) was used to characterize the vascular tissue response from craniotomy, window implantation, and electrode insertion in mouse motor cortex. We observed initial vasodilation ~40% greater than original diameter 2-3 days post-surgery (dps). After 4 weeks, dilation subsided in large vessels (&gt;50 ??m diameter) but persisted in smaller vessels (25-50 ??m diameter). Neovascularization began 8-12 dps and vessel migration continued throughout the study. Vasodilation and neovascularization were primarily associated with craniotomy and window implantation rather than electrode insertion. Initial evidence of capillary re-mapping in the region surrounding the implanted electrode was manifest in OCA image dissimilarity. Further investigation, including higher resolution imaging, is required to validate the finding. Spontaneous lesions also occurred in many electrode animals, though the inception point appeared random and not directly associated with electrode insertion. OCA allows high resolution, label-free in vivo visualization of neurovascular tissue, which may help determine any biological contribution to chronic electrode signal degradation. Vascular and flow-based biomarkers can aid development of novel neural prostheses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hammer</LastName>
                    <ForeName>Daniel X</ForeName>
                    <Initials>DX</Initials>
                    <Affiliation>Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring MD 20993, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lozzi</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring MD 20993, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abliz</LastName>
                    <ForeName>Erkinay</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring MD 20993, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greenbaum</LastName>
                    <ForeName>Noah</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring MD 20993, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Agrawal</LastName>
                    <ForeName>Anant</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring MD 20993, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krauthamer</LastName>
                    <ForeName>Victor</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring MD 20993, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Welle</LastName>
                    <ForeName>Cristin G</ForeName>
                    <Initials>CG</Initials>
                    <Affiliation>Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring MD 20993, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Opt Express</MedlineTA>
            <NlmUniqueID>101540630</NlmUniqueID>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4133009</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">(110.4500) Optical coherence tomography</Keyword>
            <Keyword MajorTopicYN="N">(170.1470) Blood or tissue constituent monitoring</Keyword>
            <Keyword MajorTopicYN="N">(170.3880) Medical and biological imaging</Keyword>
            <Keyword MajorTopicYN="N">(170.6900) Three-dimensional microscopy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1364/BOE.5.002823</ArticleId>
            <ArticleId IdType="pii">213654</ArticleId>
            <ArticleId IdType="pubmed">25136505</ArticleId>
            <ArticleId IdType="pmc">PMC4133009</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136493</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2156-7085</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedical optics express</Title>
                <ISOAbbreviation>Biomed Opt Express</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In vivo quantitative photoacoustic microscopy of gold nanostar kinetics in mouse organs.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2679-85</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1364/BOE.5.002679</ELocationID>
            <Abstract>
                <AbstractText>We developed a high-resolution photoacoustic microscopy (PAM) system with a near-infrared (NIR) laser to noninvasively monitor the distribution of gold nanostar (GNS) in blood vessels, liver and spleen in mice. Photoacoustic images of organs at deep depths were continuously acquired in vivo every 30 minutes after a single dose of GNS by tail vein injection. The experimental results showed that GNS accumulated significantly in both liver and spleen from blood circulation after administration, which was qualitatively validated by fluorescence imaging. Our studies demonstrate that PAM might be potentially used for noninvasive tracing the kinetics of exogenous nanoparticles in biological system.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Weitao</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Biomedical Engineering, College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, 29 Yudao Street, Nanjing, Jiangsu, 210016, China ; Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Xiaolian</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Niu</LastName>
                    <ForeName>Gang</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xiaoyuan</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qian</LastName>
                    <ForeName>Zhiyu</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Biomedical Engineering, College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, 29 Yudao Street, Nanjing, Jiangsu, 210016, China ; zhiyu@nuaa.edu.cn.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nie</LastName>
                    <ForeName>Liming</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA ; Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361005, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Opt Express</MedlineTA>
            <NlmUniqueID>101540630</NlmUniqueID>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4132997</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">(000.1430) Biology and medicine</Keyword>
            <Keyword MajorTopicYN="N">(110.5125) Photoacoustics</Keyword>
            <Keyword MajorTopicYN="N">(170.3880) Medical and biological imaging</Keyword>
            <Keyword MajorTopicYN="N">(180.0180) Microscopy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1364/BOE.5.002679</ArticleId>
            <ArticleId IdType="pii">211533</ArticleId>
            <ArticleId IdType="pubmed">25136493</ArticleId>
            <ArticleId IdType="pmc">PMC4132997</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136491</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2156-7085</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedical optics express</Title>
                <ISOAbbreviation>Biomed Opt Express</ISOAbbreviation>
            </Journal>
            <ArticleTitle>High resolution three-dimensional photoacoutic tomography with CCD-camera based ultrasound detection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2635-47</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1364/BOE.5.002635</ELocationID>
            <Abstract>
                <AbstractText>A photoacoustic tomograph based on optical ultrasound detection is demonstrated, which is capable of high resolution real-time projection imaging and fast three-dimensional (3D) imaging. Snapshots of the pressure field outside the imaged object are taken at defined delay times after photoacoustic excitation by use of a charge coupled device (CCD) camera in combination with an optical phase contrast method. From the obtained wave patterns photoacoustic projection images are reconstructed using a back propagation Fourier domain reconstruction algorithm. Applying the inverse Radon transform to a set of projections recorded over a half rotation of the sample provides 3D photoacoustic tomography images in less than one minute with a resolution below 100 ??m. The sensitivity of the device was experimentally determined to be 5.1 kPa over a projection length of 1 mm. In vivo images of the vasculature of a mouse demonstrate the potential of the developed method for biomedical applications.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nuster</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Physics, Karl-Franzens-University Graz, 8010 Graz, Austria.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Slezak</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paltauf</LastName>
                    <ForeName>Guenther</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Physics, Karl-Franzens-University Graz, 8010 Graz, Austria.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Opt Express</MedlineTA>
            <NlmUniqueID>101540630</NlmUniqueID>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4132994</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">(110.0110) Imaging systems</Keyword>
            <Keyword MajorTopicYN="N">(170.3880) Medical and biological imaging</Keyword>
            <Keyword MajorTopicYN="N">(170.5120) Photoacoustic imaging</Keyword>
            <Keyword MajorTopicYN="N">(170.6960) Tomography</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1364/BOE.5.002635</ArticleId>
            <ArticleId IdType="pii">212422</ArticleId>
            <ArticleId IdType="pubmed">25136491</ArticleId>
            <ArticleId IdType="pmc">PMC4132994</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136480</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2156-7085</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedical optics express</Title>
                <ISOAbbreviation>Biomed Opt Express</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Photothermal tomography for the functional and structural evaluation, and early mineral loss monitoring in bones.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2488-502</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1364/BOE.5.002488</ELocationID>
            <Abstract>
                <AbstractText>Salient features of a new non-ionizing bone diagnostics technique, truncated-correlation photothermal coherence tomography (TC-PCT), exhibiting optical-grade contrast and capable of resolving the trabecular network in three dimensions through the cortical region with and without a soft-tissue overlayer are presented. The absolute nature and early demineralization-detection capability of a marker called thermal wave occupation index, estimated using the proposed modality, have been established. Selective imaging of regions of a specific mineral density range has been demonstrated in a mouse femur. The method is maximum-permissible-exposure compatible. In a matrix of bone and soft-tissue a depth range of ~3.8 mm has been achieved, which can be increased through instrumental and modulation waveform optimization. Furthermore, photoacoustic microscopy, a comparable modality with TC-PCT, has been used to resolve the trabecular structure and for comparison with the photothermal tomography.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kaiplavil</LastName>
                    <ForeName>Sreekumar</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Center for Advanced Diffusion-Wave Technologies (CADIFT), Dept. of Mechanical and Industrial Engineering, University of Toronto, 5 King's College Road, Toronto, ON, M5S 3G8, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mandelis</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Center for Advanced Diffusion-Wave Technologies (CADIFT), Dept. of Mechanical and Industrial Engineering, University of Toronto, 5 King's College Road, Toronto, ON, M5S 3G8, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Xueding</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Radiology, University of Michigan School of Medicine, Ann Arbor, MI 48109-5667, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>Ting</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Radiology, University of Michigan School of Medicine, Ann Arbor, MI 48109-5667, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Opt Express</MedlineTA>
            <NlmUniqueID>101540630</NlmUniqueID>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4132983</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">(110.6960) Tomography</Keyword>
            <Keyword MajorTopicYN="N">(170.0170) Medical optics and biotechnology</Keyword>
            <Keyword MajorTopicYN="N">(170.6935) Tissue characterization</Keyword>
            <Keyword MajorTopicYN="N">(350.5340) Photothermal effects</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1364/BOE.5.002488</ArticleId>
            <ArticleId IdType="pii">200572</ArticleId>
            <ArticleId IdType="pubmed">25136480</ArticleId>
            <ArticleId IdType="pmc">PMC4132983</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136404</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1942-0994</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Oxidative medicine and cellular longevity</Title>
                <ISOAbbreviation>Oxid Med Cell Longev</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase.</ArticleTitle>
            <Pagination>
                <MedlinePgn>893516</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/893516</ELocationID>
            <Abstract>
                <AbstractText>Background. Endogenous cannabinoid anandamide (AEA) protects neurons from oxidative injury in rodent models; however the mechanism of AEA-induced neuroprotection remains to be determined. Activation of neuronal NADPH oxidase 2 (Nox2) contributes to oxidative damage of the brain, and inhibition of Nox2 can attenuate cerebral oxidative stress. We aimed to determine whether the neuronal Nox2 was involved in protection mediated by AEA. Methods. The mouse hippocampal neuron cell line HT22 was exposed to hydrogen peroxide (H2O2) to mimic oxidative injury of neurons. The protective effect of AEA was assessed by measuring cell metabolic activity, apoptosis, lactate dehydrogenase (LDH) release, cellular morphology, intracellular reactive oxygen species (ROS), and antioxidant and oxidant levels and Nox2 expression. Results. HT22 cells exposed to H2O2 demonstrated morphological changes, decreased LDH release, reduced metabolic activity, increased levels of intracellular ROS and oxidized glutathione (GSSG), reduced levels of superoxide dismutase (SOD), and reduced glutathione (GSH) and increased expression of Nox2. AEA prevented these effects, a property abolished by simultaneous administration of CB1 antagonist AM251 or CB1-siRNA. Conclusion. Nox2 inhibition is involved in AEA-induced cytoprotection against oxidative stress through CB1 activation in HT22 cells.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jia</LastName>
                    <ForeName>Ji</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">0000-0002-8559-3305</Identifier>
                    <Affiliation>Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Mingchun</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Anesthesiology, Xi'an No. 4 Hospital, Xi'an 710032, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Xiajing</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Anesthesiology, Xi'an No. 4 Hospital, Xi'an 710032, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhai</LastName>
                    <ForeName>Qian</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Tao</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Qiang</ForeName>
                    <Initials>Q</Initials>
                    <Identifier Source="ORCID">0000-0002-3620-3446</Identifier>
                    <Affiliation>Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiong</LastName>
                    <ForeName>Lize</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Oxid Med Cell Longev</MedlineTA>
            <NlmUniqueID>101479826</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Pharmacol. 2004 Oct 1;500(1-3):289-97</RefSource>
                <PMID Version="1">15464041</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Oxid Med Cell Longev. 2014;2014:242180</RefSource>
                <PMID Version="1">24829620</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cereb Cortex. 2005 Dec;15(12):2013-20</RefSource>
                <PMID Version="1">15788701</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Pharmacol. 2006 Jun;148(4):442-51</RefSource>
                <PMID Version="1">16682966</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Physiol Rev. 2007 Jan;87(1):245-313</RefSource>
                <PMID Version="1">17237347</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stroke. 2007 Nov;38(11):3000-6</RefSource>
                <PMID Version="1">17916764</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stroke. 2009 Jun;40(6):2157-64</RefSource>
                <PMID Version="1">19372445</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cereb Blood Flow Metab. 2009 Jul;29(7):1262-72</RefSource>
                <PMID Version="1">19417757</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Lett. 2010 Jan 18;469(1):39-43</RefSource>
                <PMID Version="1">19945511</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res. 2010 Nov 4;1359:291-7</RefSource>
                <PMID Version="1">20816674</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stroke. 2011 Feb;42(2):389-96</RefSource>
                <PMID Version="1">21183751</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Antioxid Redox Signal. 2011 Apr 15;14(8):1505-17</RefSource>
                <PMID Version="1">20812869</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res. 2012 Apr 27;1451:110-6</RefSource>
                <PMID Version="1">22436849</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Phytomedicine. 2012 Jun 15;19(8-9):819-24</RefSource>
                <PMID Version="1">22571976</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Pharmacol. 2012 Dec 15;697(1-3):47-52</RefSource>
                <PMID Version="1">23041154</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroscience. 2012 Dec 27;227:313-26</RefSource>
                <PMID Version="1">23069763</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Basic Clin Pharmacol Toxicol. 2013 Jan;112(1):25-33</RefSource>
                <PMID Version="1">22759348</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2013 Jan;143(1):179-84</RefSource>
                <PMID Version="1">23201308</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Neurosci. 2012;13:156</RefSource>
                <PMID Version="1">23272707</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>CNS Neurosci Ther. 2013 Mar;19(3):163-9</RefSource>
                <PMID Version="1">23253171</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Mol Neurobiol. 2013 Apr;33(3):443-52</RefSource>
                <PMID Version="1">23354671</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Pharm. 2013 May 6;10(5):2045-53</RefSource>
                <PMID Version="1">23534345</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMJ. 2002 Nov 23;325(7374):1199</RefSource>
                <PMID Version="1">12446534</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2003 May 15;23(10):4127-33</RefSource>
                <PMID Version="1">12764100</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30</RefSource>
                <PMID Version="1">15159678</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurotoxicology. 2013 May;36:24-33</RefSource>
                <PMID Version="1">23396185</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proteins. 2013 Aug;81(8):1304-17</RefSource>
                <PMID Version="1">23408552</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Biol Sci. 2013;9(8):811-7</RefSource>
                <PMID Version="1">23983614</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Biochem Cell Biol. 2013 Nov;45(11):2596-604</RefSource>
                <PMID Version="1">23994487</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Free Radic Biol Med. 2013 Dec;65:942-51</RefSource>
                <PMID Version="1">23982049</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9388-93</RefSource>
                <PMID Version="1">15964987</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4127243</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/893516</ArticleId>
            <ArticleId IdType="pubmed">25136404</ArticleId>
            <ArticleId IdType="pmc">PMC4127243</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136376</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1866-1947</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>6</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurodevelopmental disorders</Title>
                <ISOAbbreviation>J Neurodev Disord</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome.</ArticleTitle>
            <Pagination>
                <MedlinePgn>25</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/1866-1955-6-25</ELocationID>
            <Abstract>
                <AbstractText>Carriers of the fragile X premutation (FPM) have CGG trinucleotide repeat expansions of between 55 and 200 in the 5'-UTR of FMR1, compared to a CGG repeat length of between 5 and 54 for the general population. Carriers were once thought to be without symptoms, but it is now recognized that they can develop a variety of early neurological symptoms as well as being at risk for developing the late onset neurodegenerative disorder fragile X-associated tremor/ataxia syndrome (FXTAS). Several mouse models have contributed to our understanding of FPM and FXTAS, and findings from studies using these models are summarized here. This review also discusses how this information is improving our understanding of the molecular and cellular abnormalities that contribute to neurobehavioral features seen in some FPM carriers and in patients with FXTAS. Mouse models show much of the pathology seen in FPM carriers and in individuals with FXTAS, including the presence of elevated levels of Fmr1 mRNA, decreased levels of fragile X mental retardation protein, and ubiquitin-positive intranuclear inclusions. Abnormalities in dendritic spine morphology in several brain regions are associated with neurocognitive deficits in spatial and temporal memory processes, impaired motor performance, and altered anxiety. In vitro studies have identified altered dendritic and synaptic architecture associated with abnormal Ca(2+) dynamics and electrical network activity. FPM mice have been particularly useful in understanding the roles of Fmr1 mRNA, fragile X mental retardation protein, and translation of a potentially toxic polyglycine peptide in pathology. Finally, the potential for using these and emerging mouse models for preclinical development of therapies to improve neurological function in FXTAS is considered.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Berman</LastName>
                    <ForeName>Robert F</ForeName>
                    <Initials>RF</Initials>
                    <Affiliation>Department of Neurological Surgery, Room 502C, UC Davis, 1515 Newton Court, Davis, CA 95618, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Buijsen</LastName>
                    <ForeName>Ronald Am</ForeName>
                    <Initials>RA</Initials>
                    <Affiliation>Department Clinical Genetics, Erasmus MC, Rotterdam, Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Usdin</LastName>
                    <ForeName>Karen</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>NIDDK, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pintado</LastName>
                    <ForeName>Elizabeth</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>University of Seville, School of Medicine, Seville, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kooy</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Medical Genetics, University of Antwerp, Antwerp, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pretto</LastName>
                    <ForeName>Dalyir</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>UC Davis M.I.N.D. Institute, Sacramento, CA, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pessah</LastName>
                    <ForeName>Isaac N</ForeName>
                    <Initials>IN</Initials>
                    <Affiliation>Department Molecular Biosciences, UC Davis, Davis, CA, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nelson</LastName>
                    <ForeName>David L</ForeName>
                    <Initials>DL</Initials>
                    <Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zalewski</LastName>
                    <ForeName>Zachary</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Charlet-Bergeurand</LastName>
                    <ForeName>Nicholas</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Translational Medicine, IGBMC, Illkirch, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Willemsen</LastName>
                    <ForeName>Rob</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department Clinical Genetics, Erasmus MC, Rotterdam, Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hukema</LastName>
                    <ForeName>Renate K</ForeName>
                    <Initials>RK</Initials>
                    <Affiliation>Department Clinical Genetics, Erasmus MC, Rotterdam, Netherlands.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
                <PublicationType>Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Neurodev Disord</MedlineTA>
            <NlmUniqueID>101483832</NlmUniqueID>
            <ISSNLinking>1866-1947</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4135345</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CGG trinucleotide repeat</Keyword>
            <Keyword MajorTopicYN="N">FMR1</Keyword>
            <Keyword MajorTopicYN="N">FMRP</Keyword>
            <Keyword MajorTopicYN="N">FXTAS</Keyword>
            <Keyword MajorTopicYN="N">Fragile X premutation</Keyword>
            <Keyword MajorTopicYN="N">Intranuclear inclusions</Keyword>
            <Keyword MajorTopicYN="N">Mouse models</Keyword>
            <Keyword MajorTopicYN="N">RNA toxicity</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1866-1955-6-25</ArticleId>
            <ArticleId IdType="pii">1866-1955-6-25</ArticleId>
            <ArticleId IdType="pubmed">25136376</ArticleId>
            <ArticleId IdType="pmc">PMC4135345</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136373</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1741-427X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Evidence-based complementary and alternative medicine : eCAM</Title>
                <ISOAbbreviation>Evid Based Complement Alternat Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>St. John's Wort Has Metabolically Favorable Effects on Adipocytes In Vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn>862575</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/862575</ELocationID>
            <Abstract>
                <AbstractText>In addition to serving as a storage site for reserve energy, adipocytes play a critical role in whole-body insulin sensitivity and glucose metabolism. St. John's Wort (SJW) is a botanical supplement widely used as an over-the-counter treatment of depression and a variety of other conditions associated with anxiety and nerve pain. Previous studies in our laboratory demonstrated that SJW inhibits insulin-stimulated glucose uptake and adipocyte differentiation in cultured murine and mature human adipocytes. To investigate the effects of SJW on adipocyte function in vivo, we utilized C57BL/6J mice. In our studies, mice were administered SJW extract (200???mg/kg) once daily by gavage for two weeks. In contrast to our in vitro studies, mice treated with SJW extract showed increased levels of adiponectin in white adipose tissue in a depot specific manner (P &lt; 0.01). SJW also exerted an insulin-sensitizing effect as indicated by a significant increase in insulin-stimulated Akt serine phosphorylation in epididymal white adipose tissue (P &lt; 0.01). Food intake, body weight, fasting blood glucose, and fasting insulin did not differ between the two groups. These results are important as they indicate that SJW does not promote metabolic dysfunction in adipose tissue in vivo.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fuller</LastName>
                    <ForeName>Scott</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0002-2677-1677</Identifier>
                    <Affiliation>Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Richard</LastName>
                    <ForeName>Allison J</ForeName>
                    <Initials>AJ</Initials>
                    <Affiliation>Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ribnicky</LastName>
                    <ForeName>David M</ForeName>
                    <Initials>DM</Initials>
                    <Affiliation>Biotech Center, Rutgers University, New Brunswick, NJ 08901, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beyl</LastName>
                    <ForeName>Robbie</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">0000-0002-8582-744X</Identifier>
                    <Affiliation>Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mynatt</LastName>
                    <ForeName>Randall</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stephens</LastName>
                    <ForeName>Jacqueline M</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P50 AT002776</GrantID>
                    <Acronym>AT</Acronym>
                    <Agency>NCCAM NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T32 AT004094</GrantID>
                    <Acronym>AT</Acronym>
                    <Agency>NCCAM NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U54 GM104940</GrantID>
                    <Acronym>GM</Acronym>
                    <Agency>NIGMS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>05</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Evid Based Complement Alternat Med</MedlineTA>
            <NlmUniqueID>101215021</NlmUniqueID>
            <ISSNLinking>1741-427X</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4054923</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/862575</ArticleId>
            <ArticleId IdType="pubmed">25136373</ArticleId>
            <ArticleId IdType="pmc">PMC4054923</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136336</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1664-302X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in microbiology</Title>
                <ISOAbbreviation>Front Microbiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ.</ArticleTitle>
            <Pagination>
                <MedlinePgn>391</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2014.00391</ELocationID>
            <Abstract>
                <AbstractText>Human infections by the bacterial pathogen Salmonella enterica represent major disease burdens worldwide. This highly ubiquitous species consists of more than 2600 different serovars that can be divided into typhoidal and non-typhoidal Salmonella (NTS) serovars. Despite their genetic similarity, these two groups elicit very different diseases and distinct immune responses in humans. Comparative analyses of the genomes of multiple Salmonella serovars have begun to explain the basis of the variation in disease manifestations. Recent advances in modeling both enteric fever and intestinal gastroenteritis in mice will facilitate investigation into both the bacterial- and host-mediated mechanisms involved in salmonelloses. Understanding the genetic and molecular mechanisms responsible for differences in disease outcome will augment our understanding of Salmonella pathogenesis, host immunity, and the molecular basis of host specificity. This review outlines the differences in epidemiology, clinical manifestations, and the human immune response to typhoidal and NTS infections and summarizes the current thinking on why these differences might exist.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gal-Mor</LastName>
                    <ForeName>Ohad</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>The Infectious Diseases Research Laboratory, Sheba Medical Center Tel-Hashomer, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boyle</LastName>
                    <ForeName>Erin C</ForeName>
                    <Initials>EC</Initials>
                    <Affiliation>Bernhard Nocht Institute for Tropical Medicine Hamburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grassl</LastName>
                    <ForeName>Guntram A</ForeName>
                    <Initials>GA</Initials>
                    <Affiliation>Institute for Experimental Medicine, Christian Albrechts University Kiel Kiel, Germany ; Research Center Borstel Borstel, Germany.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
                <PublicationType>Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Microbiol</MedlineTA>
            <NlmUniqueID>101548977</NlmUniqueID>
            <ISSNLinking>1664-302X</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4120697</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">NTS</Keyword>
            <Keyword MajorTopicYN="N">Salmonella enterica</Keyword>
            <Keyword MajorTopicYN="N">enteric fever</Keyword>
            <Keyword MajorTopicYN="N">gastroenteritis</Keyword>
            <Keyword MajorTopicYN="N">salmonellosis</Keyword>
            <Keyword MajorTopicYN="N">typhoid</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2014.00391</ArticleId>
            <ArticleId IdType="pubmed">25136336</ArticleId>
            <ArticleId IdType="pmc">PMC4120697</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136318</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1664-042X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in physiology</Title>
                <ISOAbbreviation>Front Physiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The pleural mesothelium in development and disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>284</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fphys.2014.00284</ELocationID>
            <Abstract>
                <AbstractText>The pleural mesothelium, derived from the embryonic mesoderm, is formed by a metabolically active monolayer of cells that blanket the chest wall and lungs on the parietal and visceral surfaces, respectively. The pleura and lungs are formed as a result of an intricate relationship between the mesoderm and the endoderm during development. Mesenchymal signaling pathways such as Wnt/B-catenin, Bmp4, and sonic hedgehog appear to be quintessential for lung development. Pleural Mesothelial Cells (PMCs) are known to express Wilms tumor-1 (Wt1) gene and in lineage labeling studies of the developing embryo, PMCs were found to track into the lung parenchyma and undergo mesothelial-mesenchymal transition (MMT) to form ??-smooth muscle actin (??-SMA)-positive cells of the mesenchyme and vasculature. There is definite evidence that mesothelial cells can differentiate and this seems to play an important role in pleural and parenchymal pathologies. Mesothelial cells can differentiate into adipocytes, chondrocytes, and osteoblasts; and have been shown to clonally generate fibroblasts and smooth muscle cells in murine models. This supports the possibility that they may also modulate lung injury-repair by re-activation of developmental programs in the adult reflecting an altered recapitulation of development, with implications for regenerative biology of the lung. In a mouse model of lung fibrosis using lineage-tracing studies, PMCs lost their polarity and cell-cell junctional complexes, migrated into lung parenchyma, and underwent phenotypic transition into myofibroblasts in response to the pro-fibrotic mediator, transforming growth factor-??1 (TGF-??1). However, intra-pleural heme-oxygenase-1 (HO-1) induction inhibited PMC migration after intra-tracheal fibrogenic injury. Intra-pleural fluorescein isothiocyanate labeled nanoparticles decorated with a surface antibody to mesothelin, a surface marker of mesothelial cells, migrate into the lung parenchyma with PMCs supporting a potential role for pleural based therapies to modulate pleural mesothelial activation and parenchymal disease progression.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Batra</LastName>
                    <ForeName>Hitesh</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham Birmingham, AL, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Antony</LastName>
                    <ForeName>Veena B</ForeName>
                    <Initials>VB</Initials>
                    <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham Birmingham, AL, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Physiol</MedlineTA>
            <NlmUniqueID>101549006</NlmUniqueID>
            <ISSNLinking>1664-042X</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4117979</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Wilms tumor-1 (WT1)</Keyword>
            <Keyword MajorTopicYN="N">epithelial-mesenchymal transition (EMT)</Keyword>
            <Keyword MajorTopicYN="N">idiopathic pulmonary fibrosis (IPF)</Keyword>
            <Keyword MajorTopicYN="N">pleural mesothelial cells</Keyword>
            <Keyword MajorTopicYN="N">pleural mesothelium</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2014.00284</ArticleId>
            <ArticleId IdType="pubmed">25136318</ArticleId>
            <ArticleId IdType="pmc">PMC4117979</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136317</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1663-4365</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>6</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in aging neuroscience</Title>
                <ISOAbbreviation>Front Aging Neurosci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>198</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fnagi.2014.00198</ELocationID>
            <Abstract>
                <AbstractText>The present study identifies deregulated cytokines and mediators of the immune response in the frontal cortex and cerebellum of sporadic Creutzfeldt-Jakob disease (sCJD) MM1 and VV2 subtypes compared to age-matched controls. Deregulated genes include pro- and anti-inflammatory cytokines, toll-like receptors, colony stimulating factors, cathepsins, members of the complement system, and members of the integrin and CTL/CTLD family with particular regional and sCJD subtype patterns. Analysis of cytokines and mediators at protein level shows expression of selected molecules and receptors in neurons, in astrocytes, and/or in microglia, thus suggesting interactions between neurons and glial cells, mainly microglia, in the neuroinflammatory response in sCJD. Similar inflammatory responses have been shown in the tg340 sCJD MM1 mice, revealing a progressive deregulation of inflammatory mediators with disease progression. Yet, inflammatory molecules involved are subjected to species differences in humans and mice. Moreover, inflammatory-related cell signaling pathways NF??B/IKK and JAK/STAT are activated in sCJD and sCJD MM1 mice. Together, the present observations show a self-sustained complex inflammatory and inflammatory-related responses occurring already at early clinical stages in animal model and dramatically progressing at advanced stages of sCJD. Considering this scenario, measures tailored to modulate (activate or inhibit) specific molecules could be therapeutic options in CJD.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Llorens</LastName>
                    <ForeName>Franc</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Neurology, Clinical Dementia Center and DZNE, University Medical School, Georg-August University , G??ttingen , Germany ; Institute of Neuropathology, IDIBELL-University Hospital Bellvitge, University of Barcelona, Hospitalet de Llobregat , Barcelona , Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>L??pez-Gonz??lez</LastName>
                    <ForeName>Irene</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Institute of Neuropathology, IDIBELL-University Hospital Bellvitge, University of Barcelona, Hospitalet de Llobregat , Barcelona , Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Th??ne</LastName>
                    <ForeName>Katrin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Neurology, Clinical Dementia Center and DZNE, University Medical School, Georg-August University , G??ttingen , Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carmona</LastName>
                    <ForeName>Margarita</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Neuropathology, IDIBELL-University Hospital Bellvitge, University of Barcelona, Hospitalet de Llobregat , Barcelona , Spain ; Network Center for Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Ministry of Health , Madrid , Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zafar</LastName>
                    <ForeName>Saima</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Neurology, Clinical Dementia Center and DZNE, University Medical School, Georg-August University , G??ttingen , Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andr??oletti</LastName>
                    <ForeName>Olivier</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Ecole Nationale V??t??rinaire de Toulouse, Institut National de la Recherche Agronomique , Toulouse , France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zerr</LastName>
                    <ForeName>Inga</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Department of Neurology, Clinical Dementia Center and DZNE, University Medical School, Georg-August University , G??ttingen , Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferrer</LastName>
                    <ForeName>Isidre</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Institute of Neuropathology, IDIBELL-University Hospital Bellvitge, University of Barcelona, Hospitalet de Llobregat , Barcelona , Spain ; Network Center for Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Ministry of Health , Madrid , Spain.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Aging Neurosci</MedlineTA>
            <NlmUniqueID>101525824</NlmUniqueID>
            <ISSNLinking>1663-4365</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4120692</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Creutzfeldt???Jakob disease</Keyword>
            <Keyword MajorTopicYN="N">cytokines</Keyword>
            <Keyword MajorTopicYN="N">microglia</Keyword>
            <Keyword MajorTopicYN="N">neuroinflammation</Keyword>
            <Keyword MajorTopicYN="N">prion protein</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnagi.2014.00198</ArticleId>
            <ArticleId IdType="pubmed">25136317</ArticleId>
            <ArticleId IdType="pmc">PMC4120692</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136298</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1662-5153</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in behavioral neuroscience</Title>
                <ISOAbbreviation>Front Behav Neurosci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Modulation of social behavior by the agouti pigmentation gene.</ArticleTitle>
            <Pagination>
                <MedlinePgn>259</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fnbeh.2014.00259</ELocationID>
            <Abstract>
                <AbstractText>Agouti is a secreted neuropeptide that acts as an endogenous antagonist of melanocortin receptors. Mice and rats lacking agouti (called non-agouti) have dark fur due to a disinhibition of melanocortin signaling and pigment deposition in the hair follicle. Non-agouti animals have also been reported to exhibit altered behavior, despite no evidence for the expression of agouti outside the skin. Here we confirm that non-agouti mice show altered social behavior and uncover expression of agouti in the preputial gland, a sebaceous organ in the urinary tract that secretes molecules involved in social behavior. Non-agouti mice had enlarged preputial glands and altered levels of putative preputial pheromones and surgical removal of the gland reversed the behavioral phenotype. These findings demonstrate the existence of an autologous, out-of-skin pathway for the modulation of social behavior.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Carola</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>IRCCS Fondazione Santa Lucia Rome, Italy ; Mouse Biology Unit, European Molecular Biology Laboratory Monterotondo, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perlas</LastName>
                    <ForeName>Emerald</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Mouse Biology Unit, European Molecular Biology Laboratory Monterotondo, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zonfrillo</LastName>
                    <ForeName>Francesca</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Mouse Biology Unit, European Molecular Biology Laboratory Monterotondo, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soini</LastName>
                    <ForeName>Helena A</ForeName>
                    <Initials>HA</Initials>
                    <Affiliation>Department of Chemistry, Institute for Pheromone Research, Indiana University Bloomington, IN, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Novotny</LastName>
                    <ForeName>Milos V</ForeName>
                    <Initials>MV</Initials>
                    <Affiliation>Department of Chemistry, Institute for Pheromone Research, Indiana University Bloomington, IN, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gross</LastName>
                    <ForeName>Cornelius T</ForeName>
                    <Initials>CT</Initials>
                    <Affiliation>Mouse Biology Unit, European Molecular Biology Laboratory Monterotondo, Italy.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Behav Neurosci</MedlineTA>
            <NlmUniqueID>101477952</NlmUniqueID>
            <ISSNLinking>1662-5153</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4117936</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">agouti</Keyword>
            <Keyword MajorTopicYN="N">melanocortin receptors</Keyword>
            <Keyword MajorTopicYN="N">preputial glands</Keyword>
            <Keyword MajorTopicYN="N">social behavior</Keyword>
            <Keyword MajorTopicYN="N">sorptive stir bar extraction (SBSE)</Keyword>
            <Keyword MajorTopicYN="N">volatile organic compounds (VOCs)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnbeh.2014.00259</ArticleId>
            <ArticleId IdType="pubmed">25136298</ArticleId>
            <ArticleId IdType="pmc">PMC4117936</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25136295</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1662-5102</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in cellular neuroscience</Title>
                <ISOAbbreviation>Front Cell Neurosci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>216</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fncel.2014.00216</ELocationID>
            <Abstract>
                <AbstractText>Toll-like receptors (TLRs) and NOD-like receptors (NLRs) are innate immunity sensors that provide an early/effective response to pathogenic or injury conditions. We have reported that ethanol-induced TLR4 activation triggers signaling inflammatory responses in glial cells, causing neuroinflammation and brain damage. However, it is uncertain if ethanol is able to activate NLRs/inflammasome in astroglial cells, which is the mechanism of activation, and whether there is crosstalk between both immune sensors in glial cells. Here we show that chronic ethanol treatment increases the co-localization of caspase-1 with GFAP(+) cells, and up-regulates IL-1?? and IL-18 in the frontal medial cortex in WT, but not in TLR4 knockout mice. We further show that cultured cortical astrocytes expressed several inflammasomes (NLRP3, AIM2, NLRP1, and IPAF), although NLRP3 mRNA is the predominant form. Ethanol, as ATP and LPS treatments, up-regulates NLRP3 expression, and causes caspase-1 cleavage and the release of IL-1?? and IL-18 in astrocytes supernatant. Ethanol-induced NLRP3/caspase-1 activation is mediated by mitochondrial (m) reactive oxygen species (ROS) generation because when using a specific mitochondria ROS scavenger, the mito-TEMPO (500 ??M) or NLRP3 blocking peptide (4 ??g/ml) or a specific caspase-1 inhibitor, Z-YVAD-FMK (10 ??M), abrogates mROS release and reduces the up-regulation of IL-1?? and IL-18 induced by ethanol or LPS or ATP. Confocal microscopy studies further confirm that ethanol, ATP or LPS promotes NLRP3/caspase-1 complex recruitment within the mitochondria to promote cell death by caspase-1-mediated pyroptosis, which accounts for ???73% of total cell death (???22%) and the remaining (???25%) die by caspase-3-dependent apoptosis. Suppression of the TLR4 function abrogates most ethanol effects on NLRP3 activation and reduces cell death. These findings suggest that NLRP3 participates, in ethanol-induced neuroinflammation and highlight the NLRP3/TLR4 crosstalk in ethanol-induced brain injury.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Alfonso-Loeches</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Molecular and Cellular Pathology of Alcohol Laboratory, Prince Felipe Research Center Valencia, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ure??a-Peralta</LastName>
                    <ForeName>Juan R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Molecular and Cellular Pathology of Alcohol Laboratory, Prince Felipe Research Center Valencia, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morillo-Bargues</LastName>
                    <ForeName>Maria Jos??</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Molecular and Cellular Pathology of Alcohol Laboratory, Prince Felipe Research Center Valencia, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oliver-De La Cruz</LastName>
                    <ForeName>Jorge</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Molecular and Cellular Pathology of Alcohol Laboratory, Prince Felipe Research Center Valencia, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guerri</LastName>
                    <ForeName>Consuelo</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Molecular and Cellular Pathology of Alcohol Laboratory, Prince Felipe Research Center Valencia, Spain.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Cell Neurosci</MedlineTA>
            <NlmUniqueID>101477935</NlmUniqueID>
            <ISSNLinking>1662-5102</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4118026</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">IL-??</Keyword>
            <Keyword MajorTopicYN="N">NLRP3-inflammasome</Keyword>
            <Keyword MajorTopicYN="N">ROS</Keyword>
            <Keyword MajorTopicYN="N">TLR4</Keyword>
            <Keyword MajorTopicYN="N">apoptosis</Keyword>
            <Keyword MajorTopicYN="N">astrocytes</Keyword>
            <Keyword MajorTopicYN="N">ethanol</Keyword>
            <Keyword MajorTopicYN="N">pyroptosis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2014.00216</ArticleId>
            <ArticleId IdType="pubmed">25136295</ArticleId>
            <ArticleId IdType="pmc">PMC4118026</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136149</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1466-1861</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Mediators of inflammation</Title>
                <ISOAbbreviation>Mediators Inflamm.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Antagonizing arachidonic Acid-derived eicosanoids reduces inflammatory th17 and Th1 cell-mediated inflammation and colitis severity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>917149</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/917149</ELocationID>
            <Abstract>
                <AbstractText>During colitis, activation of two inflammatory T cell subsets, Th17 and Th1 cells, promotes ongoing intestinal inflammatory responses. n-6 polyunsaturated fatty acid- (PUFA-) derived eicosanoids, such as prostaglandin E2 (PGE2), promote Th17 cell-mediated inflammation, while n-3 PUFA antagonize both Th17 and Th1 cells and suppress PGE2 levels. We utilized two genetic mouse models, which differentially antagonize PGE2 levels, to examine the effect on Th17 cells and disease outcomes in trinitrobenzene sulfonic acid- (TNBS-) induced colitis. Fat-1 mice contain the ??3 desaturase gene from C. elegans and synthesize n-3 PUFA de novo, thereby reducing the biosynthesis of n-6 PUFA-derived eicosanoids. In contrast, Fads1 Null mice contain a disrupted ??5 desaturase gene and produce lower levels of n-6 PUFA-derived eicosanoids. Compared to Wt littermates, Fat-1 and Fads1 Null mice exhibited a similar colitic phenotype characterized by reduced colonic mucosal inflammatory eicosanoid levels and mRNA expression of Th17 cell markers (IL-17A, ROR????, and IL-23), decreased percentages of Th17 cells and, improved colon injury scores (P ??? 0.05). Thus, during colitis, similar outcomes were obtained in two genetically distinct models, both of which antagonize PGE2 levels via different mechanisms. Our data highlight the critical impact of n-6 PUFA-derived eicosanoids in the promotion of Th17 cell-mediated colonic inflammation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Monk</LastName>
                    <ForeName>Jennifer M</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>Program in Integrative Nutrition &amp; Complex Diseases, Center for Translational Environmental Health Research, Texas A&amp;M University, College Station, TX, USA ; Department of Nutrition &amp; Food Science, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Turk</LastName>
                    <ForeName>Harmony F</ForeName>
                    <Initials>HF</Initials>
                    <Affiliation>Program in Integrative Nutrition &amp; Complex Diseases, Center for Translational Environmental Health Research, Texas A&amp;M University, College Station, TX, USA ; Department of Nutrition &amp; Food Science, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fan</LastName>
                    <ForeName>Yang-Yi</ForeName>
                    <Initials>YY</Initials>
                    <Identifier Source="ORCID">0000-0002-2912-511X</Identifier>
                    <Affiliation>Program in Integrative Nutrition &amp; Complex Diseases, Center for Translational Environmental Health Research, Texas A&amp;M University, College Station, TX, USA ; Department of Nutrition &amp; Food Science, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Callaway</LastName>
                    <ForeName>Evelyn</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Program in Integrative Nutrition &amp; Complex Diseases, Center for Translational Environmental Health Research, Texas A&amp;M University, College Station, TX, USA ; Department of Nutrition &amp; Food Science, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weeks</LastName>
                    <ForeName>Brad</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Department of Veterinary Pathobiology, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Peiying</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McMurray</LastName>
                    <ForeName>David N</ForeName>
                    <Initials>DN</Initials>
                    <Affiliation>Department of Nutrition &amp; Food Science, Texas A&amp;M University, College Station, TX, USA ; Department of Microbial Pathogenesis and Immunology, Texas A&amp;M University System Health Science Center, College Station, TX, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chapkin</LastName>
                    <ForeName>Robert S</ForeName>
                    <Initials>RS</Initials>
                    <Affiliation>Program in Integrative Nutrition &amp; Complex Diseases, Center for Translational Environmental Health Research, Texas A&amp;M University, College Station, TX, USA ; Department of Nutrition &amp; Food Science, Texas A&amp;M University, College Station, TX, USA ; Department of Microbial Pathogenesis and Immunology, Texas A&amp;M University System Health Science Center, College Station, TX, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mediators Inflamm</MedlineTA>
            <NlmUniqueID>9209001</NlmUniqueID>
            <ISSNLinking>0962-9351</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Immunol. 1999 Dec;11(6):648-56</RefSource>
                <PMID Version="1">10631550</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Scand J Immunol. 2000 Jan;51(1):23-8</RefSource>
                <PMID Version="1">10632972</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int Rev Immunol. 2000;19(1):51-62</RefSource>
                <PMID Version="1">10723677</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Int Med Res. 2000;28(1):28-35</RefSource>
                <PMID Version="1">10815645</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Digestion. 2001;63 Suppl 1:73-80</RefSource>
                <PMID Version="1">11173914</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2009 Mar 16;206(3):535-48</RefSource>
                <PMID Version="1">19273625</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2009 May;39(5):1301-12</RefSource>
                <PMID Version="1">19384872</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Immunol. 2009;27:485-517</RefSource>
                <PMID Version="1">19132915</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prostaglandins Leukot Essent Fatty Acids. 2009 Apr;80(4):195-200</RefSource>
                <PMID Version="1">19264469</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Mol Med. 2009 May;15(5):199-207</RefSource>
                <PMID Version="1">19362058</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Med. 2009 Jun;15(6):633-40</RefSource>
                <PMID Version="1">19465928</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2009 Sep;39(9):2629-35</RefSource>
                <PMID Version="1">19662632</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gut. 2009 Dec;58(12):1606-11</RefSource>
                <PMID Version="1">19628674</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>World J Gastroenterol. 2009 Dec 14;15(46):5784-8</RefSource>
                <PMID Version="1">19998498</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pharmacol Sci. 2010;112(1):1-5</RefSource>
                <PMID Version="1">20051652</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Immunol. 2010 Jan;30(1):80-9</RefSource>
                <PMID Version="1">19936899</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2010 Aug;40(8):2174-81</RefSource>
                <PMID Version="1">20486123</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Inflamm Bowel Dis. 2010 Oct;16(10):1808-13</RefSource>
                <PMID Version="1">20222127</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Inflamm Bowel Dis. 2011 Jan;17(1):336-45</RefSource>
                <PMID Version="1">20564531</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2011 Jul 15;187(2):733-47</RefSource>
                <PMID Version="1">21666057</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Transl Sci. 2011 Aug;4(4):268-73</RefSource>
                <PMID Version="1">21884514</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Gastrointest Liver Physiol. 2012 Jan 1;302(1):G153-67</RefSource>
                <PMID Version="1">21940900</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr. 2012 Jan;142(1):117-24</RefSource>
                <PMID Version="1">22131549</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nutrients. 2010 Mar;2(3):355-74</RefSource>
                <PMID Version="1">22254027</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr. 2012 Mar;142(3):592S-599S</RefSource>
                <PMID Version="1">22279140</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Lipid Res. 2012 Jul;53(7):1287-95</RefSource>
                <PMID Version="1">22534642</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(11):e49739</RefSource>
                <PMID Version="1">23166761</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 1999 Jan;29(1):355-66</RefSource>
                <PMID Version="1">9933118</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hepatogastroenterology. 1999 Jul-Aug;46(28):2338-42</RefSource>
                <PMID Version="1">10521993</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Gastroenterol. 2005 Feb;39(2):138-41</RefSource>
                <PMID Version="1">15681910</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lipids. 2004 Nov;39(11):1125-32</RefSource>
                <PMID Version="1">15726828</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 2005 Mar;128(3):687-94</RefSource>
                <PMID Version="1">15765404</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr. 2005 Jul;135(7):1745-51</RefSource>
                <PMID Version="1">15987859</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2006 May;116(5):1310-6</RefSource>
                <PMID Version="1">16670770</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr. 2006 Sep;136(9):2391-8</RefSource>
                <PMID Version="1">16920860</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2006 Sep;7(9):937-45</RefSource>
                <PMID Version="1">16906166</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2006 Sep;7(9):929-36</RefSource>
                <PMID Version="1">16906167</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prostaglandins Leukot Essent Fatty Acids. 2006 Dec;75(6):385-95</RefSource>
                <PMID Version="1">17011176</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Pharmacol. 2006 Nov;149(6):611-23</RefSource>
                <PMID Version="1">17016496</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr. 2007 Jan;137(1 Suppl):200S-204S</RefSource>
                <PMID Version="1">17182826</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Protoc. 2007;2(3):541-6</RefSource>
                <PMID Version="1">17406617</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Nutr Soc. 2007 May;66(2):237-59</RefSource>
                <PMID Version="1">17466105</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2007 Jun 15;178(12):8138-47</RefSource>
                <PMID Version="1">17548652</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 2007 Jun;132(7):2359-70</RefSource>
                <PMID Version="1">17570211</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2007 Jul 26;448(7152):484-7</RefSource>
                <PMID Version="1">17581588</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2007 Jul 26;448(7152):480-3</RefSource>
                <PMID Version="1">17581589</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2007 Sep;8(9):967-74</RefSource>
                <PMID Version="1">17581537</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Adv Drug Deliv Rev. 2007 Sep 30;59(11):1073-83</RefSource>
                <PMID Version="1">17825455</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>World J Gastroenterol. 2008 Jan 21;14(3):390-400</RefSource>
                <PMID Version="1">18200661</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2001 Jul;108(1):15-23</RefSource>
                <PMID Version="1">11435451</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dig Dis Sci. 2001 Nov;46(11):2336-43</RefSource>
                <PMID Version="1">11713932</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr. 2002 Jan;132(1):11-9</RefSource>
                <PMID Version="1">11773501</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2002 Apr;109(7):883-93</RefSource>
                <PMID Version="1">11927615</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Scand J Immunol. 2002 Jul;56(1):66-75</RefSource>
                <PMID Version="1">12100473</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gut. 2003 Jan;52(1):65-70</RefSource>
                <PMID Version="1">12477762</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Scand J Gastroenterol. 2002 Dec;37(12):1428-36</RefSource>
                <PMID Version="1">12523593</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2004 Feb 5;427(6974):504</RefSource>
                <PMID Version="1">14765186</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FASEB J. 2004 Aug;18(11):1318-20</RefSource>
                <PMID Version="1">15180965</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pharmacol Ther. 2004 Aug;103(2):147-66</RefSource>
                <PMID Version="1">15369681</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 1978 Oct;75(4):638-40</RefSource>
                <PMID Version="1">30669</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gut. 1980 Jul;21(7):591-6</RefSource>
                <PMID Version="1">7429322</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 1981 Sep;81(3):444-9</RefSource>
                <PMID Version="1">6114012</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 1984 Mar;86(3):453-60</RefSource>
                <PMID Version="1">6319219</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 1985 May 9;312(19):1217-24</RefSource>
                <PMID Version="1">2985986</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 1989 Feb 2;320(5):265-71</RefSource>
                <PMID Version="1">2783477</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 1989 May;96(5 Pt 1):1290-300</RefSource>
                <PMID Version="1">2539306</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 1993 Feb;91(2):651-60</RefSource>
                <PMID Version="1">8381824</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 1994 Dec;107(6):1643-52</RefSource>
                <PMID Version="1">7958674</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Gastroenterol Hepatol. 1994 Nov-Dec;9(6):539-43</RefSource>
                <PMID Version="1">7865710</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Clin Nutr. 1996 Jan;63(1):116-22</RefSource>
                <PMID Version="1">8604658</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 1998 Oct;115(4):874-82</RefSource>
                <PMID Version="1">9753490</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Semin Immunol. 2007 Dec;19(6):409-17</RefSource>
                <PMID Version="1">18053739</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Res. 2008 May 15;68(10):3985-91</RefSource>
                <PMID Version="1">18483285</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2008 Jul 1;181(1):721-35</RefSource>
                <PMID Version="1">18566439</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2008 Aug 4;205(8):1903-16</RefSource>
                <PMID Version="1">18663128</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Inflamm Bowel Dis. 2008 Sep;14(9):1175-84</RefSource>
                <PMID Version="1">18512248</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2008 Nov;9(11):1297-306</RefSource>
                <PMID Version="1">18849990</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2008 Nov 1;112(9):3696-703</RefSource>
                <PMID Version="1">18698005</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Prev Res (Phila). 2008 Sep;1(4):241-9</RefSource>
                <PMID Version="1">19138967</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2009 Mar 16;206(3):525-34</RefSource>
                <PMID Version="1">19273624</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4127240</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/917149</ArticleId>
            <ArticleId IdType="pubmed">25136149</ArticleId>
            <ArticleId IdType="pmc">PMC4127240</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25136147</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1466-1861</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Mediators of inflammation</Title>
                <ISOAbbreviation>Mediators Inflamm.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Intraperitoneal infusion of mesenchymal stem/stromal cells prevents experimental autoimmune uveitis in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>624640</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/624640</ELocationID>
            <Abstract>
                <AbstractText>Autoimmune uveitis is one of the leading causes of blindness. We here investigated whether intraperitoneal administration of human mesenchymal stem/stromal cells (hMSCs) might prevent development of experimental autoimmune uveitis (EAU) in mice. Time course study showed that the number of IFN-??- or IL-17-expressing CD4(+) T cells was increased in draining lymph nodes (DLNs) on the postimmunization day 7 and decreased thereafter. The retinal structure was severely disrupted on day 21. An intraperitoneal injection of hMSCs at the time of immunization protected the retina from damage and suppressed the levels of proinflammatory cytokines in the eye. Analysis of DLNs on day 7 showed that hMSCs decreased the number of Th1 and Th17 cells. The hMSCs did not reduce the levels of IL-1??, IL-6, IL-12, and IL-23 which are the cytokines that drive Th1/Th17 differentiation. Also, hMSCs did not induce CD4(+)CD25(+)Foxp3(+) cells. However, hMSCs increased the level of an immunoregulatory cytokine IL-10 and the population of IL-10-expressing B220(+)CD19(+) cells. Together, data demonstrate that hMSCs attenuate EAU by suppressing Th1/Th17 cells and induce IL-10-expressing B220(+)CD19(+) cells. Our results support suggestions that hMSCs may offer a therapy for autoimmune diseases mediated by Th1/Th17 responses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Oh</LastName>
                    <ForeName>Joo Youn</ForeName>
                    <Initials>JY</Initials>
                    <Affiliation>Department of Ophthalmology, Seoul National University Hospital, Seoul 110-744, Republic of Korea ; Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Seoul 110-744, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Tae Wan</ForeName>
                    <Initials>TW</Initials>
                    <Affiliation>Department of Ophthalmology, Seoul National University Boramae Medical Center, Seoul 156-707, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeong</LastName>
                    <ForeName>Hyun Jeong</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Seoul 110-744, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Hyun Ju</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Seoul 110-744, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ryu</LastName>
                    <ForeName>Jin Suk</ForeName>
                    <Initials>JS</Initials>
                    <Affiliation>Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Seoul 110-744, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wee</LastName>
                    <ForeName>Won Ryang</ForeName>
                    <Initials>WR</Initials>
                    <Affiliation>Department of Ophthalmology, Seoul National University Hospital, Seoul 110-744, Republic of Korea ; Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Seoul 110-744, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heo</LastName>
                    <ForeName>Jang Won</ForeName>
                    <Initials>JW</Initials>
                    <Affiliation>Department of Ophthalmology, Seoul National University Hospital, Seoul 110-744, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Mee Kum</ForeName>
                    <Initials>MK</Initials>
                    <Affiliation>Department of Ophthalmology, Seoul National University Hospital, Seoul 110-744, Republic of Korea ; Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Seoul 110-744, Republic of Korea ; Department of Ophthalmology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Republic of Korea.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mediators Inflamm</MedlineTA>
            <NlmUniqueID>9209001</NlmUniqueID>
            <ISSNLinking>0962-9351</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2011 Apr 22;34(4):566-78</RefSource>
                <PMID Version="1">21511185</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2011 Apr 22;34(4):554-65</RefSource>
                <PMID Version="1">21511184</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arthritis Rheum. 2011 Jun;63(6):1668-80</RefSource>
                <PMID Version="1">21384335</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Invest Ophthalmol Vis Sci. 2012 Feb;53(2):786-93</RefSource>
                <PMID Version="1">22232435</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prog Retin Eye Res. 2012 Mar;31(2):182-94</RefSource>
                <PMID Version="1">22120610</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells Dev. 2012 Apr 10;21(6):901-10</RefSource>
                <PMID Version="1">21663543</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Ophthalmol. 2012;51:7-28</RefSource>
                <PMID Version="1">22517201</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2012 Jun;30(6):1051-2</RefSource>
                <PMID Version="1">22495826</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Mol Cell Cardiol. 2012 Sep;53(3):420-8</RefSource>
                <PMID Version="1">22796574</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Hematol. 2012 Sep;40(9):761-70</RefSource>
                <PMID Version="1">22634392</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2012 Oct;30(10):2283-96</RefSource>
                <PMID Version="1">22865689</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2012 Oct 11;120(15):3142-51</RefSource>
                <PMID Version="1">22927248</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2004 Mar 1;103(5):1662-8</RefSource>
                <PMID Version="1">14592819</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ophthalmology. 2004 Mar;111(3):491-500; discussion 500</RefSource>
                <PMID Version="1">15019324</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 1998 Mar;8(3):275-83</RefSource>
                <PMID Version="1">9529145</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2005 May 15;105(10):4120-6</RefSource>
                <PMID Version="1">15692068</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2005 Sep 1;106(5):1755-61</RefSource>
                <PMID Version="1">15905186</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2006 Feb;24(2):179-89</RefSource>
                <PMID Version="1">16473830</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2006 May 11;441(7090):235-8</RefSource>
                <PMID Version="1">16648838</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2006 Aug 15;177(4):2080-7</RefSource>
                <PMID Version="1">16887966</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2007 Feb;25(2):371-9</RefSource>
                <PMID Version="1">17038675</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2008 Feb 1;180(3):1598-608</RefSource>
                <PMID Version="1">18209056</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Protoc Immunol. 2003 May;Chapter 15:Unit 15.6</RefSource>
                <PMID Version="1">18432901</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2008 May;28(5):639-50</RefSource>
                <PMID Version="1">18482568</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14638-43</RefSource>
                <PMID Version="1">18794523</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Clin Pract Rheumatol. 2008 Dec;4(12):657-66</RefSource>
                <PMID Version="1">19037227</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Med. 2009 Jan;15(1):42-9</RefSource>
                <PMID Version="1">19098906</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2008 Sep;8(9):726-36</RefSource>
                <PMID Version="1">19172693</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2009 May 15;182(10):5994-6002</RefSource>
                <PMID Version="1">19414750</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Bone Marrow Transplant. 2009 Jun;43(11):821-8</RefSource>
                <PMID Version="1">19308035</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2009 Aug 15;183(4):2312-20</RefSource>
                <PMID Version="1">19620304</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2009 Aug;27(8):1954-62</RefSource>
                <PMID Version="1">19544427</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2010 Jul 1;185(1):302-12</RefSource>
                <PMID Version="1">20511548</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2010 Sep;120(9):3073-83</RefSource>
                <PMID Version="1">20811163</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2010 Oct 8;7(4):431-42</RefSource>
                <PMID Version="1">20887949</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Immunol. 2010 Dec;22(6):768-74</RefSource>
                <PMID Version="1">21093239</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Invest Ophthalmol Vis Sci. 2011 May;52(6):3143-52</RefSource>
                <PMID Version="1">21296818</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4127236</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/624640</ArticleId>
            <ArticleId IdType="pubmed">25136147</ArticleId>
            <ArticleId IdType="pmc">PMC4127236</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136135</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">201402449</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Defective mitochondrial distribution in neurons is proposed to cause ATP depletion and calcium-buffering deficiencies that compromise cell function. However, it is unclear whether aberrant mitochondrial motility and distribution alone are sufficient to cause neurological disease. Calcium-binding mitochondrial Rho (Miro) GTPases attach mitochondria to motor proteins for anterograde and retrograde transport in neurons. Using two new KO mouse models, we demonstrate that Miro1 is essential for development of cranial motor nuclei required for respiratory control and maintenance of upper motor neurons required for ambulation. Neuron-specific loss of Miro1 causes depletion of mitochondria from corticospinal tract axons and progressive neurological deficits mirroring human upper motor neuron disease. Although Miro1-deficient neurons exhibit defects in retrograde axonal mitochondrial transport, mitochondrial respiratory function continues. Moreover, Miro1 is not essential for calcium-mediated inhibition of mitochondrial movement or mitochondrial calcium buffering. Our findings indicate that defects in mitochondrial motility and distribution are sufficient to cause neurological disease.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Nguyen</LastName>
                    <ForeName>Tammy T</ForeName>
                    <Initials>TT</Initials>
                    <Affiliation>Departments of Biochemistry.</Affiliation>
                </Author>
                <Author>
                    <LastName>Oh</LastName>
                    <ForeName>Sang S</ForeName>
                    <Initials>SS</Initials>
                    <Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109;</Affiliation>
                </Author>
                <Author>
                    <LastName>Weaver</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>MitoCare Center, Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107;</Affiliation>
                </Author>
                <Author>
                    <LastName>Lewandowska</LastName>
                    <ForeName>Agnieszka</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Departments of Biochemistry.</Affiliation>
                </Author>
                <Author>
                    <LastName>Maxfield</LastName>
                    <ForeName>Dane</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Departments of Biology and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Schuler</LastName>
                    <ForeName>Max-Hinderk</ForeName>
                    <Initials>MH</Initials>
                    <Affiliation>Departments of Biochemistry.</Affiliation>
                </Author>
                <Author>
                    <LastName>Smith</LastName>
                    <ForeName>Nathan K</ForeName>
                    <Initials>NK</Initials>
                    <Affiliation>Departments of Biochemistry.</Affiliation>
                </Author>
                <Author>
                    <LastName>Macfarlane</LastName>
                    <ForeName>Jane</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Departments of Biochemistry.</Affiliation>
                </Author>
                <Author>
                    <LastName>Saunders</LastName>
                    <ForeName>Gerald</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Palmer</LastName>
                    <ForeName>Cheryl A</ForeName>
                    <Initials>CA</Initials>
                    <Affiliation>Pathology.</Affiliation>
                </Author>
                <Author>
                    <LastName>Debattisti</LastName>
                    <ForeName>Valentina</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>MitoCare Center, Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107;</Affiliation>
                </Author>
                <Author>
                    <LastName>Koshiba</LastName>
                    <ForeName>Takumi</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Biology, Faculty of Sciences, Kyushu University, Fukuoka 812-8581, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pulst</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Neurology, University of Utah School of Medicine, Salt Lake City, UT 84112;</Affiliation>
                </Author>
                <Author>
                    <LastName>Feldman</LastName>
                    <ForeName>Eva L</ForeName>
                    <Initials>EL</Initials>
                    <Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109;</Affiliation>
                </Author>
                <Author>
                    <LastName>Hajn??czky</LastName>
                    <ForeName>Gy??rgy</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>MitoCare Center, Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107;</Affiliation>
                </Author>
                <Author>
                    <LastName>Shaw</LastName>
                    <ForeName>Janet M</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>Departments of Biochemistry, shaw@biochem.utah.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Ca2+-dependent motility</Keyword>
            <Keyword MajorTopicYN="N">Miro GTPase</Keyword>
            <Keyword MajorTopicYN="N">mitochondrial respiration</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1402449111</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1402449111</ArticleId>
            <ArticleId IdType="pubmed">25136135</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136127</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A sharp T-cell antigen receptor signaling threshold for T-cell proliferation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">201413726</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">T-cell antigen receptor (TCR) signaling is essential for activation, proliferation, and effector function of T cells. Modulation of both intensity and duration of TCR signaling can regulate these events. However, it remains unclear how individual T cells integrate such signals over time to make critical cell-fate decisions. We have previously developed an engineered mutant allele of the critical T-cell kinase zeta-chain-associated protein kinase 70 kDa (Zap70) that is catalytically inhibited by a small molecule inhibitor, thereby blocking TCR signaling specifically and efficiently. We have also characterized a fluorescent reporter Nur77-eGFP transgenic mouse line in which T cells up-regulate GFP uniquely in response to TCR stimulation. The combination of these technologies unmasked a sharp TCR signaling threshold for commitment to cell division both in vitro and in vivo. Further, we demonstrate that this threshold is independent of both the magnitude of the TCR stimulus and Interleukin 2. Similarly, we identify a temporal threshold of TCR signaling that is required for commitment to proliferation, after which T cells are able to proliferate in a Zap70 kinase-independent manner. Taken together, our studies reveal a sharp threshold for the magnitude and duration of TCR signaling required for commitment of T cells to proliferation. These results have important implications for understanding T-cell responses to infection and optimizing strategies for immunomodulatory drug delivery.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Au-Yeung</LastName>
                    <ForeName>Byron B</ForeName>
                    <Initials>BB</Initials>
                    <Affiliation>Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zikherman</LastName>
                    <ForeName>Julie</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mueller</LastName>
                    <ForeName>James L</ForeName>
                    <Initials>JL</Initials>
                    <Affiliation>Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ashouri</LastName>
                    <ForeName>Judith F</ForeName>
                    <Initials>JF</Initials>
                    <Affiliation>Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Matloubian</LastName>
                    <ForeName>Mehrdad</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cheng</LastName>
                    <ForeName>Debra A</ForeName>
                    <Initials>DA</Initials>
                    <Affiliation>Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Yiling</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shokat</LastName>
                    <ForeName>Kevan M</ForeName>
                    <Initials>KM</Initials>
                    <Affiliation>Department of Cellular and Molecular Pharmacology, andHoward Hughes Medical Institute, University of California, San Francisco, CA 94143.</Affiliation>
                </Author>
                <Author>
                    <LastName>Weiss</LastName>
                    <ForeName>Arthur</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine,Howard Hughes Medical Institute, University of California, San Francisco, CA 94143 aweiss@medicine.ucsf.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1413726111</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1413726111</ArticleId>
            <ArticleId IdType="pubmed">25136127</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136113</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>IL-6/STAT3 promotes regeneration of airway ciliated cells from basal stem cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">201409781</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The pseudostratified airway epithelium of the lung contains a balanced proportion of multiciliated and secretory luminal cells that are maintained and regenerated by a population of basal stem cells. However, little is known about how these processes are modulated in vivo, and about the potential role of cytokine signaling between stem and progenitor cells and their niche. Using a clonal 3D organoid assay, we found that IL-6 stimulated, and Stat3 inhibitors reduced, the generation of ciliated vs. secretory cells from basal cells. Gain-of-function and loss-of-function studies with cultured mouse and human basal cells suggest that IL-6/Stat3 signaling promotes ciliogenesis at multiple levels, including increases in multicilin gene and forkhead box protein J1 expression and inhibition of the Notch pathway. To test the role of IL-6 in vivo genetically, we followed the regeneration of mouse tracheal epithelium after ablation of luminal cells by inhaled SO2. Stat3 is activated in basal cells and their daughters early in the repair process, correlating with an increase in Il-6 expression in platelet-derived growth factor receptor alpha(+) mesenchymal cells in the stroma. Conditional deletion in basal cells of suppressor of cytokine signaling 3, encoding a negative regulator of the Stat3 pathway, results in an increase in multiciliated cells at the expense of secretory and basal cells. By contrast, Il-6 null mice regenerate fewer ciliated cells and an increased number of secretory cells after injury. The results support a model in which IL-6, produced in the reparative niche, functions to enhance the differentiation of basal cells, and thereby acts as a &quot;friend&quot; to promote airway repair rather than a &quot;foe.&quot;</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Tadokoro</LastName>
                    <ForeName>Tomomi</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Cell Biology, Duke University Medical Center, Durham, NC 27710; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Yang</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Cell Biology and Physiology, and Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation>
                </Author>
                <Author>
                    <LastName>Barak</LastName>
                    <ForeName>Larry S</ForeName>
                    <Initials>LS</Initials>
                    <Affiliation>Department of Cell Biology, Duke University Medical Center, Durham, NC 27710; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bai</LastName>
                    <ForeName>Yushi</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Cell Biology, Duke University Medical Center, Durham, NC 27710; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Randell</LastName>
                    <ForeName>Scott H</ForeName>
                    <Initials>SH</Initials>
                    <Affiliation>Department of Cell Biology and Physiology, and Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hogan</LastName>
                    <ForeName>Brigid L M</ForeName>
                    <Initials>BL</Initials>
                    <Affiliation>Department of Cell Biology, Duke University Medical Center, Durham, NC 27710; and brigid.hogan@dm.duke.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">cell fate</Keyword>
            <Keyword MajorTopicYN="N">epithelial repair</Keyword>
            <Keyword MajorTopicYN="N">mucociliary epithelium</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1409781111</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1409781111</ArticleId>
            <ArticleId IdType="pubmed">25136113</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136109</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Optogenetic neuronal stimulation promotes functional recovery after stroke.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">201404109</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Clinical and research efforts have focused on promoting functional recovery after stroke. Brain stimulation strategies are particularly promising because they allow direct manipulation of the target area's excitability. However, elucidating the cell type and mechanisms mediating recovery has been difficult because existing stimulation techniques nonspecifically target all cell types near the stimulated site. To circumvent these barriers, we used optogenetics to selectively activate neurons that express channelrhodopsin 2 and demonstrated that selective neuronal stimulations in the ipsilesional primary motor cortex (iM1) can promote functional recovery. Stroke mice that received repeated neuronal stimulations exhibited significant improvement in cerebral blood flow and the neurovascular coupling response, as well as increased expression of activity-dependent neurotrophins in the contralesional cortex, including brain-derived neurotrophic factor, nerve growth factor, and neurotrophin 3. Western analysis also indicated that stimulated mice exhibited a significant increase in the expression of a plasticity marker growth-associated protein 43. Moreover, iM1 neuronal stimulations promoted functional recovery, as stimulated stroke mice showed faster weight gain and performed significantly better in sensory-motor behavior tests. Interestingly, stimulations in normal nonstroke mice did not alter motor behavior or neurotrophin expression, suggesting that the prorecovery effect of selective neuronal stimulations is dependent on the poststroke environment. These results demonstrate that stimulation of neurons in the stroke hemisphere is sufficient to promote recovery.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Cheng</LastName>
                    <ForeName>Michelle Y</ForeName>
                    <Initials>MY</Initials>
                    <Affiliation>Departments of Neurosurgery,Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA 94305 gsteinberg@stanford.edu mycheng@stanford.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Eric H</ForeName>
                    <Initials>EH</Initials>
                    <Affiliation>Departments of Neurosurgery,Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA 94305.</Affiliation>
                </Author>
                <Author>
                    <LastName>Woodson</LastName>
                    <ForeName>Wyatt J</ForeName>
                    <Initials>WJ</Initials>
                    <Affiliation>Departments of Neurosurgery,Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA 94305Bioengineering, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Stephanie</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Departments of Neurosurgery,Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA 94305.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>Guohua</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Departments of Neurosurgery,Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA 94305.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Alex G</ForeName>
                    <Initials>AG</Initials>
                    <Affiliation>Psychiatry and Behavioral Sciences.</Affiliation>
                </Author>
                <Author>
                    <LastName>Arac</LastName>
                    <ForeName>Ahmet</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Departments of Neurosurgery,Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA 94305.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fenno</LastName>
                    <ForeName>Lief E</ForeName>
                    <Initials>LE</Initials>
                    <Affiliation>Bioengineering, andNeuroscience PhD Program.</Affiliation>
                </Author>
                <Author>
                    <LastName>Deisseroth</LastName>
                    <ForeName>Karl</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Bioengineering, andPsychiatry and Behavioral Sciences,Cracking the Neural Code (CNC) Program,Howard Hughes Medical Institute, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Steinberg</LastName>
                    <ForeName>Gary K</ForeName>
                    <Initials>GK</Initials>
                    <Affiliation>Departments of Neurosurgery,Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA 94305 gsteinberg@stanford.edu mycheng@stanford.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">channelrhodopsin</Keyword>
            <Keyword MajorTopicYN="N">stroke recovery</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1404109111</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1404109111</ArticleId>
            <ArticleId IdType="pubmed">25136109</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136103</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetic and pharmacological reactivation of the mammalian inactive X chromosome.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">201413620</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">X-chromosome inactivation (XCI), the random transcriptional silencing of one X chromosome in somatic cells of female mammals, is a mechanism that ensures equal expression of X-linked genes in both sexes. XCI is initiated in cis by the noncoding Xist RNA, which coats the inactive X chromosome (Xi) from which it is produced. However, trans-acting factors that mediate XCI remain largely unknown. Here, we perform a large-scale RNA interference screen to identify trans-acting XCI factors (XCIFs) that comprise regulators of cell signaling and transcription, including the DNA methyltransferase, DNMT1. The expression pattern of the XCIFs explains the selective onset of XCI following differentiation. The XCIFs function, at least in part, by promoting expression and/or localization of Xist to the Xi. Surprisingly, we find that DNMT1, which is generally a transcriptional repressor, is an activator of Xist transcription. Small-molecule inhibitors of two of the XCIFs can reversibly reactivate the Xi, which has implications for treatment of Rett syndrome and other dominant X-linked diseases. A homozygous mouse knockout of one of the XCIFs, stanniocalcin 1 (STC1), has an expected XCI defect but surprisingly is phenotypically normal. Remarkably, X-linked genes are not overexpressed in female Stc1(-/-) mice, revealing the existence of a mechanism(s) that can compensate for a persistent XCI deficiency to regulate X-linked gene expression.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Bhatnagar</LastName>
                    <ForeName>Sanchita</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Howard Hughes Medical Institute and Programs inGene Function and Expression,Molecular Medicine, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Xiaochun</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Howard Hughes Medical Institute and Programs inGene Function and Expression,Molecular Medicine, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ou</LastName>
                    <ForeName>Jianhong</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Gene Function and Expression,Molecular Medicine, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Howard Hughes Medical Institute and Programs inGene Function and Expression,Molecular Medicine, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chamberlain</LastName>
                    <ForeName>Lynn</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Howard Hughes Medical Institute and Programs inGene Function and Expression,Molecular Medicine, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Lihua J</ForeName>
                    <Initials>LJ</Initials>
                    <Affiliation>Gene Function and Expression,Molecular Medicine, andBioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wajapeyee</LastName>
                    <ForeName>Narendra</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Pathology, Yale University School of Medicine, New Haven, CT 06520.</Affiliation>
                </Author>
                <Author>
                    <LastName>Green</LastName>
                    <ForeName>Michael R</ForeName>
                    <Initials>MR</Initials>
                    <Affiliation>Howard Hughes Medical Institute and Programs inGene Function and Expression,Molecular Medicine, and Michael.Green@umassmed.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">MECP2</Keyword>
            <Keyword MajorTopicYN="N">RNA FISH</Keyword>
            <Keyword MajorTopicYN="N">RNA-seq</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1413620111</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1413620111</ArticleId>
            <ArticleId IdType="pubmed">25136103</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136095</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">201405798</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Psoriasis (Ps) and psoriasis arthritis (PsA) are poorly understood common diseases, induced by unknown environmental factors, affecting skin and articular joints. A single i.p. exposure to mannan from Saccharomyces cerevisiae induced an acute inflammation in inbred mouse strains resembling human Ps and PsA-like disease, whereas multiple injections induced a relapsing disease. Exacerbation of disease severity was observed in mice deficient for generation of reactive oxygen species (ROS). Interestingly, restoration of ROS production, specifically in macrophages, ameliorated both skin and joint disease. Neutralization of IL-17A, mainly produced by ???? T cells, completely blocked disease symptoms. Furthermore, mice depleted of granulocytes were resistant to disease development. In contrast, certain acute inflammatory mediators (C5, Fc?? receptor III, mast cells, and histamine) and adaptive immune players (???? T and B cells) were redundant in disease induction. Hence, we propose that mannan-induced activation of macrophages leads to TNF-?? secretion and stimulation of local ???? T cells secreting IL-17A. The combined action of activated macrophages and IL-17A produced in situ drives neutrophil infiltration in the epidermis and dermis of the skin, leading to disease manifestations. Thus, our finding suggests a new mechanism triggered by exposure to exogenous microbial components, such as mannan, that can induce and exacerbate Ps and PsA.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Khmaladze</LastName>
                    <ForeName>Ia</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Medical Inflammation Research, Department of Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden;</Affiliation>
                </Author>
                <Author>
                    <LastName>Kelkka</LastName>
                    <ForeName>Tiina</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Turku Doctoral Programme of Biomedical Sciences, 205 20, Turku, Finland;Medical Inflammation Research, Medicity Research Laboratory, University of Turku, 205 20, Turku, Finland; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Guerard</LastName>
                    <ForeName>Simon</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Medical Inflammation Research, Department of Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden;</Affiliation>
                </Author>
                <Author>
                    <LastName>Wing</LastName>
                    <ForeName>Kajsa</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Medical Inflammation Research, Department of Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden;</Affiliation>
                </Author>
                <Author>
                    <LastName>Pizzolla</LastName>
                    <ForeName>Angela</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Medical Inflammation Research, Department of Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden;</Affiliation>
                </Author>
                <Author>
                    <LastName>Saxena</LastName>
                    <ForeName>Amit</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Medical Inflammation Research, Department of Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden;</Affiliation>
                </Author>
                <Author>
                    <LastName>Lundqvist</LastName>
                    <ForeName>Katarina</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Clinical Dermatology and Venereology, University Hospital, 221 00 Lund, Sweden.</Affiliation>
                </Author>
                <Author>
                    <LastName>Holmdahl</LastName>
                    <ForeName>Meirav</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Clinical Dermatology and Venereology, University Hospital, 221 00 Lund, Sweden.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nandakumar</LastName>
                    <ForeName>Kutty Selva</ForeName>
                    <Initials>KS</Initials>
                    <Affiliation>Medical Inflammation Research, Department of Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden;</Affiliation>
                </Author>
                <Author>
                    <LastName>Holmdahl</LastName>
                    <ForeName>Rikard</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Medical Inflammation Research, Department of Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden;Medical Inflammation Research, Medicity Research Laboratory, University of Turku, 205 20, Turku, Finland; and rikard.holmdahl@ki.se.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Ncf1</Keyword>
            <Keyword MajorTopicYN="N">animal model</Keyword>
            <Keyword MajorTopicYN="N">autoimmune disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1405798111</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1405798111</ArticleId>
            <ArticleId IdType="pubmed">25136095</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136075</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-7445</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer research</Title>
                <ISOAbbreviation>Cancer Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mouse Models of Human Cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC; www.helmholtz-pccc.de) hosted the &quot;1st International Kloster Seeon Meeting on Mouse Models of Human Cancer&quot; in the Seeon monastery (Germany) from March 8 to 11, 2014. The meeting focused on the development and application of novel mouse models in tumor research and high-throughput technologies to overcome one of the most critical bottlenecks in translational bench-to-bedside tumor biology research. Moreover, the participants discussed basic molecular mechanisms underlying tumor initiation, progression, metastasis, and therapy resistance, which are the prerequisite for the development of novel treatment strategies and clinical applications in cancer therapy. Cancer Res; 74(17); 1-5. ??2014 AACR.</AbstractText>
                <CopyrightInformation>??2014 American Association for Cancer Research.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>B??ck</LastName>
                    <ForeName>Barbara C</ForeName>
                    <Initials>BC</Initials>
                    <Affiliation>Division of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany. Department of Vascular Biology and Tumor Angiogenesis (CBTM), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stein</LastName>
                    <ForeName>Ulrike</ForeName>
                    <Initials>U</Initials>
                    <Affiliation>Max-Delbr??ck-Center for Molecular Medicine (MDC), Berlin, Germany. Experimental and Clinical Research Center, Charit?? University Medicine, Berlin, Germany. German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Schmitt</LastName>
                    <ForeName>Clemens A</ForeName>
                    <Initials>CA</Initials>
                    <Affiliation>Max-Delbr??ck-Center for Molecular Medicine (MDC), Berlin, Germany. German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. Molecular Cancer Research Center (MKFZ), Charit?? University Medical Hospital, Berlin, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Augustin</LastName>
                    <ForeName>Hellmut G</ForeName>
                    <Initials>HG</Initials>
                    <Affiliation>Division of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany. Department of Vascular Biology and Tumor Angiogenesis (CBTM), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. augustin@angiogenese.de.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cancer Res</MedlineTA>
            <NlmUniqueID>2984705R</NlmUniqueID>
            <ISSNLinking>0008-5472</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">0008-5472.CAN-14-1424</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-14-1424</ArticleId>
            <ArticleId IdType="pubmed">25136075</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136069</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-7445</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer research</Title>
                <ISOAbbreviation>Cancer Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">A central confounding factor in the development of targeted therapies is tumor cell heterogeneity, particularly in tumor-initiating cells (TIC), within clinically identical tumors. Here, we show how activation of the Sonic Hedgehog (SHH) pathway in neural stem and progenitor cells creates a foundation for tumor cell evolution to heterogeneous states that are histologically indistinguishable but molecularly distinct. In spontaneous medulloblastomas that arise in Patched (Ptch)(+/-) mice, we identified three distinct tumor subtypes. Through cell type-specific activation of the SHH pathway in vivo, we determined that different cells of origin evolved in unique ways to generate these subtypes. Moreover, TICs in each subtype had distinct molecular and cellular phenotypes. At the bulk tumor level, the three tumor subtypes could be distinguished by a 465-gene signature and by differential activation levels of the ERK and AKT pathways. Notably, TICs from different subtypes were differentially sensitive to SHH or AKT pathway inhibitors, highlighting new mechanisms of resistance to targeted therapies. In summary, our results show how evolutionary processes act on distinct cells of origin to contribute to tumoral heterogeneity, at both bulk tumor and TIC levels. Cancer Res; 74(17); 1-11. ??2014 AACR.</AbstractText>
                <CopyrightInformation>??2014 American Association for Cancer Research.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Chow</LastName>
                    <ForeName>Kin-Hoe</ForeName>
                    <Initials>KH</Initials>
                    <Affiliation>The Jackson Laboratory, Bar Harbor, Maine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shin</LastName>
                    <ForeName>Dong-Mi</ForeName>
                    <Initials>DM</Initials>
                    <Affiliation>Laboratory of Immunogenetics, NIAID/NIH, Bethesda, Maryland. Department of Food and Nutrition, Seoul National University, Seoul, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jenkins</LastName>
                    <ForeName>Molly H</ForeName>
                    <Initials>MH</Initials>
                    <Affiliation>The Jackson Laboratory, Bar Harbor, Maine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>Emily E</ForeName>
                    <Initials>EE</Initials>
                    <Affiliation>The Jackson Laboratory, Bar Harbor, Maine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shih</LastName>
                    <ForeName>David J</ForeName>
                    <Initials>DJ</Initials>
                    <Affiliation>Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Choi</LastName>
                    <ForeName>Seungbum</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>The Jackson Laboratory, Bar Harbor, Maine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Low</LastName>
                    <ForeName>Benjamin E</ForeName>
                    <Initials>BE</Initials>
                    <Affiliation>The Jackson Laboratory, Bar Harbor, Maine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Philip</LastName>
                    <ForeName>Vivek</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>The Jackson Laboratory, Bar Harbor, Maine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rybinski</LastName>
                    <ForeName>Brad</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>The Jackson Laboratory, Bar Harbor, Maine.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bronson</LastName>
                    <ForeName>Roderick T</ForeName>
                    <Initials>RT</Initials>
                    <Affiliation>Dana Farber Cancer Institute, Boston, Massachusetts.</Affiliation>
                </Author>
                <Author>
                    <LastName>Taylor</LastName>
                    <ForeName>Michael D</ForeName>
                    <Initials>MD</Initials>
                    <Affiliation>Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yun</LastName>
                    <ForeName>Kyuson</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>The Jackson Laboratory, Bar Harbor, Maine. Kyuson.yun@jax.org.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R21 NS054235</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cancer Res</MedlineTA>
            <NlmUniqueID>2984705R</NlmUniqueID>
            <ISSNLinking>0008-5472</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">0008-5472.CAN-13-3293</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-13-3293</ArticleId>
            <ArticleId IdType="pubmed">25136069</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25136016</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-6596</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Antimicrobial agents and chemotherapy</Title>
                <ISOAbbreviation>Antimicrob. Agents Chemother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Efficacy of a Ceftazidime-Avibactam Combination in a Murine Septicemia model caused by Enterobacteriaceae species producing AmpC or Extended-Spectrum ??-lactamases.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">AAC.03579-14</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Avibactam is a novel non-??-lactam ??-lactamase inhibitor that has been shown in vitro to inhibit class A, C and some class D ??-lactamases. It is currently in phase 3 of clinical development in combination with ceftazidime. In this study, the efficacy of ceftazidime-avibactam was evaluated in a murine septicemia model against five ceftazidime-susceptible (MICs 0.06 - 0.25 ??g/ml) and 15 ceftazidime-resistant (MICs 64 - &gt;128 ??g/ml) species of Enterobacteriaceae, bearing either TEM, SHV, CTX-M extended-spectrum or AmpC ??-lactamases. In the first part of the study, ceftazidime-avibactam was administered at ratios of 4:1 and 8:1 (weight/weight) to evaluate the optimal ratio for efficacy. Against ceftazidime-susceptible isolates of Klebsiella pneumoniae and Escherichia coli, ceftazidime and ceftazidime-avibactam demonstrated similar efficacy (unit dose ED50 of &lt;1.5 - 9 mg/kg), whereas, against ceftazidime-resistant ??-lactamase-producing strains (ceftazidime unit dose ED50 of &gt;90 mg/kg), the addition of avibactam restored efficacy to ceftazidime (unit dose ED50 dropped to &lt;5-65 mg/kg). In a subsequent study, eight isolates (two AmpC and six CTX-M producers) were studied in the septicemia model. Ceftazidime-avibactam was administered at 4:1 weight/weight ratio and efficacy compared to 4:1 weight/weight ratios of either piperacillin-tazobactam or cefotaxime-avibactam . Against the eight isolates, ceftazidime-avibactam was the more effective combination, with unit dose ED50 values ranging from 2-27 mg/kg compared to &gt;90 mg/kg and 14-&gt;90 mg/kg for piperacillin-tazobactam or cefotaxime-avibactam, respectively. This study demonstrates that the potent in vitro activity observed with the ceftazidime-avibactam combination against ceftazidime-resistant Enterobacteriaceae bearing class A and class C ??-lactamases translated into good efficacy in the mouse septicemia model.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Levasseur</LastName>
                    <ForeName>Premavathy</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Novexel SA, Romainville, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Girard</LastName>
                    <ForeName>Anne-Marie</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>Novexel SA, Romainville, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lavallade</LastName>
                    <ForeName>Ludovic</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Novexel SA, Romainville, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Miossec</LastName>
                    <ForeName>Christine</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Novexel SA, Romainville, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pace</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Novexel SA, Romainville, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Coleman</LastName>
                    <ForeName>Kenneth</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Novexel SA, Romainville, France.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Antimicrob Agents Chemother</MedlineTA>
            <NlmUniqueID>0315061</NlmUniqueID>
            <ISSNLinking>0066-4804</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">AAC.03579-14</ArticleId>
            <ArticleId IdType="doi">10.1128/AAC.03579-14</ArticleId>
            <ArticleId IdType="pubmed">25136016</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135969</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1471-2970</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>369</Volume>
                    <Issue>1652</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Sep</Month>
                        <Day>26</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</Title>
                <ISOAbbreviation>Philos. Trans. R. Soc. Lond., B, Biol. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Long-term climbing fibre activity induces transcription of microRNAs in cerebellar Purkinje cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">20130508</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Synaptic activation of central neurons is often evoked by electrical stimulation leading to post-tetanic potentiation, long-term potentiation or long-term depression. Even a brief electrical tetanus can induce changes in as many as 100 proteins. Since climbing fibre activity is often associated with cerebellar behavioural plasticity, we used horizontal optokinetic stimulation (HOKS) to naturally increase synaptic input to floccular Purkinje cells in mice for hours, not minutes, and investigated how this activity influenced the transcription of microRNAs, small non-coding nucleotides that reduce transcripts of multiple, complementary mRNAs. A single microRNA can reduce the translation of as many as 30 proteins. HOKS evoked increases in 12 microRNA transcripts in floccular Purkinje cells. One of these microRNAs, miR335, increased 18-fold after 24 h of HOKS. After HOKS stopped, miR335 transcripts decayed with a time constant of approximately 2.5 h. HOKS evoked a 28-fold increase in pri-miR335 transcripts compared with an 18-fold increase in mature miR335 transcripts, confirming that climbing fibre-evoked increases in miR335 could be attributed to increases in transcription. We used three screens to identify potential mRNA targets for miR335 transcripts: (i) nucleotide complementarity, (ii) detection of increased mRNAs following microinjection of miR335 inhibitors into the cerebellum, and (iii) detection of decreased mRNAs following HOKS. Two genes, calbindin and 14-3-3-??, passed these screens. Transfection of N2a cells with miR335 inhibitors or precursors inversely regulated 14-3-3-?? transcripts. Immunoprecipitation of 14-3-3-?? co-immunoprecipitated PKC-?? and GABAA??2. Knockdown of either 14-3-3-?? or PKC-?? decreased the serine phosphorylation of GABAA??2, suggesting that 14-3-3-?? and PKC-?? under the control of miR335 homeostatically regulate the phosphorylation and insertion of GABAA??2 into the Purkinje cell post-synaptic membrane.</AbstractText>
                <CopyrightInformation>?? 2014 The Author(s) Published by the Royal Society. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Barmack</LastName>
                    <ForeName>Neal H</ForeName>
                    <Initials>NH</Initials>
                    <Affiliation>Department of Physiology and Pharmacology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA barmackn@ohsu.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Qian</LastName>
                    <ForeName>Zuyuan</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Physiology and Pharmacology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yakhnitsa</LastName>
                    <ForeName>Vadim</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Department of Physiology and Pharmacology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>REVIEW</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Philos Trans R Soc Lond B Biol Sci</MedlineTA>
            <NlmUniqueID>7503623</NlmUniqueID>
            <ISSNLinking>0962-8436</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">14-3-3-?? protein</Keyword>
            <Keyword MajorTopicYN="N">GABAA receptors</Keyword>
            <Keyword MajorTopicYN="N">PKC-??</Keyword>
            <Keyword MajorTopicYN="N">calbindin</Keyword>
            <Keyword MajorTopicYN="N">cerebellar plasticity</Keyword>
            <Keyword MajorTopicYN="N">horizontal optokinetic stimulation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">rstb.2013.0508</ArticleId>
            <ArticleId IdType="doi">10.1098/rstb.2013.0508</ArticleId>
            <ArticleId IdType="pubmed">25135969</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135889</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1460-2377</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International immunology</Title>
                <ISOAbbreviation>Int. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Role of Phage Display in Therapeutic Antibody Discovery.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">dxu082</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Phage display involves the expression of selected proteins on the surface of filamentous phage through fusion with phage coat protein, with the genetic sequence packaged within, linking phenotype to genotype selection. When combined with antibody libraries, phage display allows for rapid in vitro selection of antigen-specific antibodies and recovery of their corresponding coding sequence. Large non-immune and synthetic human libraries have been constructed as well as smaller immune libraries based on capturing a single individual's immune repertoire. This completely in vitro process allows for isolation of antibodies against poorly immunogenic targets as well- these cannot be obtained by animal immunization, thus further expanding the utility of the approach. Phage antibody display represents the first developed methodology for high throughput screening for human therapeutic antibody candidates. Recently other methods have been developed for generation of fully human therapeutic antibodies, such as single B cell screening, next generation genome sequencing and transgenic mice with human germline B cell genes. While each of these have their particular advantages, phage display has remained a key methodology for human antibody discovery due its in vitro process. Here we review the continuing role of this technique alongside other developing technologies for therapeutic antibody discovery.</AbstractText>
                <CopyrightInformation>?? The Japanese Society for Immunology. 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Chan</LastName>
                    <ForeName>Conrad E Z</ForeName>
                    <Initials>CE</Initials>
                    <Affiliation>Defense Medical and Environmental Research Institute, DSO National Laboratories, 27 Medical Drive, Singapore 117510, Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lim</LastName>
                    <ForeName>Angeline P C</ForeName>
                    <Initials>AP</Initials>
                    <Affiliation>Defense Medical and Environmental Research Institute, DSO National Laboratories, 27 Medical Drive, Singapore 117510, Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>MacAry</LastName>
                    <ForeName>Paul A</ForeName>
                    <Initials>PA</Initials>
                    <Affiliation>Department of Microbiology, Yong Loo Lin School of Medicine, 5 Science Drive 2, National University of Singapore, Singapore 117545, SingaporeImmunology Program, Centre for Life Sciences, 28 Medical Drive, National University of Singapore, Singapore 117456, Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hanson</LastName>
                    <ForeName>Brendon J</ForeName>
                    <Initials>BJ</Initials>
                    <Affiliation>Defense Medical and Environmental Research Institute, DSO National Laboratories, 27 Medical Drive, Singapore 117510, SingaporeDepartment of Microbiology, Yong Loo Lin School of Medicine, 5 Science Drive 2, National University of Singapore, Singapore 117545, Singapore hbrendon@dso.org.sg.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int Immunol</MedlineTA>
            <NlmUniqueID>8916182</NlmUniqueID>
            <ISSNLinking>0953-8178</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Phage display</Keyword>
            <Keyword MajorTopicYN="N">Therapeutic antibodies</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">dxu082</ArticleId>
            <ArticleId IdType="doi">10.1093/intimm/dxu082</ArticleId>
            <ArticleId IdType="pubmed">25135889</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135878</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-1705</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International immunopharmacology</Title>
                <ISOAbbreviation>Int. Immunopharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1567-5769(14)00320-8</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.intimp.2014.08.006</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Therapeutic strategies based on an enhanced hepatitis B virus (HBV)-specific cytotoxic T lymphocyte (CTL) activity may eradicate HBV. We previously verified that a fusion protein ubiquitin (Ub)-hepatitis B core antigen (HBcAg)-cytoplasmic transduction peptide (CTP) can enter the cytoplasm of dendritic cells and enhance T cell response to generate HBV-specific CTLs efficiently in vitro. Ub, a marker of protein degradation, may promote the generation of peptides appropriate for major histocompatibility complex class I presentation. In the present study, the specific immune responses of the fusion protein Ub-HBcAg-CTP in BALB/c mice were evaluated and the underlying mechanisms were investigated. Results showed that Ub-HBcAg-CTP increased the anti-HBcAg titer and produced the cytokines IFN-?? and IL-2. This fusion protein also induced higher percentages of IFN-??(+)CD8(+) cells and specific CTL responses. Ub-HBcAg-CTP could also upregulate the expressions of Jak2, Tyk2, STAT1, and STAT4 in T lymphocytes. In conclusion, Ub-HBcAg-CTP enhanced cellular and humoral immune responses and induced robust HBV-specific CTL activities in BALB/c mice.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Song</LastName>
                    <ForeName>Linlin</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Infectious Disease, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai 200233, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhuo</LastName>
                    <ForeName>Meng</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Infectious Disease, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai 200233, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tang</LastName>
                    <ForeName>Yuyan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Infectious Disease, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai 200233, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Xiaohua</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Infectious Disease, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai 200233, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tang</LastName>
                    <ForeName>Zhenghao</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Infectious Disease, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai 200233, China. Electronic address: tzhhao@163.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zang</LastName>
                    <ForeName>Guoqing</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Infectious Disease, Shanghai JiaoTong University Affiliated Sixth People's Hospital, Shanghai 200233, China. Electronic address: professorzangtg@126.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int Immunopharmacol</MedlineTA>
            <NlmUniqueID>100965259</NlmUniqueID>
            <ISSNLinking>1567-5769</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cytoplasmic transduction peptide</Keyword>
            <Keyword MajorTopicYN="N">Cytotoxic T lymphocyte</Keyword>
            <Keyword MajorTopicYN="N">Hepatitis B core antigen</Keyword>
            <Keyword MajorTopicYN="N">JAK/STAT signaling pathway</Keyword>
            <Keyword MajorTopicYN="N">Ubiquitin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1567-5769(14)00320-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.intimp.2014.08.006</ArticleId>
            <ArticleId IdType="pubmed">25135878</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135862</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1600-0641</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of hepatology</Title>
                <ISOAbbreviation>J. Hepatol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0168-8278(14)00556-X</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.jhep.2014.08.016</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">Current hepatic differentiation protocols for human embryonic stem cells (ESCs) require substantial improvements. MicroRNAs (miRNAs) have been reported to regulate hepatocyte cell fate during liver development, but their utility to improve hepatocyte differentiation from ESCs remains to be investigated. Therefore, our aim was to identify and to analyze hepatogenic miRNAs for their potential to improve hepatocyte differentiation from ESCs.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">By miRNA profiling and by miRNA screening, we identified miR-199a-5p among several potential hepatogenic miRNAs. Transplantation studies of miR-199a-5p-inhibited hepatocyte-like cells (HLCs) into the liver of immunodeficient fumarylacetoacetate knockout (Fah(-/-)/Rag2(-/-)/Il2rg(-/-)) mice were performed to assess the in vivo liver repopulation potential. For target determination, western blot and luciferase reporter assay were carried out.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">MiRNA profiling revealed 20 conserved candidate hepatogenic miRNAs. By miRNA screening, only miR-199a-5p inhibition in HLCs was found to be able to enhance the in vitro hepatic differentiation from mouse as well as human ESCs. MiR-199a-5p inhibition in human ESCs-derived HLCs enhanced the engraftment and repopulation capacity in the liver of Fah(-/-)/Rag2(-/-)/Il2rg(-/-) mice. Furthermore, we identified SMARCA4 and MST1 as novel targets of miR-199a-5p that may contribute to the improved hepatocyte generation and in vivo liver repopulation.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings demonstrate that miR-199a-5p inhibition in ES-derived HLCs leads to improved hepatocyte differentiation and upon transplantation, are able to engraft and repopulate the liver of Fah(-/-)/Rag2(-/-)/Il2rg(-/-) mice. Thus, our findings suggest that miRNA modulation may serve as promising approach to generate more mature HLCs from stem cell sources for the treatment of liver diseases.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>M??bus</LastName>
                    <ForeName>Selina</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Junior Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; Translational Hepatology and Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Dakai</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Junior Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; Translational Hepatology and Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yuan</LastName>
                    <ForeName>Qinggong</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; WINCORE, Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7-9, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>L??dtke</LastName>
                    <ForeName>Timo H-W</ForeName>
                    <Initials>TH</Initials>
                    <Affiliation>Institute for Molecular Biology Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Balakrishnan</LastName>
                    <ForeName>Asha</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; WINCORE, Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7-9, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sgodda</LastName>
                    <ForeName>Malte</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Translational Hepatology and Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rani</LastName>
                    <ForeName>Bhavna</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Junior Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; Translational Hepatology and Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kispert</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Institute for Molecular Biology Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ara??zo-Bravo</LastName>
                    <ForeName>Marcos J</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Computational Biology and Bioinformatics Group, Max Planck Institute for Molecular Biomedicine, R??ntgenstr. 20, 48149 M??nster, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Vogel</LastName>
                    <ForeName>Arndt</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Manns</LastName>
                    <ForeName>Michael P</ForeName>
                    <Initials>MP</Initials>
                    <Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ott</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; WINCORE, Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7-9, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cantz</LastName>
                    <ForeName>Tobias</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Translational Hepatology and Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; Computational Biology and Bioinformatics Group, Max Planck Institute for Molecular Biomedicine, R??ntgenstr. 20, 48149 M??nster, Germany. Electronic address: cantz.tobias@mh-hannover.de.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sharma</LastName>
                    <ForeName>Amar Deep</ForeName>
                    <Initials>AD</Initials>
                    <Affiliation>Junior Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; Translational Hepatology and Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Electronic address: sharma.amar@mh-hannover.de.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Hepatol</MedlineTA>
            <NlmUniqueID>8503886</NlmUniqueID>
            <ISSNLinking>0168-8278</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hepatocyte differentiation</Keyword>
            <Keyword MajorTopicYN="N">Liver repopulation and embryonic stem cells</Keyword>
            <Keyword MajorTopicYN="N">microRNA</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0168-8278(14)00556-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jhep.2014.08.016</ArticleId>
            <ArticleId IdType="pubmed">25135862</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135858</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2139</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Brain, behavior, and immunity</Title>
                <ISOAbbreviation>Brain Behav. Immun.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0889-1591(14)00408-5</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.bbi.2014.07.016</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Neuroinflammation is known to be involved in epileptogenesis with unclear mechanisms. Inhibition of soluble epoxide hydrolase (sEH) seems to offer anti-inflammatory protection to ischemic brain injury in rodents. Thus, it is hypothesized that sEH inhibition might also affect the neuroinflammatory responses caused by epileptic seizures. In the present study, we investigated the involvement of sEH in neuroinflammation, seizure generation and subsequent epileptogenesis using two mouse models of temporal lobe epilepsy. Experimental epileptic seizures were induced by either pilocarpine or electrical amygdala kindling in both wild-type (WT) C57BL/6 mice and sEH knockout (sEH KO) mice. The sEH expression in the hippocampus was detected by immunohistochemistry and Western blot analysis. The effects of the sEH hydrolase inhibitors, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA) and N-[1-(1-oxopropyl)-4-piperidinyl]-N'-[4-(trifluoromethoxy) phenyl)-urea (TPPU), and of the genetic deletion of sEH on seizure-induced neuroinflammatory responses and the development of epilepsy were evaluated. In the hippocampus of WT mice, sEH was mainly expressed in astrocytes (GFAP(+)), neurons (NeuN(+)) and scattered microglia (Iba-1(+)) in the regions of CA1, CA3 and dentate gyrus. Expression of sEH was significantly increased on day 7, 14, 21 and 28 after pilocarpine-induced status epilepticus (SE). Administration with sEH inhibitors attenuated the SE-induced up-regulation of interleukin-1?? (IL-1??) and interleukin-6 (IL-6), the degradation of EETs, as well as I??B phosphorylation. Following treatment with AUDA, the frequency and duration of spontaneous motor seizures in the pilocarpine-SE mice were decreased and the seizure-induction threshold of the fully kindled mice was increased. Up-regulation of hippocampal IL-1?? and IL-6 was found in both WT and sEH KO mice after successful induction of SE. Notably, sEH KO mice were more susceptible to seizures than WT mice. Seizure related neuroinflammation and ictogenesis were attenuated by pharmacological inhibition of sEH enzymatic activity but not by sEH genetic deletion. Therefore, sEH may play an important role in the generation of epilepsy. Furthermore, the effectiveness of AUDA in terms of anti-inflammatory and anti-ictogenesis properties suggests that it may have clinical therapeutic implication for epilepsy in the future, particularly when treating temporal lobe epilepsy.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Hung</LastName>
                    <ForeName>Yu-Wen</ForeName>
                    <Initials>YW</Initials>
                    <Affiliation>Institute of Physiology, National Yang-Ming University, Taipei, Taiwan; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan; Brain Research Center, National Yang-Ming University, Taipei, Taiwan; Laboratory of Neurophysiology, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hung</LastName>
                    <ForeName>Shao-Wen</ForeName>
                    <Initials>SW</Initials>
                    <Affiliation>Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan; Laboratory of Neurophysiology, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Animal Medicine, Animal Technology Laboratories, Agricultural Technology Research Institute, Hsinchu, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Yi-Chen</ForeName>
                    <Initials>YC</Initials>
                    <Affiliation>Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan; Laboratory of Neurophysiology, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wong</LastName>
                    <ForeName>Lin-King</ForeName>
                    <Initials>LK</Initials>
                    <Affiliation>Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan; Laboratory of Neurophysiology, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lai</LastName>
                    <ForeName>Ming-Tsong</ForeName>
                    <Initials>MT</Initials>
                    <Affiliation>Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan; Laboratory of Neurophysiology, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Tzong-Shyuan</ForeName>
                    <Initials>TS</Initials>
                    <Affiliation>Institute of Physiology, National Yang-Ming University, Taipei, Taiwan. Electronic address: tslee@ym.edu.tw.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shih</LastName>
                    <ForeName>Yang-Hsin</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Neurosurgery, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>Yung-Yang</ForeName>
                    <Initials>YY</Initials>
                    <Affiliation>Institute of Physiology, National Yang-Ming University, Taipei, Taiwan; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Brain Research Center, National Yang-Ming University, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan; Laboratory of Neurophysiology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan. Electronic address: yylin@vghtpe.gov.tw.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Brain Behav Immun</MedlineTA>
            <NlmUniqueID>8800478</NlmUniqueID>
            <ISSNLinking>0889-1591</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Epilepsy</Keyword>
            <Keyword MajorTopicYN="N">Neuroinflammation</Keyword>
            <Keyword MajorTopicYN="N">Proinflammatory cytokines</Keyword>
            <Keyword MajorTopicYN="N">Soluble epoxide hydrolase</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25135858</ArticleId>
            <ArticleId IdType="pii">S0889-1591(14)00408-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbi.2014.07.016</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135834</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1550-6606</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <ISOAbbreviation>J. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Bispecificity for Myelin and Neuronal Self-Antigens Is a Common Feature of CD4 T Cells in C57BL/6 Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">1400523</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The recognition of multiple ligands by a single TCR is an intrinsic feature of T cell biology, with important consequences for physiological and pathological processes. Polyspecific T cells targeting distinct self-antigens have been identified in healthy individuals as well as in the context of autoimmunity. We have previously shown that the 2D2 TCR recognizes the myelin oligodendrocyte glycoprotein epitope (MOG)35-55 as well as an epitope within the axonal protein neurofilament medium (NF-M15-35) in H-2(b) mice. In this study, we assess whether this cross-reactivity is a common feature of the MOG35-55-specific T cell response. To this end, we analyzed the CD4 T cell response of MOG35-55-immunized C57BL/6 mice for cross-reactivity with NF-M15-35. Using Ag recall responses, we established that an important proportion of MOG35-55-specific CD4 T cells also responded to NF-M15-35 in all mice tested. To study the clonality of this response, we analyzed 22 MOG35-55-specific T cell hybridomas expressing distinct TCR. Seven hybridomas were found to cross-react with NF-M15-35. Using an alanine scan of NF-M18-30 and an in silico predictive model, we dissected the molecular basis of cross-reactivity between MOG35-55 and NF-M15-35. We established that NF-M F24, R26, and V27 proved important TCR contacts. Strikingly, the identified TCR contacts are conserved within MOG38-50. Our data indicate that due to linear sequence homology, part of the MOG35-55-specific T cell repertoire of all C57BL/6 mice also recognizes NF-M15-35, with potential implications for CNS autoimmunity.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by The American Association of Immunologists, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lucca</LastName>
                    <ForeName>Liliana E</ForeName>
                    <Initials>LE</Initials>
                    <Affiliation>INSERM, U1043, Toulouse F-31300, France; Centre National de la Recherche Scientifique, U5282, Toulouse F-31300, France; Centre de Physiopathologie Toulouse-Purpan, Universit?? Toulouse 3, Toulouse F-31300, France;</Affiliation>
                </Author>
                <Author>
                    <LastName>Desbois</LastName>
                    <ForeName>Sabine</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>INSERM, U1043, Toulouse F-31300, France; Centre National de la Recherche Scientifique, U5282, Toulouse F-31300, France; Centre de Physiopathologie Toulouse-Purpan, Universit?? Toulouse 3, Toulouse F-31300, France;</Affiliation>
                </Author>
                <Author>
                    <LastName>Ramadan</LastName>
                    <ForeName>Abdulraouf</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>INSERM, U1043, Toulouse F-31300, France; Centre National de la Recherche Scientifique, U5282, Toulouse F-31300, France; Centre de Physiopathologie Toulouse-Purpan, Universit?? Toulouse 3, Toulouse F-31300, France;</Affiliation>
                </Author>
                <Author>
                    <LastName>Ben-Nun</LastName>
                    <ForeName>Avraham</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel; Department of Chemical Support, Weizmann Institute of Science, Rehovot 7610001, Israel;</Affiliation>
                </Author>
                <Author>
                    <LastName>Eisenstein</LastName>
                    <ForeName>Miriam</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel; Department of Chemical Support, Weizmann Institute of Science, Rehovot 7610001, Israel;</Affiliation>
                </Author>
                <Author>
                    <LastName>Carri??</LastName>
                    <ForeName>Nad??ge</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>INSERM, U1043, Toulouse F-31300, France; Centre National de la Recherche Scientifique, U5282, Toulouse F-31300, France; Centre de Physiopathologie Toulouse-Purpan, Universit?? Toulouse 3, Toulouse F-31300, France;</Affiliation>
                </Author>
                <Author>
                    <LastName>Gu??ry</LastName>
                    <ForeName>Jean-Charles</ForeName>
                    <Initials>JC</Initials>
                    <Affiliation>INSERM, U1043, Toulouse F-31300, France; Centre National de la Recherche Scientifique, U5282, Toulouse F-31300, France; Centre de Physiopathologie Toulouse-Purpan, Universit?? Toulouse 3, Toulouse F-31300, France;</Affiliation>
                </Author>
                <Author>
                    <LastName>Sette</LastName>
                    <ForeName>Alessandro</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>La Jolla Institute for Allergy and Immunology, San Diego, CA 92109;</Affiliation>
                </Author>
                <Author>
                    <LastName>Nguyen</LastName>
                    <ForeName>Phuong</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Geiger</LastName>
                    <ForeName>Terrence L</ForeName>
                    <Initials>TL</Initials>
                    <Affiliation>Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mars</LastName>
                    <ForeName>Lennart T</ForeName>
                    <Initials>LT</Initials>
                    <Affiliation>INSERM, U1043, Toulouse F-31300, France; Centre National de la Recherche Scientifique, U5282, Toulouse F-31300, France; Centre de Physiopathologie Toulouse-Purpan, Universit?? Toulouse 3, Toulouse F-31300, France;</Affiliation>
                </Author>
                <Author>
                    <LastName>Liblau</LastName>
                    <ForeName>Roland S</ForeName>
                    <Initials>RS</Initials>
                    <Affiliation>INSERM, U1043, Toulouse F-31300, France; Centre National de la Recherche Scientifique, U5282, Toulouse F-31300, France; Centre de Physiopathologie Toulouse-Purpan, Universit?? Toulouse 3, Toulouse F-31300, France; D??partement d'Immunologie, Centre Hospitalier Universitaire Toulouse, H??pital Purpan, Toulouse F-31300, France roland.liblau@inserm.fr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Immunol</MedlineTA>
            <NlmUniqueID>2985117R</NlmUniqueID>
            <ISSNLinking>0022-1767</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">jimmunol.1400523</ArticleId>
            <ArticleId IdType="doi">10.4049/jimmunol.1400523</ArticleId>
            <ArticleId IdType="pubmed">25135834</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135828</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1550-6606</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <ISOAbbreviation>J. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>CD1dhiCD5+ B Cells Expanded by GM-CSF In Vivo Suppress Experimental Autoimmune Myasthenia Gravis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">1303397</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">IL-10-competent subset within CD1d(hi)CD5(+) B cells, also known as B10 cells, has been shown to regulate autoimmune diseases. Whether B10 cells can prevent or suppress the development of experimental autoimmune myasthenia gravis (EAMG) has not been studied. In this study, we investigated whether low-dose GM-CSF, which suppresses EAMG, can expand B10 cells in vivo, and whether adoptive transfer of CD1d(hi)CD5(+) B cells would prevent or suppress EAMG. We found that treatment of EAMG mice with low-dose GM-CSF increased the proportion of CD1d(hi)CD5(+) B cells and B10 cells. In vitro coculture studies revealed that CD1d(hi)CD5(+) B cells altered T cell cytokine profile but did not directly inhibit T cell proliferation. In contrast, CD1d(hi)CD5(+) B cells inhibited B cell proliferation and its autoantibody production in an IL-10-dependent manner. Adoptive transfer of CD1d(hi)CD5(+) B cells to mice could prevent disease, as well as suppress EAMG after disease onset. This was associated with downregulation of mature dendritic cell markers and expansion of regulatory T cells resulting in the suppression of acetylcholine receptor-specific T cell and B cell responses. Thus, our data have provided significant insight into the mechanisms underlying the tolerogenic effects of B10 cells in EAMG. These observations suggest that in vivo or in vitro expansion of CD1d(hi)CD5(+) B cells or B10 cells may represent an effective strategy in the treatment of human myasthenia gravis.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by The American Association of Immunologists, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Sheng</LastName>
                    <ForeName>Jian Rong</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Department of Neurology, University of Chicago, Chicago, IL 60637 sheng1@uchicago.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Quan</LastName>
                    <ForeName>Songhua</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Neurology, University of Chicago, Chicago, IL 60637.</Affiliation>
                </Author>
                <Author>
                    <LastName>Soliven</LastName>
                    <ForeName>Betty</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Department of Neurology, University of Chicago, Chicago, IL 60637.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Immunol</MedlineTA>
            <NlmUniqueID>2985117R</NlmUniqueID>
            <ISSNLinking>0022-1767</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">jimmunol.1303397</ArticleId>
            <ArticleId IdType="doi">10.4049/jimmunol.1303397</ArticleId>
            <ArticleId IdType="pubmed">25135828</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135772</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1365-2443</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Genes to cells : devoted to molecular &amp; cellular mechanisms</Title>
                <ISOAbbreviation>Genes Cells</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Neonatal lethality of neural crest cell-specific Rest knockout mice is associated with gastrointestinal distension caused by aberrations of myenteric plexus.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/gtc.12172</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">RE1-silencing transcription factor (REST), also known as NRSF (neuron-restrictive silencer factor), is a well-known transcriptional repressor of neural genes. Rest null mice have embryonic lethality which prevents further investigations of the functions of the Rest gene in vivo. We studied neonatal but not embryonic lethality that was characterized by gastrointestinal tract dilation in the neural crest cell (NCC)-specific Rest conditional knockout (CKO) mice. While no histological abnormalities except the thinning of the digestive tract as a consequence of the gas accumulation were found in the digestive tract of the mutant mice, they do not have proper gastric retention after oral dye administration and the reduction of acetylcholinesterase (AChE) activity in NCC-derived myenteric plexus in the stomach was detected. High CO2 concentration in the dilated digestive tract of the Rest??CKO mice indicates a failure of gut function by underdeveloped cholinergic transmission in the enteric nervous system. The observed gastrointestinal distension phenotype provides a model for understanding the genetic and molecular basis of NCC defects in humans.</AbstractText>
                <CopyrightInformation>?? 2014 The Authors Genes to Cells ?? 2014 by the Molecular Biology Society of Japan and Wiley Publishing Asia Pty Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Aoki</LastName>
                    <ForeName>Hitomi</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Tissue and Organ Development, Regeneration, and Advanced Medical Science, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hara</LastName>
                    <ForeName>Akira</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Oomori</LastName>
                    <ForeName>Yoshiyuki</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Shimizu</LastName>
                    <ForeName>Yasutake</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Yamada</LastName>
                    <ForeName>Yasuhiro</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Kunisada</LastName>
                    <ForeName>Takahiro</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Genes Cells</MedlineTA>
            <NlmUniqueID>9607379</NlmUniqueID>
            <ISSNLinking>1356-9597</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/gtc.12172</ArticleId>
            <ArticleId IdType="pubmed">25135772</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25135720</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1672-0733</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>34</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban</Title>
                <ISOAbbreviation>J. Huazhong Univ. Sci. Technol. Med. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Glucocorticoid receptor agonist dexamethasone attenuates renal ischemia/reperfusion injury by up-regulating eNOS/iNOS.</ArticleTitle>
            <Pagination>
                <MedlinePgn>516-20</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11596-014-1308-y</ELocationID>
            <Abstract>
                <AbstractText>The aim of this study was to determine the effect of dexamethasone (DEX) on renal ischemia/reperfusion injury (IRI). C57BL/6 mice were randomly divided into Sham group, IRI group and DEX group. The mice in IRI and DEX groups subjected to renal ischemia for 60 min, were treated with saline or DEX (4 mg/kg, i.p.) 60 min prior to I/R. After 24 h of reperfusion, the renal function, renal pathological changes, activation of extracellular signal-regulated kinase (ERK) and glucocorticoid receptor (GR), and the levels of iNOS and eNOS were detected. The results showed DEX significantly decreased the damage to renal function and pathological changes after renal IRI. Pre-treatment with DEX reduced ERK activation and down-regulated the level of iNOS, whereas up-regulated the level of eNOS after renal IRI. DEX could further promote the activation of GR. These findings indicated GR activation confers preconditioning-like protection against acute IRI partially by up-regulating the ratio of eNOS/iNOS.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Jiong</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Nephrology, Huazhong University of Science and Technology, Wuhan, 430030, China, zhangjiong831224@163.com.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jun-Hua</ForeName>
                    <Initials>JH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Le</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiao</LastName>
                    <ForeName>Fang</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lan</LastName>
                    <ForeName>Xiao-Qin</ForeName>
                    <Initials>XQ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yue-Qiang</ForeName>
                    <Initials>YQ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Gang</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yao</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>J Huazhong Univ Sci Technolog Med Sci</MedlineTA>
            <NlmUniqueID>101169627</NlmUniqueID>
            <ISSNLinking>1672-0733</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11596-014-1308-y</ArticleId>
            <ArticleId IdType="pubmed">25135720</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135708</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-6830</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cellular and molecular neurobiology</Title>
                <ISOAbbreviation>Cell. Mol. Neurobiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hesperidin Alleviates Cognitive Impairment, Mitochondrial Dysfunction and Oxidative Stress in a Mouse Model of Alzheimer's Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The role of mitochondrial dysfunction and oxidative stress has been well-documented in Alzheimer's disease (AD). Bioflavonoids are being utilised as neuroprotectants in the treatment of various neurological disorders, including AD. Therefore, we conducted this current study in order to explore the effects of hesperidin (a flavanone glycoside) against amyloid-?? (A??)-induced cognitive dysfunction, oxidative damage and mitochondrial dysfunction in mice. Three-month-old APPswe/PS1dE9 transgenic mice were randomly assigned to a vehicle group, two hesperidin (either 50 or 100??mg/kg per??day) groups, or an Aricept (2.5??mg/kg per??day) group. After 16??weeks of treatment, although there was no obvious change in A?? deposition in the hesperidin-treated (100??mg/kg per??day) group, however, we found that the administration of hesperidin (100??mg/kg per??day) resulted in the reduction of learning and memory deficits, improved locomotor activity, and the increase of anti-oxidative defense and mitochondrial complex I-IV enzymes activities. Furthermore, Glycogen synthase kinase-3?? (GSK-3??) phosphorylation significantly increased in the hesperidin-treated (100??mg/kg per??day) group. Taken together, these findings suggest that a reduction in mitochondrial dysfunction through the inhibition of GSK-3?? activity, coupled with an increase in anti-oxidative defense, may be one of the mechanisms by which hesperidin improves cognitive function in the APPswe/PS1dE9 transgenic mouse model of AD.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Dongmei</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Pathogen Biology, Medical College, Henan University of Science and Technology, Building 6, Anhui, Jianxi District, Luoyang, 471003, People's Republic of China, wdmzgadyx@163.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Xiaoying</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Wenlan</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Yong</ForeName>
                    <Initials>Y</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Mol Neurobiol</MedlineTA>
            <NlmUniqueID>8200709</NlmUniqueID>
            <ISSNLinking>0272-4340</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10571-014-0098-x</ArticleId>
            <ArticleId IdType="pubmed">25135708</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135690</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">0148-6071</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JPEN. Journal of parenteral and enteral nutrition</Title>
                <ISOAbbreviation>JPEN J Parenter Enteral Nutr</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Arginine Supplementation Induces Arginase Activity and Inhibits TNF-?? Synthesis in Mice Spleen Macrophages After Intestinal Obstruction.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">0148607114546374</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Background: The purpose of this study was to assess the effect of arginine supplementation on arginase activity, tumor necrosis factor-?? (TNF-??) and interleukin-10 (IL-10) synthesis in cultured splenic macrophages from a murine model of intestinal obstruction (IO). The effects of nitric oxide synthase (iNOS) inhibition were also studied using iNOS knockout animals. Material and Methods: Male C57BL6/J wild-type (WT) and iNOS knockout (iNOS-/-) mice were randomized into 6 groups: Sham and Sham-/- (standard chow), IO and IO-/- (standard chow + IO), and Arg and Arg-/- (standard chow supplemented with arginine + IO). After 7 days of treatment with standard or supplemented chow, IO was induced. Arginase activity as well as TNF-?? and IL-10 levels were analyzed in splenic macrophage cultures. Results: Arginine supplementation and the absence of iNOS increased arginase activity in splenic macrophages (Arg, IO-/-, and Arg-/- groups vs the Sham group; P &lt; .05). Arginine was also related to a decrease in TNF-?? levels (Arg vs IO group, P &lt; .05) and maintenance of IL-10 levels (Arg vs other groups, P &gt; .05). The inhibition of iNOS did not result in effects on the concentration of cytokines (Sham-/-, IO-/-, and Arg-/- vs other, P &lt; .05). Conclusions: Arginine supplementation and iNOS inhibition led to increased arginase activity. Arginine availability decreased plasma TNF-?? levels, which may be directly related to nitric oxide derived from arginine.</AbstractText>
                <CopyrightInformation>?? 2014 American Society for Parenteral and Enteral Nutrition.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Quirino</LastName>
                    <ForeName>Iara Eliza Pac??fico</ForeName>
                    <Initials>IE</Initials>
                    <Affiliation>Department of Clinical Analysis and Toxicology, Pharmacy School, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Carneiro</LastName>
                    <ForeName>Matheus Batista Heitor</ForeName>
                    <Initials>MB</Initials>
                    <Affiliation>Department of Biochemistry and Immunology, Biologic Sciences Institute, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cardoso</LastName>
                    <ForeName>Valbert Nascimento</ForeName>
                    <Initials>VN</Initials>
                    <Affiliation>Department of Clinical Analysis and Toxicology, Pharmacy School, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>das Gra??as Carvalho Dos Santos</LastName>
                    <ForeName>Rosana</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Clinical Analysis and Toxicology, Pharmacy School, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Vieira</LastName>
                    <ForeName>Leda Quercia</ForeName>
                    <Initials>LQ</Initials>
                    <Affiliation>Department of Biochemistry and Immunology, Biologic Sciences Institute, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fiuza</LastName>
                    <ForeName>Jacqueline Ara??jo</ForeName>
                    <Initials>JA</Initials>
                    <Affiliation>Ren?? Rachou Research Center, Funda????o Oswaldo Cruz, Belo Horizonte, MG, Brazil Department of Parasitology, Biologic Sciences Institute Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Alvarez-Leite</LastName>
                    <ForeName>Jacqueline Isaura</ForeName>
                    <Initials>JI</Initials>
                    <Affiliation>Department of Biochemistry and Immunology, Biologic Sciences Institute, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>de Vasconcelos Generoso</LastName>
                    <ForeName>Simone</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Nutrition, Nursing School, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil simonenutufmg@gmail.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Correia</LastName>
                    <ForeName>Maria Isabel Toulson Davisson</ForeName>
                    <Initials>MI</Initials>
                    <Affiliation>Department of Surgery, Medical School, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>JPEN J Parenter Enteral Nutr</MedlineTA>
            <NlmUniqueID>7804134</NlmUniqueID>
            <ISSNLinking>0148-6071</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">arginase</Keyword>
            <Keyword MajorTopicYN="N">immune modulation</Keyword>
            <Keyword MajorTopicYN="N">inducible nitric oxide synthase</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">0148607114546374</ArticleId>
            <ArticleId IdType="doi">10.1177/0148607114546374</ArticleId>
            <ArticleId IdType="pubmed">25135690</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135648</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-3649</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vascular pharmacology</Title>
                <ISOAbbreviation>Vascul. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Activation of Nrf2 by dimethyl fumarate improves vascular calcification.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1537-1891(14)00125-6</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vph.2014.06.007</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Dimethyl fumarate (DMF) has several pharmacological benefits including immunomodulation and prevention of fibrosis, which are dependent on the NF-E2-related factor 2 (Nrf2) antioxidant pathways. Therefore, we hypothesized that DMF could attenuate vascular calcification via Nrf2 activation. Vascular calcification induced by hyperphosphataemia was significantly inhibited by DMF in vascular smooth muscle cells (VSMCs) in a dose-dependent manner. DMF-mediated Nrf2 upregulation was accompanied by the reduced expressions of genes related with osteoblast-like phenotype based on promoter activity, mRNA and protein expression, and von Kossa staining. Likewise, Nrf2 overexpression significantly decreased the formation of calcium deposit similar to the level of osteogenic staining in VSMCs, and DMF with Nrf2 knockdown failed to attenuate hyperphosphatemia induced vascular calcification. Furthermore, DMF significantly attenuated the calcification of ex vivo ring culture from both rat common carotid artery and mouse thoracic aorta as well as in vivo mouse model of Vitamin D3-induced calcification consistent with the increased Nrf2 protein levels in early stage of calcification by DMF. In conclusion, our data support that DMF stimulates Nrf2 activity to attenuate hyperphosphatamia in vitro or Vitamin D3-induced in vivo vascular calcification, which would be a beneficial effect on vascular diseases induced by oxidative stress such as vascular calcification.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ha</LastName>
                    <ForeName>Chae-Myeong</ForeName>
                    <Initials>CM</Initials>
                    <Affiliation>Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea; BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Sungmi</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Choi</LastName>
                    <ForeName>Young-Keun</ForeName>
                    <Initials>YK</Initials>
                    <Affiliation>Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jeong</LastName>
                    <ForeName>Ji-Yun</ForeName>
                    <Initials>JY</Initials>
                    <Affiliation>Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Oh</LastName>
                    <ForeName>Chang Joo</ForeName>
                    <Initials>CJ</Initials>
                    <Affiliation>Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bae</LastName>
                    <ForeName>Kwi-Hyun</ForeName>
                    <Initials>KH</Initials>
                    <Affiliation>Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Sun Joo</ForeName>
                    <Initials>SJ</Initials>
                    <Affiliation>Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Ji-Hyun</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Keun-Gyu</ForeName>
                    <Initials>KG</Initials>
                    <Affiliation>Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University, Daegu, Republic of Korea; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jun</LastName>
                    <ForeName>Do Youn</ForeName>
                    <Initials>DY</Initials>
                    <Affiliation>Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University, Daegu, Republic of Korea. Electronic address: dyjun@knu.ac.kr.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>In-Kyu</ForeName>
                    <Initials>IK</Initials>
                    <Affiliation>BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu, Republic of Korea; Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University, Daegu, Republic of Korea; Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. Electronic address: leei@knu.ac.kr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vascul Pharmacol</MedlineTA>
            <NlmUniqueID>101130615</NlmUniqueID>
            <ISSNLinking>1537-1891</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chemical compounds</Keyword>
            <Keyword MajorTopicYN="N">Dimethyl fumarate</Keyword>
            <Keyword MajorTopicYN="N">Dimethyl fumarate (PubChem CID: 637568)</Keyword>
            <Keyword MajorTopicYN="N">Hyperphosphatemia</Keyword>
            <Keyword MajorTopicYN="N">NF-E2-related factor 2</Keyword>
            <Keyword MajorTopicYN="N">Osteoblast</Keyword>
            <Keyword MajorTopicYN="N">Vascular calcification</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25135648</ArticleId>
            <ArticleId IdType="pii">S1537-1891(14)00125-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vph.2014.06.007</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135647</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-3649</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vascular pharmacology</Title>
                <ISOAbbreviation>Vascul. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-??B pathway.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1537-1891(14)00128-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vph.2014.06.008</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Lectin-like receptor for oxidized low density lipoprotein (LOX-1) plays a key role in endothelial ox-LDL endocytosis, endothelial dysfunction and atherogenesis. In the present study, the effect of lipopolysaccharide (LPS) on LOX-1 expression and the underlying molecular pathways were investigated. Human umbilical vein endothelial cells (HUVECs) were treated with LPS and the protein expressions of LOX-1, TLR4, TLR2, MyD88, Nox4, Nox2, PI3K, p38MAPK, JNK, ERK, Nrf1, Nrf2 and p65 were examined by Western blotting. The intracellular reactive oxygen species (ROS) production was examined by flow cytometry with fluorescence probe DCFH2-DA. The role of TLR4, MyD88 and Nox4 were determined with specific siRNA. The endothelial ox-LDL uptake and the endothelial-monocyte adhesion were evaluated with DiI-ox-LDL and Hoechst 33342 respectively. The effect of LPS on LOX-1 expression in aorta tissue was also studied with male C57/BL6 mice by intraperitoneal injection of LPS. The results showed that LPS induced LOX-1 protein expression in a time- and concentration-dependent manner. The mRNA expression of LOX-1 was also upregulated. The protein expression of LOX-1 and phosphorylated p38MAPK, p65 was significantly enhanced by LPS both in vitro and in vivo. LPS induced LOX-1 expression was blocked by siRNA for TLR4, MyD88, and Nox4 and inhibitors for p38MAPK, NF-??B, cyclooxygenase-2, and NADPH oxidase. Both LPS induced ox-LDL uptake and endothelial-monocyte adhesion were significantly inhibited by anti-LOX-1 antibody. LPS dramatically induced LOX-1 protein expression in aorta tissues. In conclusion, our data suggested that LPS induces LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK/NF-??B pathway in endothelial cells, which provides new regulatory mechanisms for LOX-1 expression.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zhao</LastName>
                    <ForeName>Wenwen</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ma</LastName>
                    <ForeName>Guixin</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Xiuping</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Electronic address: xpchen@umac.mo.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vascul Pharmacol</MedlineTA>
            <NlmUniqueID>101130615</NlmUniqueID>
            <ISSNLinking>1537-1891</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Endothelial cells</Keyword>
            <Keyword MajorTopicYN="N">LOX-1</Keyword>
            <Keyword MajorTopicYN="N">Lipopolysaccharide</Keyword>
            <Keyword MajorTopicYN="N">ROS</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25135647</ArticleId>
            <ArticleId IdType="pii">S1537-1891(14)00128-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vph.2014.06.008</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135642</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1083-351X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of biological chemistry</Title>
                <ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Molecular characterization of arylsulfatase G - Molecular characterization of arylsulfatase G - expression, processing, glycosylation, transport and activity.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">jbc.M114.584144</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Arylsulfatase G (ARSG) is a recently identified lysosomal sulfatase that was shown to be responsible for the degradation of 3-O- sulfated N-sulfoglucosamine residues of heparan sulfate glycosaminoglycans. Deficiency of ARSG leads to a new type of mucopolysaccharidosis, as described in a mouse model. Here we provide a detailed molecular characterization of the endogenous murine enzyme. ARSG is expressed and proteolytically processed in a tissue-specific manner. The 63-kDa single-chain precursor protein localizes to pre-lysosomal compartments and tightly associates with organelle membranes, most propably the endoplasmic reticulum. In contrast, proteolytically processed ARSG fragments of 34, 18 and 10 kDa were found in lysosomal fractions and lost their membrane association. The processing sites and a disulfide bridge between the 18- and 10-kDa chains could be roughly mapped. Proteases participating in the processing were identified as cathepsins B and L. Proteolytic processing is dispensable for hydrolytic sulfatase activity in vitro. Lysosomal transport of ARSG in the liver is independent of mannose 6-phosphate, sortilin and Limp2. However, mutation of glycosylation site N497 abrogates transport of ARSG to lysosomes in human fibrosarcoma cells, due to impaired mannose 6-phosphate modification.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, The American Society for Biochemistry and Molecular Biology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Kowalewski</LastName>
                    <ForeName>Bj??rn</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Bielefeld University, Germany;</Affiliation>
                </Author>
                <Author>
                    <LastName>L??bke</LastName>
                    <ForeName>Torben</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Bielefeld University, Germany;</Affiliation>
                </Author>
                <Author>
                    <LastName>Kollmann</LastName>
                    <ForeName>Katrin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>University Medical Center Hamburg-Eppendorf; Children's Hospital, Germany;</Affiliation>
                </Author>
                <Author>
                    <LastName>Braulke</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>University Medical Center Hamburg-Eppendorf; Children's Hospital, Germany;</Affiliation>
                </Author>
                <Author>
                    <LastName>Reinheckel</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Albert-Ludwigs-Universit??t-Freiburg, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dierks</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Bielefeld University, Germany;</Affiliation>
                </Author>
                <Author>
                    <LastName>Damme</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Bielefeld University, Germany; mdamme@biochem.uni-kiel.de.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Biol Chem</MedlineTA>
            <NlmUniqueID>2985121R</NlmUniqueID>
            <ISSNLinking>0021-9258</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Arylsulfatase G</Keyword>
            <Keyword MajorTopicYN="N">enzyme processing</Keyword>
            <Keyword MajorTopicYN="N">heparan sulfate</Keyword>
            <Keyword MajorTopicYN="N">lysosomal glycoprotein</Keyword>
            <Keyword MajorTopicYN="N">lysosomal storage disease</Keyword>
            <Keyword MajorTopicYN="N">lysosome</Keyword>
            <Keyword MajorTopicYN="N">mannose 6-phosphate</Keyword>
            <Keyword MajorTopicYN="N">mucopolysacchridosis</Keyword>
            <Keyword MajorTopicYN="N">proteolytic processing</Keyword>
            <Keyword MajorTopicYN="N">sulfatase</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25135642</ArticleId>
            <ArticleId IdType="pii">M114.584144</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.M114.584144</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135621</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1477-7827</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>12</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Reproductive biology and endocrinology : RB&amp;E</Title>
                <ISOAbbreviation>Reprod. Biol. Endocrinol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Critical periods of increased fetal vulnerability to a maternal high fat diet.</ArticleTitle>
            <Pagination>
                <MedlinePgn>80</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fetal adaptations to high fat (HF) diet in utero (IU) that may predispose to Metabolic Syndrome (MetS) in adulthood include changes in fetal hepatic gene expression. Studies were performed to determine whether maternal exposure to HF diet at different stages during pregnancy had different effects on the fetus, including hepatic gene expression.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Female wild type mice were fed either a HF or breeding chow (C) for 2 wks prior to mating. The experimental groups were composed of embryonic day (e) 18.5 fetuses obtained from WT female mice that were fed HF (HF, 35.5% fat) or breeding chow (C, 9.5% fat) for 2 wk before mating until e9.5 of pregnancy (periconception-midpregnancy). At e9.5 dams were switched to the opposite diet (C-HF or HF-C).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Exposure to HF diet throughout pregnancy reduced maternal weight gain compared to C diet (p &lt; 0.02 HF vs. C). HF-C dams had significantly decreased adiponectin levels and litter size when compared to C-HF (p &lt; 0.02 HF-C vs C-HF). Independent of the timing of exposure to HF, fetal weight and length were significantly decreased when compared to C diet (HF, C-HF and HF-C vs. C p &lt; 0.02). HF diet during the second half of pregnancy increased expression of genes in the fetal liver associated with fetal growth (C-HF vs C p &lt; 0.001), glucose production (C-HF vs C p &lt; 0.04), oxidative stress and inflammation (C-HF vs C p &lt; 0.01) compared to C diet.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This model defines that there are critical periods during gestation in which the fetus is actively shaped by the environment. Early exposure to a HF diet determines litter size while exposure to HF during the second half of pregnancy leads to dysregulation of expression of key genes responsible for fetal growth, hepatic glucose production and oxidative stress. These findings underscore the importance of future studies designed to clarify how these critical periods may influence future risk of developing MetS later in life.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Plata</LastName>
                    <ForeName>Maria Del</ForeName>
                    <Initials>MD</Initials>
                </Author>
                <Author>
                    <LastName>Williams</LastName>
                    <ForeName>Lyda</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Seki</LastName>
                    <ForeName>Yoshinori</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Hartil</LastName>
                    <ForeName>Kirsten</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Kaur</LastName>
                    <ForeName>Harpreet</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>Chia-Lei</ForeName>
                    <Initials>CL</Initials>
                </Author>
                <Author>
                    <LastName>Fiallo</LastName>
                    <ForeName>Ariana</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Glenn</LastName>
                    <ForeName>Alan S</ForeName>
                    <Initials>AS</Initials>
                </Author>
                <Author>
                    <LastName>Katz</LastName>
                    <ForeName>Ellen B</ForeName>
                    <Initials>EB</Initials>
                </Author>
                <Author>
                    <LastName>Fuloria</LastName>
                    <ForeName>Mamta</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Charron</LastName>
                    <ForeName>Maureen J</ForeName>
                    <Initials>MJ</Initials>
                </Author>
                <Author>
                    <LastName>Vuguin</LastName>
                    <ForeName>Patricia M</ForeName>
                    <Initials>PM</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Reprod Biol Endocrinol</MedlineTA>
            <NlmUniqueID>101153627</NlmUniqueID>
            <ISSNLinking>1477-7827</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1477-7827-12-80</ArticleId>
            <ArticleId IdType="doi">10.1186/1477-7827-12-80</ArticleId>
            <ArticleId IdType="pubmed">25135621</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135600</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-1971</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pediatric cardiology</Title>
                <ISOAbbreviation>Pediatr Cardiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>CCN1 Mutation is Associated with Atrial Septal Defect.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The genetic basis of congenital heart disease remains unknown in most of the cases. Recently, a novel mouse model shed new light on the role of CCN1/CYR61, a matricellular regulatory factor, in cardiac morphogenesis. In a candidate gene approach, we analyzed a cohort of 143 patients with atrial septal defects (ASD) by sequencing the coding exons of CCN1. In addition to three frequent polymorphisms, we identified an extremely rare novel heterozygous missense mutation (c.139C??&gt;??T; p.R47W) in one patient with severe ASD. The mutation leads to an exchange of residues with quite different properties in a highly conserved position of the N-terminal insulin-like growth factor binding protein module. Further bioinformatic analysis, exclusion of known ASD disease genes as well as the exclusion of the mutation in a very high number of ethnically matched controls (more than 1,000 individuals) and in public genetic databases, indicates that the p.R47W variant is a probable disease-associated mutation. The report about ASD in mice in heterozygous Ccn 1 +/- animals strongly supports this notion. Our study is the first to suggest a relationship between a probable CCN1 mutation and ASD. Our purpose here was to draw attention to CCN1, a gene that we believe may be important for genetic analysis in patients with congenital heart disease.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Perrot</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Cardiovascular Genetics, Experimental &amp; Clinical Research Center (ECRC), a joint cooperation between the Charit?? Medical Faculty and the Max-Delbr??ck Center for Molecular Medicine, Charit??-Universit??tsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany, andreas.perrot@charite.de.</Affiliation>
                </Author>
                <Author>
                    <LastName>Schmitt</LastName>
                    <ForeName>Katharina R</ForeName>
                    <Initials>KR</Initials>
                </Author>
                <Author>
                    <LastName>Roth</LastName>
                    <ForeName>Eva-Maria G</ForeName>
                    <Initials>EM</Initials>
                </Author>
                <Author>
                    <LastName>Stiller</LastName>
                    <ForeName>Brigitte</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Posch</LastName>
                    <ForeName>Maximilian G</ForeName>
                    <Initials>MG</Initials>
                </Author>
                <Author>
                    <LastName>Browne</LastName>
                    <ForeName>Edmund N L</ForeName>
                    <Initials>EN</Initials>
                </Author>
                <Author>
                    <LastName>Timmann</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Horstmann</LastName>
                    <ForeName>Rolf D</ForeName>
                    <Initials>RD</Initials>
                </Author>
                <Author>
                    <LastName>Berger</LastName>
                    <ForeName>Felix</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Ozcelik</LastName>
                    <ForeName>Cemil</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Pediatr Cardiol</MedlineTA>
            <NlmUniqueID>8003849</NlmUniqueID>
            <ISSNLinking>0172-0643</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00246-014-1001-8</ArticleId>
            <ArticleId IdType="pubmed">25135600</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135599</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-6903</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurochemical research</Title>
                <ISOAbbreviation>Neurochem. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Behavioral and Neurochemical Changes Induced by Repetitive Combined Treatments of Ketamine and Amphetamine in Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The combined abuse of recreational drugs such as ketamine (Ket) and amphetamine (Amph) should be seriously considered important social and health issues. Numerous studies have documented the behavioral and neurochemical changes associated with polydrug administration; however, most studies have only examined the acute effects. The consequences following chronic repetitive polydrug use are less studied. In the present study, intraperitoneal injections of saline, Amph (5??mg/kg), low dose Ket (LK, 10??mg/kg), high dose Ket (HK, 50??mg/kg), or Amph plus LK or HK (ALK or AHK) were conducted twice a day for three consecutive days, and one final treatment was administered on day 4. After seven total treatments, animal behaviors, including locomotion, stereotypy and ataxia, were examined in a novel open field. The expression of GAD67 and dopamine (DA) levels were assessed in the striatum and motor-related cortices using immunohistochemistry and high-performance liquid chromatography. Drug-induced hyperactivities and Amph-mediated potentiation of Ket-triggered ataxia manifested after repeated drug treatments. A significant increase in the number of GAD67-positive puncta in the striatum and motor-related cortices was observed, suggesting a neural adaptive change in the GABAergic system. Four hours after the final treatment, while the behavioral hyperactivities had ceased, considerable changes were still evident in the motor-related cortices, suggesting modulation to the DAergic system. Together, our results show the interactive effects of these two drugs in behavioral and neurochemical aspects and neural adaptive changes in the GABAergic and DAergic systems.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lai</LastName>
                    <ForeName>Chuan-Ching</ForeName>
                    <Initials>CC</Initials>
                    <Affiliation>Graduate Institute of Anatomy and Cell Biology, College of Medicine, National Taiwan University, No. 1, Section??1, Ren-Ai Rd, Taipei, 100, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Li-Jen</ForeName>
                    <Initials>LJ</Initials>
                </Author>
                <Author>
                    <LastName>Yin</LastName>
                    <ForeName>Hsiang-Shu</ForeName>
                    <Initials>HS</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurochem Res</MedlineTA>
            <NlmUniqueID>7613461</NlmUniqueID>
            <ISSNLinking>0364-3190</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11064-014-1419-7</ArticleId>
            <ArticleId IdType="pubmed">25135599</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135573</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1759-5037</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature reviews. Endocrinology</Title>
                <ISOAbbreviation>Nat Rev Endocrinol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Thyroid hormone receptors and resistance to thyroid hormone disorders.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/nrendo.2014.143</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Thyroid hormone action is predominantly mediated by thyroid hormone receptors (THRs), which are encoded by the thyroid hormone receptor ?? (THRA) and thyroid hormone receptor ?? (THRB) genes. Patients with mutations in THRB present with resistance to thyroid hormone ?? (RTH??), which is a disorder characterized by elevated levels of thyroid hormone, normal or elevated levels of TSH and goitre. Mechanistic insights about the contributions of THR?? to various processes, including colour vision, development of the cochlea and the cerebellum, and normal functioning of the adult liver and heart, have been obtained by either introducing human THRB mutations into mice or by deletion of the mouse Thrb gene. The introduction of the same mutations that mimic human THR?? alterations into the mouse Thra and Thrb genes resulted in distinct phenotypes, which suggests that THRA and THRB might have non-overlapping functions in human physiology. These studies also suggested that THRA mutations might not be lethal. Seven patients with mutations in THR?? have since been described. These patients have RTH?? and presented with major abnormalities in growth and gastrointestinal function. The hypothalamic-pituitary-thyroid axis in these individuals is minimally affected, which suggests that the central T3 feedback loop is not impaired in patients with RTH??, in stark contrast to patients with RTH??.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ortiga-Carvalho</LastName>
                    <ForeName>T??nia M</ForeName>
                    <Initials>TM</Initials>
                    <Affiliation>Instituto de Biof??sica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, S/N, Cidade Universit??ria, 21941-902, Rio de Janeiro, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sidhaye</LastName>
                    <ForeName>Aniket R</ForeName>
                    <Initials>AR</Initials>
                    <Affiliation>Departments of Paediatrics and Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, CMSC 10-113, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wondisford</LastName>
                    <ForeName>Fredric E</ForeName>
                    <Initials>FE</Initials>
                    <Affiliation>Departments of Paediatrics and Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, CMSC 10-113, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Nat Rev Endocrinol</MedlineTA>
            <NlmUniqueID>101500078</NlmUniqueID>
            <ISSNLinking>1759-5029</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">nrendo.2014.143</ArticleId>
            <ArticleId IdType="doi">10.1038/nrendo.2014.143</ArticleId>
            <ArticleId IdType="pubmed">25135573</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135492</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-2661</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Research in veterinary science</Title>
                <ISOAbbreviation>Res. Vet. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immunogenicity of recombinant BCGs expressing predicted antigenic epitopes of bovine viral diarrhea virus E2 gene.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0034-5288(14)00205-7</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.rvsc.2014.07.004</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">To develop a vaccine to prevent diseases caused by Mycobacterium tuberculosis and bovine viral diarrhea virus (BVDV) simultaneously, recombinant Bacillus Calmette-Guerin (rBCG) vaccines expressing different regions of the BVDV E2 gene were constructed. Using DNASTAR 6.0 software, potential antigenic epitopes were predicted, and six regions were chosen to generate recombinant plasmids with the pMV361 vector (pMV361-E2-1, pMV361-E2-2, pMV361-E2-3, pMV361-E2-4, pMV361-E2-5 and pMV361-E2-6, respectively). The recombinant plasmids were transformed into BCG, and protein expression was thermally induced at 45?????C. Mice were immunized with 5????????10(6) CFU/200?????L of each rBCG strain. Compared with other groups, BVDV E2 specific antibody titers were higher in mice immunized with rBCG-E2-6. Ratios and numbers of CD4+, CD8+ and IL-12 expressing spleen lymphocytes of the rBCG-E2-6 group also were higher than those of other groups. Thus, the rBCG-E2-6 vaccine showed the highest immunogenicity of all groups based on the humoral and cellular responses to vaccination.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Dongxu</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>College of Chinese Medicine Material, Jilin Agricultural University, Changchun 130118, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lu</LastName>
                    <ForeName>Huijun</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Institute of Military Veterinary, Academy of Military Medical Sciences, Changchun 130122, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shi</LastName>
                    <ForeName>Kun</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>College of Chinese Medicine Material, Jilin Agricultural University, Changchun 130118, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Su</LastName>
                    <ForeName>Fengyan</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>College of Chinese Medicine Material, Jilin Agricultural University, Changchun 130118, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Jianming</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>College of Chinese Medicine Material, Jilin Agricultural University, Changchun 130118, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Du</LastName>
                    <ForeName>Rui</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>College of Chinese Medicine Material, Jilin Agricultural University, Changchun 130118, China. Electronic address: durui197107@sina.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Res Vet Sci</MedlineTA>
            <NlmUniqueID>0401300</NlmUniqueID>
            <ISSNLinking>0034-5288</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antigen site</Keyword>
            <Keyword MajorTopicYN="N">BVDV</Keyword>
            <Keyword MajorTopicYN="N">Immunogenicity</Keyword>
            <Keyword MajorTopicYN="N">Recombinant BCG vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0034-5288(14)00205-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.rvsc.2014.07.004</ArticleId>
            <ArticleId IdType="pubmed">25135492</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135485</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1477-3155</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>12</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of nanobiotechnology</Title>
                <ISOAbbreviation>J Nanobiotechnology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transient extracellular application of gold nanostars increases hippocampal neuronal activity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>31</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">BackgroundWith the increased use of nanoparticles in biomedical applications there is a growing need to understand the effects that nanoparticles may have on cell function. Identifying these effects and understanding the mechanism through which nanoparticles interfere with the normal functioning of a cell is necessary for any therapeutic or diagnostic application. The aim of this study is to evaluate if gold nanoparticles can affect the normal function of neurons, namely their activity and coding properties.ResultsWe synthesized star shaped gold nanoparticles of 180??nm average size. We applied the nanoparticles to acute mouse hippocampal slices while recording the action potentials from single neurons in the CA3 region. Our results show that CA3 hippocampal neurons increase their firing rate by 17% after the application of gold nanostars. The increase in excitability lasted for as much as 50??minutes after a transient 5??min application of the nanoparticles. Further analyses of the action potential shape and computational modeling suggest that nanoparticles block potassium channels responsible for the repolarization of the action potentials, thus allowing the cell to increase its firing rate.ConclusionsOur results show that gold nanoparticles can affect the coding properties of neurons by modifying their excitability.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Salinas</LastName>
                    <ForeName>Kirstie</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Kereselidze</LastName>
                    <ForeName>Zurab</ForeName>
                    <Initials>Z</Initials>
                </Author>
                <Author>
                    <LastName>DeLuna</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Peralta</LastName>
                    <ForeName>Xomalin G</ForeName>
                    <Initials>XG</Initials>
                </Author>
                <Author>
                    <LastName>Santamaria</LastName>
                    <ForeName>Fidel</ForeName>
                    <Initials>F</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Nanobiotechnology</MedlineTA>
            <NlmUniqueID>101152208</NlmUniqueID>
            <ISSNLinking>1477-3155</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">s12951-014-0031-y</ArticleId>
            <ArticleId IdType="doi">10.1186/PREACCEPT-7863745011292633</ArticleId>
            <ArticleId IdType="pubmed">25135485</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135478</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5549</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular and cellular biology</Title>
                <ISOAbbreviation>Mol. Cell. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>TPC1 has two variant isoforms and their removal has different effects on endo-lysosomal functions compared to loss of TPC2.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">MCB.00113-14</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Organelle ion homeostasis within the endo-lysosomal system is critical for physiological functions. TPCs (Two-Pore Channels) are cation channels that reside in endo-lysosomal organelles and over-expression results in endo-lysosomal trafficking defects. However, the impact of lack of TPC expression on endo-lysosomal trafficking is unknown. Here, we characterize Tpcn1 expression in two transgenic mouse lines (Tpcn1(XG716) and Tpcn1(T159)) and show expression of a novel evolutionarily conserved Tpcn1B transcript from an alternative promoter, raising important questions regarding the status of Tpcn1 expression in mice recently described as Tpcn1 knockouts. We show that the transgenic Tpcn1(T159) line lacks expression of both Tpcn1 isoforms in all tissues analysed. Using mouse embryonic fibroblasts (MEFs) from Tpcn1(-/-) and Tpcn2(-/-) animals we show that lack of Tpcn1 or Tpcn2 expression has no significant impact on resting endo-lysosomal pH or morphology. However, differential effects were observed in endo-lysosomal function upon loss of Tpcn1 or Tpcn2 expression; thus, while Tpcn1(-/-) MEFs have impaired trafficking of cholera toxin from the plasma membrane to the Golgi, Tpcn2(-/-) MEFs show slower kinetics of ligand-induced PDGFR?? degradation, which is dependent on trafficking to lysosomes. Our findings indicate that TPC1 and TPC2 have important, but distinct roles in the endo-lysosomal pathway.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ruas</LastName>
                    <ForeName>Margarida</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Pharmacology, Oxford University, UK margarida.ruas@pharm.ox.ac.uk john.parrington@pharm.ox.ac.uk.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chuang</LastName>
                    <ForeName>Kai-Ting</ForeName>
                    <Initials>KT</Initials>
                    <Affiliation>Department of Pharmacology, Oxford University, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Davis</LastName>
                    <ForeName>Lianne C</ForeName>
                    <Initials>LC</Initials>
                    <Affiliation>Department of Pharmacology, Oxford University, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Al-Douri</LastName>
                    <ForeName>Areej</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Pharmacology, Oxford University, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tynan</LastName>
                    <ForeName>Patricia W</ForeName>
                    <Initials>PW</Initials>
                    <Affiliation>Department of Pharmacology, Oxford University, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tunn</LastName>
                    <ForeName>Ruth</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Pharmacology, Oxford University, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Teboul</LastName>
                    <ForeName>Lydia</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>The Mary Lyon Centre, MRC Harwell, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Galione</LastName>
                    <ForeName>Antony</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Pharmacology, Oxford University, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Parrington</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Pharmacology, Oxford University, UK margarida.ruas@pharm.ox.ac.uk john.parrington@pharm.ox.ac.uk.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Cell Biol</MedlineTA>
            <NlmUniqueID>8109087</NlmUniqueID>
            <ISSNLinking>0270-7306</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">MCB.00113-14</ArticleId>
            <ArticleId IdType="doi">10.1128/MCB.00113-14</ArticleId>
            <ArticleId IdType="pubmed">25135478</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135476</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5549</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular and cellular biology</Title>
                <ISOAbbreviation>Mol. Cell. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Regulation of the Death-Associated Protein Kinase-1 expression and Autophagy via ATF6 Requires Apoptosis Signal-Regulating Kinase-1.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">MCB.00397-14</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The death-associated protein kinase 1 (DAPK1) is an important regulator of cell death and autophagy. Recently we have identified that ATF6, an ER resident transcription factor, in association with the transcription factor CEBP-?? regulates the IFN-??-induced expression of Dapk1. IFN-??-induced proteolytic processing of ATF6 and phosphorylation of C/EBP-?? were essential for the formation of a novel transcriptional complex that regulates DAPK1. Here we report that IFN-?? activates ASK1-MKK3/MKK6-p38MAP kinase pathway for controlling the activity of ATF6. The terminal enzyme in this pathway, p38MAP kinase, phosphorylates a critical threonine residue in ATF6, upstream of its DNA binding domain. ATF6 mutants defective for p38 MAPK phosphorylation fail to undergo proteolytic processing in the Golgi, drive IFN-?? induced gene expression and autophagy. We also show that mice lacking Ask1 are highly susceptible to lethal bacterial infection owing to defective autophagy. Together, these results identify a novel host-defense pathway controlled by IFN-?? signaling.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Gade</LastName>
                    <ForeName>Padmaja</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Departments of Microbiology and Immunology &amp; Medicine, University of Maryland School of Medicine, Greenebaum Cancer, Baltimore, MD 21201.</Affiliation>
                </Author>
                <Author>
                    <LastName>Manjegowda</LastName>
                    <ForeName>Srikanta B</ForeName>
                    <Initials>SB</Initials>
                    <Affiliation>Departments of Microbiology and Immunology &amp; Medicine, University of Maryland School of Medicine, Greenebaum Cancer, Baltimore, MD 21201.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nallar</LastName>
                    <ForeName>Shreeram C</ForeName>
                    <Initials>SC</Initials>
                    <Affiliation>Departments of Microbiology and Immunology &amp; Medicine, University of Maryland School of Medicine, Greenebaum Cancer, Baltimore, MD 21201.</Affiliation>
                </Author>
                <Author>
                    <LastName>Maachani</LastName>
                    <ForeName>Uday B</ForeName>
                    <Initials>UB</Initials>
                    <Affiliation>Departments of Microbiology and Immunology &amp; Medicine, University of Maryland School of Medicine, Greenebaum Cancer, Baltimore, MD 21201.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cross</LastName>
                    <ForeName>Alan S</ForeName>
                    <Initials>AS</Initials>
                    <Affiliation>Departments of Microbiology and Immunology &amp; Medicine, University of Maryland School of Medicine, Greenebaum Cancer, Baltimore, MD 21201.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kalvakolanu</LastName>
                    <ForeName>Dhananjaya V</ForeName>
                    <Initials>DV</Initials>
                    <Affiliation>Departments of Microbiology and Immunology &amp; Medicine, University of Maryland School of Medicine, Greenebaum Cancer, Baltimore, MD 21201 dkalvako@umaryland.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Cell Biol</MedlineTA>
            <NlmUniqueID>8109087</NlmUniqueID>
            <ISSNLinking>0270-7306</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">MCB.00397-14</ArticleId>
            <ArticleId IdType="doi">10.1128/MCB.00397-14</ArticleId>
            <ArticleId IdType="pubmed">25135476</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135473</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0127</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>21</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of biomedical science</Title>
                <ISOAbbreviation>J. Biomed. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evaluation of Gram-negative bacterial infection by a stable and conjugative bioluminescence plasmid in a mouse model.</ArticleTitle>
            <Pagination>
                <MedlinePgn>78</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">BackgroundThe green fluorescence protein (GFP)-associated fluorescence method and the luciferase-associated bioluminescence method are the two major methods for IVIS imaging system to investigate the bacterial infection in animal models. The aim of this study was to evaluate the infection route of Gram-negative bacteria carrying a stable and broad range of conjugative bioluminescence plasmid pSE-Lux1 in a mouse model.ResultsBoth encapsulated and non-encapsulated Gram-negative bacteria were used as hosts to evaluate conjugation efficiency and plasmid stability of pSE-Lux1, a recombinant of pSE34 and luxABCDE operon. The plasmid conjugation efficiencies of pSE-Lux1 ranged from 10??3 to 10??7 in various Gram-negative bacteria. Plasmid pSE-Lux1 maintained in Escherichia coli, Klebsiella pneumoniae, and Salmonella enterica serovars Choleraesues (abbreviated S. Choleraesuis) and Typhimurium (S. Typhimurium), than in Acinetobacter baumannii and Serratia marcescens, was shown to be of better stability for at least four days. To investigate systemic bacterial infections, K. pneumoniae T strain CG354 was intravenous injected and was non-pathogenic to Balb/c mice for a long-term bioluminescence monitoring for 6??days. For examining dynamic distributions of gastrointestinal tract infection, the invasion protein SipB-deficient mutant OU5045??sipB and OU5046??sipB of Salmonella enterica serovar Typhimurium constructed in this study, compared to wild-type strain OU5045 and its virulence plasmid-less strain OU5046, were of less virulence to mice.ConclusionsThis is the first study to evaluate the conjugative and stable bioluminescence vehicle system of pSE-Lux1 in a wide range of Gram-negative bacteria, which system can provide a useful reporter approach to trace systemic and gastrointestinal bacterial infections in a mouse model.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Yao-Kuang</ForeName>
                    <Initials>YK</Initials>
                </Author>
                <Author>
                    <LastName>Chu</LastName>
                    <ForeName>Chishih</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Chih-Hsiung</ForeName>
                    <Initials>CH</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Chyi-Liang</ForeName>
                    <Initials>CL</Initials>
                </Author>
                <Author>
                    <LastName>Chiu</LastName>
                    <ForeName>Cheng-Hsun</ForeName>
                    <Initials>CH</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Biomed Sci</MedlineTA>
            <NlmUniqueID>9421567</NlmUniqueID>
            <ISSNLinking>1021-7770</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">s12929-014-0078-y</ArticleId>
            <ArticleId IdType="doi">10.1186/s12929-014-0078-y</ArticleId>
            <ArticleId IdType="pubmed">25135473</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
